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 Impaired lipid metabolism at rest has been linked to the development of insulin resistance 
and an attenuation of plasma concentration of the hormone adiponectin.  However, it has been 
suggested that increasing fatty acid oxidation at rest, via exercise or otherwise, may increase 
plasma adiponectin.  The current literature addressing changes substrate utilization and possible 
direct effects on adiponectin during and following exercise is not well established.  Therefore, 
the purpose of this dissertation was to examine concomitant changes in adiponectin and substrate 
utilization both at rest and during various exercise modalities, as this may provide implications 
for improving metabolic responses and in turn, affect insulin sensitivity.  Pre-, mid-, and post-
exercise measurements were obtained for five separate studies.  Each study incorporated a single, 
unique exercise modality, which included: acute aerobic, chronic aerobic, acute resistance, 
chronic resistance, or acute stretching exercise.  Chronic resistance training significantly 
increased adiponectin levels, although resting substrate utilization did not significantly change 
pre- to post-exercise.  All acute exercise modalities significantly increased glucose utilization 
during exercise.  However, none of the acute exercise modalities nor the chronic aerobic exercise 
modality elicited significant changes in adiponectin.  First degree family history of type 2 
diabetes mellitus had a significant inverse correlation with adiponectin concentration, whereas 
regular aerobic exercise had a significant direct correlation with adiponectin.  Body fat 
percentage and body mass index did not have significant inverse correlations with adiponectin.  
These results suggest that substrate utilization does not directly affect adiponectin concentration 
and that the regulation of this hormone is likely dependent on other factors.  The results do, 
however, highlight the importance of implementing a chronic exercise training program to limit 




CHAPTER 1. INTRODUCTION 
 1.1 Overview 
Regardless of the type, intensity, or duration of exercise, chronic has irrefutably been 
shown to help to prevent, or at least limit several health disparities including, but not limited to 
cardiovascular disease, cancer, obesity, and diabetes (1).  The underlying biological mechanisms 
responsible for the improvements in health parameters as a result of exercise are not fully 
understood.  Some of the possible metabolic mechanisms associated with lipid-induced insulin 
resistance and the reversal of insulin resistance following exercise are discussed in depth in 
Appendix 1.  Determining the role of specific mechanisms associated with improvements in 
insulin sensitivity, fitness, and overall health is critical to strengthen the evidence for 
implementing specific exercise prescriptions among healthy and diseased populations. 
Acute exercise, defined as a single bout of exercise, can elicit changes in the molecular 
biology, biochemistry, and physiology of the human body.  Acute exercise studies have 
demonstrated changes in the expression of several genes (2, 3), the expression of lipid and 
glucose metabolites (4), increased expression of some inflammatory markers, (5) and decreased 
the expression of other inflammatory markers (6).  Acute exercise also causes a variety of 
vascular, neural, metabolic, and endocrine responses (7).   
Chronic exercise, defined as consistently repeated acute exercise bouts over a given 
period of time, yields adaptations which are much different to those seen following an acute 
exercise bout.  The adaptations which occur at the molecular, biochemical, and physiological 
level following chronic exercise are primarily due to the cumulative effects of repeated acute 
exercise responses (7), and therefore, distinctions must be made between adaptations to chronic 
exercise and responses to acute exercise.  While each response and adaptation to exercise is 
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important and evidently interdependent, the focus of this dissertation is centered on the 
physiological aspects, specifically the metabolic and endocrine responses and adaptations to 
various exercise modalities.   
Metabolic activity in the human body is highly regulated and dependent on several feed-
forward and feedback mechanisms which are activated by numerous external and internal 
environmental cues.  The external cue of physical inactivity can lead to impaired substrate (lipid, 
carbohydrate, or amino acid) metabolism and negatively affect exercise performance as well as 
energy homeostasis and insulin sensitivity (8-10).  Much like exercise, acute and chronic 
inactivity results in numerous responses and adaptations via changes in molecular biology, 
biochemistry, and physiology.  The external cue of exercise, on the other hand, has been shown 
to improve energy homeostasis and reverse several metabolic impairments in glucose 
metabolism (11-13) and lipid metabolism (14-16) as seen in insulin resistant (17) and diabetic 
patients (18, 19). 
Changes in substrate metabolism have been demonstrated during and following acute 
aerobic exercise studies (16, 20-22), chronic aerobic exercise studies (23, 24), acute resistance 
exercise studies (25, 26), chronic resistance exercise studies (12, 13, 27), and combined exercise 
studies (28, 29).  Some studies have shown increases in glucose oxidation (30), while others have 
shown decreases in glucose oxidation (31).  Some studies have shown increases in fat oxidation 
(32), some have shown no increases in fat oxidation (33), and others have shown increases in 
both glucose and fat oxidation (4).  These equivocal results have made it difficult to identify the 




Similarly, the variability in the adipose tissue-derived hormone, adiponectin, responses 
have been highly variable following exercise.  Adiponectin has been shown to play an important 
role in insulin sensitivity as well as glucose and lipid metabolism (2), thus changes in 
adiponectin should theoretically be seen as a result of changes in substrate utilization.  Currently 
however, there are few studies that have examined the role of substrate utilization on plasma 
adiponectin during and following exercise.  Several studies have examined changes in glucose 
kinetics (12, 30) and free fatty acid (FFA) oxidation (14, 34) following exercise; though, none 
have measured these changes concomitantly with changes in plasma adiponectin nor compared 
the differences in plasma adiponectin concentration following aerobic versus resistance training 
exercise.  The effects of any type of exercise on the expression of adiponectin have shown 
variable results.  Some suggest exercise yields increased adiponectin levels following acute (35) 
or chronic training (36), while other studies suggest no change following acute (37) or chronic 
training (38). 
Due to the variability in methodology and analysis between these studies, it has been 
difficult to establish which variables play the most significant roles in altering substrate 
utilization and improving insulin sensitivity. Not only can the measurement technique (gas 
analysis, tracers, biopsy) and experimental model (cell cultures, animal models, humans) affect 
the results of a study, but gender, training status, diet, muscle fiber type, muscle glycogen and 
lipid content, exercise intensity, exercise duration, exercise type, all affect substrate metabolism 
differently during and following exercise, making it difficult to compare the effects between 
studies.  Exercise intensity and intramuscular glycogen and fat stores have been studied 
extensively and have been shown to greatly affect substrate utilization and exercise performance 
(4); however, further research is needed to determine the role of various exercise modalities on 
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substrate utilization.  It is currently unknown if a specific form of exercise, or exercise modality, 
generates superior changes compared to other modalities.  Therefore the focus of this dissertation 
was on exercise modality, which included acute aerobic, acute resistance, chronic aerobic, 
chronic resistance, and acute stretching exercise.  
Purpose: 
The purpose of this dissertation was to:  
1.) Examine changes in substrate metabolism during and following various 
exercise training modalities to determine how specific exercise modalities 
affect fuel utilization during and following exercise. 
2.) Examine changes in adiponectin levels following various exercise training 
modalities to determine if adiponectin is directly linked to changes in substrate 
metabolism and determine if altered substrate utilization (via supplementation) 
directly affects plasma adiponectin concentration. 
3.) Provide implications for which modality, if any, produces the greatest changes 
and how these changes may lead to improved exercise performance and insulin 
sensitivity.    
1.2 Substrate Metabolism 
Acute Exercise 
A single bout of exercise is known to affect systemic metabolism and consequently cause 
a shift in energy homeostasis in an intensity-dependent fashion (30, 39).  Adiponectin has been 
implicated in the regulation of energy homeostasis, which suggests that substrate metabolism 
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may be tightly linked with adiponectin concentration.  Numerous factors contribute to the shift in 
energy homeostasis following acute exercise; however, the likely initial factor is a result of 
skeletal muscle contraction.  Muscle contraction, whether through resistance or aerobic exercise 
mitigates the adenosine triphosphate / adenosine monophosphate (ATP/AMP) ratio, which in 
turn activates 5’ AMP activated protein kinase (AMPK) (40).  The extent of AMPK activation 
appears to be directly related to exercise intensity (40, 41).  Higher exercise intensity yields a 
lower ATP/AMP ratio, greater AMPK activation, and thus, greater substrate oxidation.  
Numerous studies have suggested AMPK phosphorylates and inhibits acetyl-CoA carboxylase 
(ACC), which inhibits the production of malonyl-CoA and relieves the inhibition of carnitine 
palmitoyltransferase 1 (CPT1) to transport long-chain fatty acids into the mitochondria to allow 
increased FA oxidation (40).  AMPK also increases skeletal muscle glucose uptake, increases 
citrate levels, and increases levels of nicotinamide adenine dinucleotide (NAD
+)
 and Sirtuin-1 
(SIRT-1), both of which increase peroxisome proliferator-activated receptor gamma coactivator 
1-alpha (PGC-1α) expression.  Some studies have suggested that SIRT-1 may regulate the 
expression of adiponectin (42) via NAD
+
 (43) further supporting the notion that exercise-induced 
changes in substrate metabolism can alter plasma adiponectin.  Chronically, this signaling 
cascade acts to induce mitochondrial biogenesis, improve glucose and lipid transport, and in turn, 
alter substrate utilization and protect against insulin resistance (40, 41).  Thus, the intensity-
dependent shift in energy balance appears to be dependent on the activation of AMPK and its 
subsequent signaling cascade. 
Muscle contraction also induces calcium release from the sarcoplasmic reticulum, which 
in turn, activates calcineurin (40).  Calcineurin has been shown to up-regulate the expression of 
insulin receptor, protein kinase B (Akt), glucose transporter type 4 (GLUT-4), and PGC-1α 
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expression in the glycolytic extensor digtorum longus (EDL) muscle of transgenic mice given a 
high fat diet (44), indicating increased substrate oxidation in skeletal muscle.  In normal 
functioning muscle cells, calcineurin is activated by increased levels of cytoplasmic calcium, 
thus, muscle contraction alone does indeed improve insulin sensitivity and glucose uptake via an 
insulin-independent mechanism.  Adiponectin appears to up-regulate the expression of several of 
these signaling molecules involved in acute muscle contraction and improved insulin sensitivity 
(45); however, the current literature examining acute muscle contraction and changes in plasma 
adiponectin are equivocal and will be discussed further in the next section.  
Exercise is the product of continually repeated muscle contraction and as a result of this 
repeated contraction, the associated signaling cascade and the replenishment of ATP is amplified 
to meet the necessary energy demands.  ATP replenishment is achieved via the creatine 
phosphate pathway, anaerobic glycolysis, glucose oxidation, amino acid deamination, or FFA 
oxidation (7).  Untrained individuals participating in less than one hour of moderate- to high-
intensity aerobic exercise are highly dependent on blood glucose to provide fuel for the increased 
energy demand (46).  In fact, it has been shown that glucose oxidation may account for 30-50% 
of substrate metabolism during exercise in untrained populations (47).  During short-duration 
exercise, blood glucose is replenished 3-5 fold by liver glycogenolysis, and glucose uptake is 
increased 20-35 fold.  Exercise intensity and duration appear to have a direct linear relationship 
with the extent of glucose uptake as a result of the muscle contraction signaling cascade 
described above.  A greater percentage of glucose uptake has been observed with shorter 
duration, higher intensity exercise  (46).  Thus, performance during short-duration, high-intensity 
aerobic exercise in untrained individuals is highly dependent on glucose oxidation (11).  Not 
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surprisingly, this type of exercise has been shown to be effective in improving insulin sensitivity 
(48). 
The role of fat metabolism during and following short-duration acute aerobic exercise; 
however, is quite complex and should not be overlooked.  Coggan et al. (16) demonstrated a 
small, but significant percentage of fat is oxidized during 30 minutes of high-intensity aerobic 
exercise (75-80% VO2 max) in recreationally active individuals.  This finding suggests that if the 
ability to utilize fat becomes impaired, then exercise performance may be compromised for both 
trained and untrained individuals, even for short-duration, high-intensity aerobic exercise.  
Similarly, 30 minutes of resistance training has been shown to activate lipolysis, the degree of 
which is dependent on the availability of  intramyocellular lipids (IMCL) (4).  The authors 
suggested that if IMCL stores are available, they will be utilized regardless of exercise intensity 
in order to spare muscle glycogen.  More recently, Koopman et al. (26) found that IMCL content, 
as well as muscle glycogen content, significantly decreased following 45 minutes of high-
intensity resistance training.  The authors suggested that both lipid and glucose oxidation are 
important for exercise performance and improved insulin sensitivity but that substrate utilization 
is dependent upon muscle fiber type.   
Thus substrate oxidation may be more dependent on availability than intensity.  This 
notion is supported by the idea that although the body primarily oxidizes substrates during acute 
exercise, a single aerobic exercise session has been shown to augment IMCL synthesis, 
particularly when fat availability is high (22), and consequently prevents the accumulation of 
deleterious metabolites such as diacylglycerol (DAG) and ceramides, which are known to 
activate pro-inflammatory pathways associated with insulin resistance.  Similar results have been 
seen in rats.  When given the drug Thiazolidinedione, IMCL synthesis increased while 
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metabolite accumulation decreased and subsequent pro-inflammatory pathways were inactivated 
(49), suggesting that an acute bout of aerobic exercise can act to down-regulate pro-
inflammatory pathways (21).  Given that the pro-inflammatory cytokine, tumor necrosis factor- 
alpha (TNF-α) has antagonistic effects to adiponectin, these findings further suggest that 
adiponectin expression is up-regulated following acute aerobic exercise, which is supported by 
some studies (35), but not others (37), thus further research is still necessary.   
It is currently unknown if acute stretching has similar effects on lipid metabolism to those 
seen with resistance training.  Recent studies have demonstrated that stretching exercise elicits 
many of the same benefits of resistance training including increased flexibility and maintained 
strength (50), improved exercise performance (51), and improved glucose transport (52).  Acute 
resistance training exercise has been shown to increase lipid oxidation for up to 24 hours post-
exercise, but it is unknown if stretching yields similar results.   Acute resistance training has also 
been shown to improve insulin sensitivity via improvements in glucoregulatory function (44) and 
lipid metabolism (40).  It is likely that the mechanisms responsible for these changes following 
acute resistance training and the changes following acute stretching exercise are due to different 
mechanisms than those seen following acute aerobic exercise since resistance training is known 
to activate, rather than repress, pro-inflammatory pathways (53).  Thus the expression of 
adiponectin may not be the same with this type of training and deserves further investigation.  
Currently, no studies have examined changes in substrate utilization or adiponectin levels 






It has been clearly demonstrated that chronic aerobic exercise training leads to increases 
in the size and number of mitochondria, in addition to increases in mitochondrial enzymes 
involved in fatty acid oxidation, the citrate cycle, respiratory chain,  ATP synthesis, and insulin 
sensitivity (54).  It has been suggested that these changes are due to muscle fibers switching to 
more oxidative type, increasing mitochondrial density, GLUT-4 concentration, glycogen 
synthase activity (23) and increased reliance on more on IMCL stores for fat oxidation during 
exercise (16).  Even independent of weight loss, exercise seems to elicit improvements in insulin 
sensitivity.  One study involving obese girls showed that twelve weeks of aerobic exercise 
improved insulin sensitivity without any changes in body weight, percent body fat, or markers of 
inflammation (23).  This further suggests that changes such as increased oxidative muscle fiber 
type, increased mitochondrial density, GLUT-4 concentration, and glycogen synthase activity, 
and decreased IMCL are more responsible for changes in insulin signaling as a result of exercise 
rather than changes in hormone and inflammatory signaling seen with acute aerobic exercise 
studies.  These results also imply that adiponectin expression may not change following chronic 
aerobic exercise, which has been demonstrated in some studies (38), but not others (36), thus 
further examination is necessary. 
A lack of physical activity or excess caloric intake leads to excess lipid storage in adipose 
tissue and within skeletal muscle.  This excess lipid storage has been linked to an increased 
reliance on glucose oxidation (55) and increased insulin resistance as reviewed by Samuel et. al 
(56).  Impaired lipid metabolism not only limits aerobic performance during exercise (57), but 
has also been linked to the development of insulin resistance (17).  Impaired FFA oxidation 
during exercise leads to several changes in metabolism including increased reliance on other 
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substrates via muscle and liver glycogenolysis, increased blood glucose utilization, increased 
amino acid deamination, or increased ketogenesis, all of which hasten fatigue and negatively 
affect exercise performance.  Conversely, improved lipid metabolism, as seen following aerobic 
exercise (58), leads to improved exercise performance and improved insulin sensitivity.  
Substrate utilization in working skeletal muscle is highly regulated by several feed-forward and 
feedback mechanisms, many of which are affected as a result of chronic exercise training or lack 
thereof.  Aerobically trained individuals are able to oxidize a high percentage of fat, even during 
high-intensity exercise (58).  This is because aerobic exercise leads to up-regulation in IMCL 
storage, lipolysis, lipid oxidation, improvements in exercise performance (58) and improvements 
in insulin sensitivity, (23).     
Much like chronic aerobic exercise, chronic resistance training augments GLUT-4 
protein, insulin receptor protein, and glycogen synthase protein and activity, thereby improving 
skeletal muscle glucose uptake and glycemic control (12).  This may be partially due to changes 
in muscle fiber type characteristics.  A study on chronically resistance trained powerlifters and 
recreationally active controls observed significant differences in the composition of skeletal 
muscle fibers, with trained lifters demonstrating a greater percentage of type II fibers, suggesting 
that muscle fiber type shifting as a result of chronic resistance training may contribute to changes 
in substrate metabolism during exercise (59).  This hypothesis is supported by another study 
which observed elevated post-prandial carbohydrate oxidation in resistance trained males 
compared to sedentary controls (60).  Area under the curve for both blood glucose and insulin 
(over time) was lower in resistance trained males compared to sedentary males, suggesting better 
insulin sensitivity in the resistance trained group and as previously suggested, the increase in 
type II fiber expression in resistance trained individuals could explain the difference in post-
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prandial carbohydrate metabolism.  Interestingly, resistance training has also been shown to 
attenuate mitochondrial content following chronic high-volume, resistance training (61), due to 
an augmentation in type II fiber area, suggesting a decreased ability to oxidize lipids.  Therefore, 
it can be suggested that the mechanisms responsible for improved insulin sensitivity following 
chronic resistance training are significantly different than those seen following chronic aerobic 
training.   
Chronic resistance training has also shown improvements in glycelated hemoglobin 
(HbA1C levels), (12) insulin sensitivity, and increased levels of adiponectin in diabetic men (62) 
without changes in plasma glucose, insulin, or lipid levels.  This may suggest adiponectin does 
not play a role in changes in substrate utilization following resistance training.  However, a 
recent study showed that augmented levels of adiponectin are associated with improvements in 
fat oxidation and insulin sensitivity and that plasma adiponectin concentration is up-regulated 
with aerobic exercise (35).  Further research is needed to confirm these findings following 
resistance training and to determine if aerobic training is superior to resistance training in terms 
of adiponectin expression. 
1.3 Adiponectin 
Adiponectin is an adipocyte-derived hormone that plays an important role in insulin 
sensitivity as well as glucose and lipid metabolism (2).  There are three different isoforms of 
adiponectin, including low molecular weight (LMW), medium molecular weight (MMW) and 
high molecular weight (HMW).  HMW appears to be the more active form of adiponectin 
compared to MMW or LMW (63) and greater expression of this isoform has been implicated in 
greater insulin sensitivity (64).  However, the HMW form has not been shown to change 
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following exercise in lean, healthy individuals (65) and is not associated with acute 
improvements in insulin-sensitivity (66) whereas total adiponectin has been shown to change 
following exercise in some studies in lean, healthy individuals (67).  All participants for the 
current dissertation were lean and insulin-sensitive and therefore, total, rather than HMW 
adiponectin was measured.  There are two types of adiponectin receptors, AdipoR1 receptors are 
expressed in skeletal muscle cells, AdipoR2 receptors are expressed in skeletal muscle and liver 
cells, and both receptor types are expressed in adipose tissue (68).   
Adiponectin functions to regulate glucose and lipid storage as well as transport and 
oxidation, which in turn, affects and insulin sensitivity (69).  Some research suggests that 
adiponectin mitigates hepatic gluconeogenesis while hepatic glycolysis and glucose uptake are 
unaffected (70).  Other research suggests that adiponectin may act to increase FFA oxidation via 
activation of AMPK, and in turn, reduce the concentration of FFAs in the blood and the 
concentration of lipid metabolites in skeletal muscle and liver (71).  Further research suggests 
that in addition to increased fat oxidation, adiponectin may act to increase lipogenesis and lipid 
transport, and to increase glycolysis.  The liver adiponectin knock-out (KO) mice have 
demonstrated down-regulated mRNA expression of:  glycolytic enzymes, TCA cycle enzymes, 
lipogenic enzymes, fatty acid activation enzymes, and beta-oxidation enzymes (69).  Expectedly, 
the KO mice exhibited less fat accumulation in white adipose tissue (WAT) and lower total body 
weight compared to wild-type (WT) after 16 weeks of high-fat diet (HFD) feeding.  After only 
30 days of HFD, WT and KO mice did not exhibit differences in WAT or skeletal muscle, but 
liver had significantly less lipid droplets due to decreased lipogenesis.  Thus adiponectin appears 
to function as a mediator to clear lipids from plasma via increased β-oxidation through up-
regulation of the AMPK pathway as well as increased expression of rate-limiting enzymes 
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involved in lipogenesis.  The down-regulation of lipogenesis, lipid transport, and oxidation will 
result in delayed clearance of lipids from plasma, which may contribute to the development of 
insulin resistance and lipotoxicitiy associated with low expression of adiponectin.   
Currently, the mechanisms responsible for the regulation of adiponectin are a matter of 
debate.   There are several genetic factors which likely influence adiponectin regulation and 
adipocyte mRNA expression including differences in PGC-1α, nuclear respiratory factor-1 
(NRF1) (72), SIRT-1 (42), and peroxisome proliferator-activated receptor- gamma (PPARγ) (73) 
gene expression, among others.  First degree family history of type 2 diabetes, defined as a first-
degree relative (mother or father) having type 2 diabetes is a major risk factor for the 
development of insulin resistance and type 2 diabetes in the offspring (74).  This risk factor may 
be partially due to differences in several key metabolic genes as mentioned above, but is also 
likely due to lifestyle factors including habitual physical inactivity and poor diet (75).  Further 
investigation is necessary to determine if first degree family of type 2 diabetes is correlated with 
plasma adiponectin concentration.  If so, this correlation could highlight the importance of 
regular physical activity for this population to maintain insulin sensitivity. 
Aside from genetic factors, there are several other proposed mechanisms responsible for 
the regulation of adiponectin.  Despite the apparent role of adiponectin in lipid clearance from 
the blood, postprandial and post-absorptive states do not appear to affect plasma adiponectin 
concentration.  Studies in human models have demonstrated that HMW adiponectin 
concentration fluctuates in healthy, lean males by approximately 40 percent from late night to 
early morning, whereas the fasted versus fed state appears to have no significant effect on 
adiponectin (76).  Therefore, circadian rhythm appears to be involved, at least to some extent, in 
the regulation of adiponectin.  In rats, adiponectin messenger ribonucleic acid (mRNA) was 
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down-regulated following fasting or stimulation of beta-adrenergic receptors in WAT and brown 
adipose tissue (BAT), likely due to a combination of an increased rate of lipolysis, lipid 
transport, and less lipid storage; however, serum adiponectin was unaffected.  Refeeding 
normalized mRNA expression (77), which suggests that insulin may be an agonist to adiponectin 
mRNA expression in the short-term, but insulin does not appear to have an immediate effect on 
plasma protein expression.  Conversely, chronic overfeeding has been shown to down-regulate 
the secretion of adiponectin from the adipocyte (78).  Combined, these results suggest that the 
secretion of adiponectin may be regulated by chronic, rather than acute changes, namely the 
development of insulin resistance in adipocytes.   
Insulin appears to regulate adiponectin mRNA expression in adipocyte cell culture as 
well (79).  In addition, Motoshima et. al (80) suggested that adiponectin secretion from visceral, 
but not subcutaneous, fat in humans is regulated by insulin and correlates with obesity, in vitro.  
Degawa-Yamauchi et al. (78); however, did not find any correlation between serum adiponectin 
and serum insulin, suggesting insulin does not regulate adiponectin expression.  Combined, these 
results may indicate that insulin initiates alterations in mRNA expression; however, protein 
expression of adiponectin may be regulated by unknown secondary mechanisms or as previously 
suggested, the secretion may become impaired in an insulin-resistant state.  
Motoshima et al. (76) also noted that adiponectin secretion from visceral fat was higher 
than from subcutaneous fat, and the secretion of adiponectin from visceral fat had a stronger 
negative correlation with body mass index (BMI) compared to the secretion of adiponectin from 
subcutaneous fat.  This is an apparent paradox given that numerous studies have found negative 
correlations between plasma adiponectin and waist-to-hip ratio (WHR), body fat percentage, and 
BMI (81).  In contrast to these ideas, Degawa-Yamauchi et. al (82) found that subcutaneous 
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adiponectin mRNA negatively correlated with BMI and positively correlated with serum 
adiponectin, while there was no correlation between omental adiponectin mRNA and BMI or 
serum adiponectin.  In addition, the secretion of adiponectin from subcutaneous versus omental 
adipose was not different over a 24 hour period.  These conflicting results demand further 
research.   
Gender differences could potentially explain some of these discrepancies; though, the 
aforementioned studies did not separate results based on gender.  Men generally have more 
omental fat compared to women and tend to have lower levels of adiponectin, although some 
researchers suggest these differences are due to testosterone levels (83).  Another study found 
that growth hormone may act to regulate the expression of adiponectin (84), and still others 
suggest glucocorticoids significantly decrease adiponectin release from subcutaneous, but not 
omental adipose (82).  This suggests that adiponectin is directly regulated by changes in glucose 
metabolism.  Most studies; however, have suggested that hormones, such as leptin, testosterone, 
growth hormone, and cortisol have no correlation with adiponectin (77, 81).  It may be that the 
metabolic state has a greater influence on plasma adiponectin, but this too deserves further 
investigation.  Furthermore, additional research is needed to determine if a first degree family 
history of type 2 diabetes, which is a major risk factor in the development of insulin resistance, 
(74) is linked to lower plasma adiponectin concentration.  
Exercise 
Despite the clear improvements in insulin sensitivity following exercise, study results 
examining the effects of exercise on adiponectin have shown equivocal results.  Most studies 
have demonstrated that HMW form of adiponectin tends to increase with higher intensities or in 
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the presence of weight loss, while no change or a decrease occurs following low- to moderate- 
exercise intensities (85); however, the reasoning for this remains unclear.  It may be partially due 
to the exercise intensity-dependent activation of AMPK and an increased accumulation of NAD
+
 
(41), as this has been shown to increase SIRT-1 expression and in turn, regulate the expression of 
adiponectin (42). 
Exercise appears to elicit changes in the expression of adiponectin receptors, though this 
regulation is a matter of debate.  When a wide range of normal weight, overweight, and obese 
individuals with normal glucose tolerance, impaired glucose tolerance, and type II diabetes were 
placed on a four-week physical training regimen, (2) exercise increased the expression of 
adiponectin and its receptors (AdipoR1 & AdipoR2).  This increased expression may act to 
mediate improvements in insulin sensitivity, glucose metabolism, and lipid metabolism seen as a 
result of exercise.  However, the authors also found that the more insulin resistance that a given 
participant had, the higher the expression of the AdipoR2, regardless of body fat percentage.  In 
an earlier study, this research lab also found that an increased expression of AdipoR1 and 
AdipoR2 mRNA positively associated with obesity, plasma glucose, plasma lipid levels, and 
insulin resistance.  The same four week exercise regimen increased serum adiponectin, and 
AdipoR1 & AdipoR2 mRNA in skeletal muscle.  They also found that three hours of exercise 
was sufficient to increase mRNA expression of AdipoR1 & AdipoR2, phosphorylation of 
AMPK, but did not have an effect on serum adiponectin. (36).  These results suggest that both 
insulin resistance and exercise mediate up-regulation in adiponectin receptor expression, thus 
further research is needed to clarify these findings.   
It is possible that exercise may cause an initial decrease in plasma adiponectin due to 
increased free fatty acid concentration in the plasma, thereby increasing the expression of 
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adiponectin receptor mRNA.  The increased clearance of lipid metabolites from the plasma as a 
result of chronic exercise may be responsible for higher levels of plasma adiponectin and lower 
expression of adiponectin receptors.  This hypothesis is supported by (67) who found that 20 
minutes of rowing in elite male rowers decreased adiponectin immediately post-exercise, but 
adiponectin levels increased above resting levels 30 minutes after exercise.  Conversely, 
adiponectin significantly decreased 30 minutes after exercise in non-elite rowers.  Growth 
hormone, leptin, insulin, and glucose were not different from resting levels, further supporting 
the previously mentioned notion that adiponectin changes independently of these hormones.  The 
initial decrease in adiponectin seen in the elite rowers may have been due to increased lipolysis 
and lipid transport into plasma, while an increase in FFA oxidation and lipid clearance from 
plasma 30 min post-exercise may explain increase in adiponectin, given that trained individuals 
are able to oxidize lipids post-exercise more quickly than untrained individuals.  This study, 
along with a more recent acute aerobic exercise study have shown an increase in adiponectin 
(35), but others (38, 86), have shown no change.  Similarly, chronic aerobic exercise has been 
shown to increase adiponectin (36) or cause no change in adiponectin (38).  Chronic resistance 
training has been shown to increase adiponectin (87) or cause on change in adiponectin (88).  
The acute effects of acute resistance training or stretching on adiponectin are relatively unknown.  
It appears that the regulation of substrate utilization and adiponectin share similar signaling 
molecules and thus, may be dependent on one another.  The combination of these equivocal 
results and the unknown regulation of adiponectin warrant further investigation.   
1.4 Effects of Supplementation  
Several supplements are known to affect exercise performance, substrate utilization, 
plasma glucose concentration, plasma lipid levels, and plasma adiponectin concentration.  
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Therefore, two exercise intervention modalities in the current study incorporated 
supplementation to determine if the combination of a supplement plus exercise would amplify 
the effects of the supplement on exercise performance, substrate utilization, and adiponectin 
concentration.  
Caffeine 
In several studies, caffeine has been shown to enhance fatty acid mobilization from 
adipose tissue, and in turn lower the respiratory exchange ratio (RER) and spare muscle 
glycogen in submaximal acute exercise lasing 30-60 minutes (7, 89).  This mechanism is likely 
due to an increase in catecholamine concentration, which blocks glucose uptake, thereby 
increasing FFA oxidation.  Increased catecholamine release also enhances glucose release from 
the liver and FFA release from adipose tissue (7).  If plasma adiponectin is regulated by plasma 
lipid levels as hypothesized, this supplement should mitigate plasma adiponectin expression. 
Despite the proposed mechanism of increased FFA oxidation with caffeine ingestion, 
some studies have seen no effect of caffeine on aerobic function, RER or FFA uptake into 
skeletal muscle (90-92).  Untrained individuals tested at 75% VO2max elicited no benefit from 
caffeine supplementation (92).  Overall however, caffeine ingestion appears to be effective for 
improving low- to moderate-intensity aerobic exercise performance regardless of training status, 
(93, 94) whereas caffeine ingestion prior to high-intensity exercise may only be beneficial to 
trained athletes (95); however, more studies are needed to verify these outcomes and further 
research is needed to determine whether a caffeine-induced substrate shift is associated with 





Nicotinic acid, also known as niacin, is pharmacologically used to improve cholesterol 
levels by blocking fat breakdown in adipose and liver tissue.  As a consequence of this action, 
very low density lipoprotein (VLDL) formation decreases in the liver, thus less low density 
lipoprotein (LDL) and more high density lipoprotein (HDL) are formed, thereby lowering blood 
lipids (162).  Consequently, this supplement should increase plasma adiponectin concentration, 
and indeed that has been demonstrated (96). 
Recently, Plaisance et al. (92) demonstrated that an acute dosage of niacin decreased 
plasma non-esterified fatty acid (NEFA) levels by decreasing lipolysis in adipocytes.  Niacin 
administration also increased adiponectin, primarily HMW adiponectin, but not other adipokines 
such as leptin or resistin in lean mice.  The authors suggested that NEFA may inhibit adiponectin 
secretion by acting on adipocyte receptors.  It was also suggested that beta-hydroxybuterate, 
which is up-regulated during starvation, acts on one of the adiponectin receptors (AdipoR1 or 
AdipoR2) to decrease serum FFA and decrease ketogenesis while increasing adiponectin 
concentration.  Thus, it appears that adiponectin is inhibited by high concentrations of NEFA and 
is stimulated by low concentrations of NEFA.  Based on this evidence, it can be hypothesized 
that adiponectin is a catabolic hormone, which may partially explain why it is inhibited in 
diabetic and insulin resistant individuals, which demonstrate high levels of the anabolic 
hormone, insulin (63); however, insulin regulation of adiponectin remains a matter of debate.  
Other studies, such as the recent study by Kelley et al. (35) in which exercise training increased 
HMW adiponectin while increasing fat oxidation, support the findings that the adiponectin 
hormone is up-regulated by low levels of NEFA, which activates PPARγ, and in turn, stimulates 
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mitochondrial biogenesis and increases fat oxidation; although, this theory has not been directly 
measured therefore further investigation is needed.  
Given that HMW adiponectin may be directly affected by NEFA concentration, it is 
possible that there may be a direct link between substrate utilization and adiponectin 
concentration in the plasma.  Following fasting, NEFA concentration will rise; however, the 
fasted state appears to have no effect on adiponectin.  Time of day does have a significant effect 
on adiponectin and therefore, participants were not fasted for the current research studies 
examining adiponectin, but measurements were taken at the same time of day. 
Melatonin 
Also of interest, melatonin supplementation has been shown to increase glucose transport 
(97), increase liver and muscle glycogen content, maintain homeostatic blood glucose 
concentrations, and increase lipid utilization immediately following aerobic exercise (98).  
Whether or not melatonin affects substrate utilization following resistance or stretching exercise 
and what effect melatonin has on plasma adiponectin concentration following resistance or 
stretching exercise is currently unknown.  A recent study by Nelson et al. (103) demonstrated 
that acute melatonin supplementation increases glucose oxidation during aerobic exercise, which 
suggests the supplement acts to improve insulin sensitivity.   
Melatonin supplementation has been shown to attenuate body weight gain in rats given a 
high fat diet, decrease plasma glucose, insulin and triglycerides, while reducing adiponectin 
concentration (99).  These results suggest that the regulation of adiponectin may not be regulated 
by blood glucose or lipid concentration and are supported by earlier studies which demonstrated 
that melatonin leads to an inhibition in the accumulation of lipid droplets in pre-adipocytes 
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(100).  However, if melatonin does indeed increase lipid utilization, it could encourage free fatty 
acid availability and oxidation, in other words, high NEFA concentration in plasma.  As 
previously mentioned, this has been proposed to cause a reduction in adiponectin expression, as 
was seen in high-fat fed rats given melatonin.  The extent of change in substrate utilization and 
plasma adiponectin concentration following melatonin supplementation in humans is largely 
unexplored and deserves further investigation. 
Rationale 
Considering exercise modality may have a large effect on substrate utilization, plasma 
adiponectin concentration and exercise performance, various exercise modalities were examined 
in the current study.  Higher intensity exercise, whether acute, chronic, aerobic, resistance, or 
stretching, should theoretically augment plasma adiponectin and alter substrate utilization.  
Therefore all modalities were performed at moderate-to-high intensities.  Acute aerobic exercise 
was performed to complete exhaustion, chronic aerobic exercise was performed at an average 
high rating of perceived exertion, acute resistance training was performed at 75% one-repetition 
maximum (1RM), chronic resistance training was performed at an average of > 75% 1RM, and 
acute stretching exercise was performed by stretching each muscle to its maximal threshold.  
Furthermore, limiting or enhancing lipid or glucose metabolism via supplementation during 
high-intensity chronic or acute aerobic exercise in untrained individuals should diminish or 
improve plasma adiponectin concentration, respectively.  Finally, first degree family history of 
type 2 diabetes, high body fat percentage, high BMI, high waist-to-hip ratio, and lifestyle habits 
including physical inactivity, caffeine consumption, and high-fat diet are all major risk factors in 
the development of insulin resistance (74, 75, 101).  Each of these variables will be correlated 
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with plasma adiponectin concentration to determine if any relationships exist between lower 



















CHAPTER 2. METHODS 
 2.1 Acute Aerobic Exercise 
Subjects 
Untrained males (n = 17) and females (n = 8) between the ages of 18-26 were recruited to 
participate in the study.  All participants were non-smokers, were not taking any medication, 
with the exception of oral contraceptives, and did not regularly perform any type of cycling 
exercise more than one time per week.  Subject characteristics are shown in table 1.  All 
participants were healthy as indicated by the Physical Activity Readiness Questionnaire (PAR-
Q).  Informed consent was obtained from all participants prior to the onset of the first exercise 
trial and the study protocol was approved by the Institutional Review Board of Louisiana State 
University. 
Table 1. Subject Characteristics for the acute aerobic exercise modality.   
Subject Characteristics Men 
n = 17 
Women 
n = 8 
Age (yr) 21.3 ± 2.2 20.8 ± 1.7 
Weight (kg) 78.0 ± 13.9 60.1 ± 5.1  * 
Height (cm) 177.9 ± 6.7 167.9 ± 4.6  * 
BMI 24.5 ± 2.2 21.5 ± 2.3  * 
Body Fat % 19.3 ± 6.1 22.4 ± 2.6 
Fat Mass (kg) 15.1 ± 0.9 13.5 ± 0.3 
Fat Free Mass (kg) 63.0 ± 13.0 46.7 ± 4.7  * 
Reg. Caffeine Consumption (%) 17.6 50.0 
Reg. Aerobic Exercise (%) 35.3 75.0 
Reg. High Fat Diet (%) 41.8 37.5 








Participants were asked to abstain from caffeine and alcohol consumption 48 hours prior 
to each trial and were asked to abstain from exercise for 24 hours prior to each trial.  In addition, 
participants entered the lab three hours postprandial and were asked to consume a standard meal 
of approximately 270 kilocalories (60% CHO, 15% PRO, 25% Fat) prior to each exercise trial to 
ensure consistent results across all participants and between each trial.  It should be noted that 
studies have demonstrated that an overnight fast does provide valid and reliable responses to 
exercise; however, by examining participants three hours postprandial, the current study 
provided responses that are more applicable to real-world settings.  Presumably, most of the 
population does not exercise on a regular basis following an overnight fast, rather exercise takes 
place after some form of nutrients have been consumed.  Additionally, several studies have 
shown that the ingestion of carbohydrates prior to exercise enhances endurance performance 
(102).  Thus, by examining lipid metabolism three hours postprandial, we were able to provide 
much more useful information as it applies to the general public, and as previously mentioned, 
the fasting state has no effect on plasma adiponectin concentration (76). 
Upon arrival to the testing site, all baseline measures were obtained (table 1).  Each 
participant sat quietly for five minutes, after which resting heart rate was obtained.  Heart rate 
data was obtained through a Polar heart rate monitor (Polar Electro, Kempele, Finland).  Height 
and weight were measured using a Detecto medical scale (Cardinal Scale Manufacturing Co., 
Webb City, MO), body fat was measured via the seven-site skinfold technique using Lange 
skinfold calipers (Beta Technology, Inc., Cambridge, MD), and a questionnaire regarding 
exercise and dietary habits was completed and analyzed using My Diet Analysis software 
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(Pearson Education Inc., Upper Saddle River, NJ).  A sample questionnaire is provided in 
Appendix 2.  Regular caffeine consumption was considered a combination of any of the 
following equating to ≥ five per week: eight ounces of coffee/tea, twelve ounces of caffeinated 
soda, and one energy shot/drink.  Regular aerobic exercise was considered ≥ 150 minutes of total 
aerobic exercise per week.  Regular high fat diet was considered ≥ an average of 35% of total 
daily caloric intake from fat. 
Exercise Protocol 
Following the completion of baseline testing, resting respiratory exchange ratio (RER) 
data was obtained through indirect calorimetry (Moxus Modular VO2 System, Pittsburgh, PA).  
Heart rate, volume of oxygen consumed (VO2), and respiratory exchange ratio (RER) were 
monitored for the duration of the study.  All exercise protocols were performed on a 
mechanically braked cycle ergometer (Monark Exercise AB, Norrbotten, Sweden).  Before each 
exercise session, male participants completed a 10 minute warm- up at a 50 watt (W) power 
output maintaining 50 revolutions per minute (rpm).  Female participants completed a 10 minute 
warm-up at a 25 W power output, then began the initial workload at 50W, increasing the 
workload by 25 W every 6 minutes until exhaustion.  This was done to compensate for the 
reduced muscle mass and aerobic capacity seen in the female group.  A pedal frequency of 50 
rpm was maintained for the entirety of the warm-up and exercise phases for both males and 
females.  In addition, rating of perceived exertion (RPE) and signs and symptoms of possible 
cardiopulmonary dysfunction was monitored every 2-3 minutes throughout the test.  Participants 
then began the initial workload at 100W.  The workload then increased by 50W every 6 minutes 
until the participant could no longer maintain his or her pedal frequency.  This time point was 




 Supplements were administered using a balanced, randomized, double-blind, crossover 
design.  Upon arrival to the research site, each participant was randomly assigned to a placebo, 
caffeine, or nicotinic acid supplement.  For each subsequent visit, the participant was 
administered a different supplement, ensuring that each of the three supplements were ingested 
for three different exercise trials.  A one-week washout period separated each exercise trial to 
eliminate any carry-over effect.  For the niacin trial, each participant was administered 1000 
milligrams (mg) of niacin, for the caffeine trial, each participant was administered five 
mg/kilogram (kg) of body weight, and for the placebo trial, each participant was administered a 
methylcellulose placebo supplement capsule.  Each supplement was ingested at least 30 minutes 
prior to the onset of the exercise protocol. 
Plasma Analysis 
For each trial, the participant sat quietly for 30 minutes after ingesting the supplement, 
after which ten milliliters (ml) of blood was drawn from the cubital vein to determine initial 
plasma adiponectin values.  Immediately following the completion of each exercise trial, an 
additional ten ml of blood was drawn from the same location to determine post-exercise plasma 
adiponectin levels.  Blood was collected into sodium heparin vacutainers and immediately 
centrifuged.  Plasma was then separated and stored at -80 degrees Fahrenheit until further 
analysis.  All plasma samples were analyzed to determine the concentration of total plasma 
adiponectin via western blot. Protein was quantified for each sample, as determined by 
bicinchoninic acid (BCA) assay (Sigma-Aldrich, St. Louis, MO), and equal amounts of protein 
from each sample were subjected to electrophoresis.  Proteins were separated in 7.5% 
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polyacrylamide (acrylamide from National Diagnostics) gels containing sodium dodecyl sulfate 
(SDS) and transferred to nitrocellulose membrane in 25 mM Tris, 192 mM glycine, and 20% 
methanol. Following transfer, the membrane was blocked overnight in 4% milk at 4°C then 
probed with human-anti-adiponectin (1:1000 in 1% BSA in 1X Tris-buffered saline-tween). 
Results were visualized with horseradish peroxidase (HRP)-conjugated mouse-anti-human 
secondary antibody (1:1000 in 1% nonfat milk in 1X Tris-buffered saline-tween) and enhanced 
chemiluminescence.  Each membrane was probed with anti- α Tubulin as a loading control 
(1:1000 in 1% BSA in 1X Tris-buffered saline-tween) and densitometric analysis of blots was 
performed using Image J software.  
Statistical Analysis 
 All data were analyzed using a repeated-measures analysis of variance (ANOVA) to 
compare differences in RER, time to exhaustion, and plasma adiponectin and alpha-tubulin 
concentration between and within subjects as well as between and within trials.  Correlations of 
co-variables were tested using simple linear regression and significant differences were 
identified using Tukey post-hoc tests.  p < 0.05 was considered significant.  All values are 
presented as mean ± SD.  All statistical analysis was completed using SAS v9.2 (SAS Institute, 
Inc. Cary, NC). 
 2.2 Chronic Aerobic Exercise 
Subjects 
Recreationally active females (n = 38) ages 18-24 were recruited to participate in the 
study.  All participants were non-smokers and were not taking any medication, with the 
exception of oral contraceptives.  Subject characteristics are shown in table 2.  All participants 
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were healthy as indicated by the Physical Activity Readiness Questionnaire (PAR-Q).  Informed 
consent was obtained from all participants prior to the onset of the first exercise trial and the 
study protocol was approved by the Institutional Review Board of Louisiana State University.   
Table 2. Subject Characteristics for the chronic aerobic exercise modality.   
Baseline Subject Characteristics Exercise  
n = 18 
Control  
n = 20 
Age (yr) 21 ± 0.8 21 ± 1.3 
Weight (kg) 62.9 ± 6.3 61.5 ± 9.2 
Height (cm) 166.0 ± 5.1 164.9 ± 4.2 
BMI 22.79 ± 2.1 21.87 ± 3.1 
Body Fat % 32.4 ± 5.1 29.7 ± 6.1 
Fat Mass (kg) 20.5 ± 3.8 18.6 ± 6.3 
Fat Free Mass (kg) 42.8 ± 5.7 42.8 ± 4.3 
* No statistical differences between groups at baseline. BMI Body Mass Index. 
 
Experimental Protocol 
At the onset of the study, participants were randomly assigned to an aerobic exercise 
group (E) or a control group (C).  In order to minimize subject variability, participants were 
asked to abstain from alcohol and caffeine consumption as well as strenuous physical activity for 
48 hours prior to baseline testing.   Baseline measurements were established for height and body 
weight using a Detecto medical scale (Cardinal Scale Manufacturing Co., Webb City, MO), body 
fat percentage was determined by duel energy x-ray absorptiometry (DXA), and estimated VO2 
max was determined by a 1.5 mile run.   
Participants then completed the 15-week exercise intervention.  A week-by-week 
description for the exercise intervention is described in table 3.  Participants were required to 
participate in a minimum of 80% of the exercise sessions to be included in the analysis.  
Following training, and prior to running a full marathon, all baseline measurements were re-
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tested.  This was done to minimize confounding inflammatory responses that are associated with 
completing a full marathon (26.2 mile) race. 
Table 3. Training Protocol for the chronic aerobic exercise modality.  
Week Mon Tues Wed Thur Fri Sat Sun Total 
(miles/wk)  
1 Rest 3 3 3 Rest 6 Cross 15 
2 Rest 3 4 3 Rest 7 Cross 17 
3 Rest 3 4 3 Rest 8 Cross 18 
4 Rest 3 4 3 Rest 7 Cross 17 
5 Rest 3 5 3 Rest 10 Cross 21 
6 Rest 3 6 3 Rest 12 Cross 24 
7 Rest 3 5 4 Rest 11 Cross 23 
8 Rest 4 7 4 Rest 14 Cross 29 
9 Rest 4 8 5 Rest 16 Cross 33 
10 Rest 4 9 5 Rest 18 Cross 36 
11 Rest 5 9 5 Rest 20-22 Cross 39-41 
12 Rest 5 10 5 Rest 20 Cross 40 
13 Rest 5 10 5 Rest 12 Cross 32 
14 Rest 5 6 5 Rest 8 Cross 24 
15 Rest 3 4 2 Rest RACE  
Numbers= number of miles run; cross= cross training. 
 
Plasma Analysis 
During initial baseline testing at the onset of the study, an overnight fasting blood sample 
was drawn from the cubital vein of each participant.  Prior to the blood draw, participants were 
asked to abstain from caffeine and alcohol consumption as well as exercise for 48 hours.  This 
procedure was repeated at the conclusion of the study and a second fasting blood sample was 
obtained 48 hours after the final exercise testing; this was done to minimize any carry-over 
effects from an acute exercise bout.  Blood was collected into sodium heparin vacutainers and 
immediately centrifuged.  Plasma was then separated and stored at -80 degrees Fahrenheit until 
further analysis.  All plasma samples were analyzed to determine the concentration of total 
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plasma adiponectin via western blot. Protein was quantified for each sample, as determined by 
bicinchoninic acid (BCA) assay (Sigma-Aldrich, St. Louis, MO), and equal amounts of protein 
from each sample were subjected to electrophoresis.  Proteins were separated in 7.5% 
polyacrylamide (acrylamide from National Diagnostics) gels containing sodium dodecyl sulfate 
(SDS) and transferred to nitrocellulose membrane in 25 mM Tris, 192 mM glycine, and 20% 
methanol. Following transfer, the membrane was blocked overnight in 4% milk at 4°C then 
probed with human-anti-adiponectin (1:1000 in 1% BSA in 1X Tris-buffered saline-tween). 
Results were visualized with horseradish peroxidase (HRP)-conjugated mouse-anti-human 
secondary antibody (1:1000 in 1% nonfat milk in 1X Tris-buffered saline-tween) and enhanced 
chemiluminescence.  Each membrane was probed with anti- α Tubulin as a loading control 
(1:1000 in 1% BSA in 1X Tris-buffered saline-tween) and densitometric analysis of blots was 
performed using Image J software.  
Statistical Analysis 
 All data were analyzed using a repeated-measure ANOVA and paired t-tests where 
appropriate.  Correlations of co-variables were tested using simple linear regression and 
significant differences were identified using Tukey post-hoc tests.  p < 0.05 was considered 
significant.  All values are presented as mean ± SD.  All statistical analysis was completed using 
SAS v9.2 (SAS Institute, Inc. Cary, NC). 
 2.3 Acute Resistance Training 
Subjects 
Untrained healthy males (n = 17) and females (n = 12) age 18-35 with a body mass index 
(BMI) of less than 30 were recruited to participate in the study.  All participants were non-
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smokers, were not taking any medication, with the exception of oral contraceptives, and did not 
regularly perform any type of resistance training exercise more than one time per week.  Subject 
characteristics are shown in table 4.  All participants were healthy as indicated by the Physical 
Activity Readiness Questionnaire (PAR-Q).  Informed consent was obtained from all participants 
prior to the onset of the first exercise trial and the study protocol was approved by the 
Institutional Review Board of Louisiana State University.   
Table 4. Subject Characteristics for the acute resistance exercise modality.   
Subject Characteristics Men  
n = 17 
Women  
n = 12 
Age (yr) 23.1 ± 4.1 20.6 ± 1.36 
Weight (kg) 78 ± 10.3 62.0 ± 8.8  * 
Height (cm) 176.5 ± 6.4 163.7 ± 4.7  * 
BMI 25.0 ± 2.8 23.1 ± 2.9 * 
Body Fat % 17.9 ± 5.9 24.3 ± 5.7  * 
Fat Mass (kg) 14.3 ± 6.5 15.4 ± 5.2 
Fat Free Mass (kg) 63.7 ± 6.1 46.6 ± 4.7  * 
Reg. Caffeine Consumption (%) 36.4         35.0 
Reg. Resistance Exercise (%) 27.3 60.0 * 
* Denotes p < 0.05 between groups. BMI Body Mass Index. BMI Body Mass Index. 
 
Experimental Protocol 
Participants were asked to abstain from vigorous physical activity, caffeine and alcohol 
consumption 48 hours prior to each trial.  In addition, participants came in a minimum of three 
hours postprandial and were asked to consume the same meal (60% CHO, 15% protein, 25% fat) 
prior to each trail to ensure consistent results across all participants and between each trial.   
Upon arrival to the research site, height and weight were measured using a Detecto medical scale 
(Cardinal Scale Manufacturing Co., Webb City, MO), body fat was measured via the 7-site 
skinfold technique using Lange skinfold calipers (Beta Technology, Inc., Cambridge, MD), and a 
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questionnaire regarding exercise and dietary habits was completed and analyzed using My Diet 
Analysis software (Pearson Education Inc., Upper Saddle River, NJ).  A sample questionnaire is 
provided in Appendix 2.  Regular caffeine consumption was considered a combination of any of 
the following equating to ≥ 5 per week: cups of coffee/tea, 12 oz caffeinated sodas, and energy 
shots/drinks.  Regular aerobic exercise was considered ≥ 150 minutes of total aerobic exercise 
per week.  Regular high fat diet was considered ≥ an average of 35% of total daily caloric intake 
from fat. 
Each participant was then randomly assigned to the control or exercise trial.  On the 
subsequent visit, the participant was assigned to whichever trial was not administered during the 
first visit.  Each exercise trial was separated by a minimum of one week.  Each participant 
completed a total of three trials.  The first trial was used to determine a one repetition maximum 
(1RM) for box squat and bench press exercises.  The next trial consisted of either a high-
intensity resistance training protocol lasting approximately 30 minutes or a control trial, in which 
the participants sat quietly for 30 minutes. 
Venous blood samples were collected immediately before and after each protocol and 
dermal punctures were administered pre- and post-exercise to determine changes in blood 
glucose concentration. 
Exercise Protocol 
The exercise intervention set, rep, and rest scheme was based off of previous acute 
resistance training studies that have demonstrated increases in lipid oxidation, decreases in 
intramyocellular lipid (IMCL) stores, decreases in glycogen stores (26), and increases in plasma 
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glycerol (4).  Therefore it can be assumed that lipid utilization was increasing with this type of 
exercise. 
A 1RM for the box squat and bench press exercises were determined during the first trial.  
On one of the two subsequent trials, participants completed 6 sets of 12 repetitions on squats and 
bench press at 75% 1RM following a pre-exercise blood draw.  60 seconds of rest were allotted 
between sets.  For the box squat exercise, participants lowered themselves down onto the box in 
a slow, controlled manner to prevent injury.  Boxes were used as a depth cue so participants 
know when they have reached the proper depth (approximately 90 degree angle at the knee).  
The boxes also ensured that there were separate eccentric and concentric phases of the squat.  
Once the proper depth had been reached, participants raised themselves to an upright, standing 
position, and then repeated this process for the allotted number of repetitions.  For the bench 
press exercise, participants lowered the bar down onto their chest in a slow, controlled manner to 
prevent injury.  Once the bar had touched the chest, participants pressed the bar upward until 
their arms were fully extended, and then repeat this process for the allotted number of 
repetitions.  If necessary, the weight lifted was decreased to ensure all sets and reps were 
completed and that the allotted 60 second rest period was maintained for the entirety of the 
exercise protocol.   
Plasma Analysis 
Blood glucose concentration measurements were taken to via dermal puncture 
immediately pre- and post-exercise to determine the extent of glucose utilization and uptake.  
Prior to the exercise intervention, 10 ml of blood was drawn from the cubital vein to determine 
initial plasma adiponectin values.  Immediately following the completion of each exercise trial, 
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an additional 10 ml of blood was drawn from the same location to determine post-exercise 
plasma adiponectin levels.  Blood was collected into sodium heparin vacutainers and 
immediately centrifuged.  Plasma was then separated and stored at -80 degrees Fahrenheit until 
further analysis.  All plasma samples were analyzed to determine the concentration of total 
plasma adiponectin via western blot. Protein was quantified for each sample, as determined by 
bicinchoninic acid (BCA) assay (Sigma-Aldrich, St. Louis, MO), and equal amounts of protein 
from each sample were subjected to electrophoresis.  Proteins were separated in 7.5% 
polyacrylamide (acrylamide from National Diagnostics) gels containing sodium dodecyl sulfate 
(SDS) and transferred to nitrocellulose membrane in 25 mM Tris, 192 mM glycine, and 20% 
methanol. Following transfer, the membrane was blocked overnight in 4% milk at 4°C then 
probed with human-anti-adiponectin (1:1000 in 1% BSA in 1X Tris-buffered saline-tween). 
Results were visualized with horseradish peroxidase (HRP)-conjugated mouse-anti-human 
secondary antibody (1:1000 in 1% nonfat milk in 1X Tris-buffered saline-tween) and enhanced 
chemiluminescence.  Each membrane was probed with anti- α Tubulin as a loading control 
(1:1000 in 1% BSA in 1X Tris-buffered saline-tween) and densitometric analysis of blots was 
performed using Image J software.  
Statistical Analysis 
 All data were analyzed using repeated-measures ANOVA and paired t-tests where 
appropriate.  Correlations of co-variables were tested using simple linear regression and 
significant differences were identified using Tukey post-hoc tests.  p < 0.05 was considered 
significant.  All values are presented as mean ± SD.  All statistical analysis was completed using 
SAS v9.2 (SAS Institute, Inc. Cary, NC). 
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2.4 Chronic Resistance Exercise 
Subjects 
Untrained, healthy men (n=40) age 18-35 with a body mass index (BMI) of less than 30 
were recruited to participate in the study.   All participants were non-smokers, were not taking 
any medication, and did not regularly perform any type of resistance training exercise more than 
one time per week.  Subject characteristics are shown in table 5.  All participants were healthy as 
indicated by the Physical Activity Readiness Questionnaire (PAR-Q).  Informed consent was 
obtained from all participants prior to the onset of the first exercise trial and the study protocol 
was approved by the Institutional Review Board of Louisiana State University. 
Table 5. Subject characteristics for the chronic resistance exercise modality. 
Subject Characteristics Exercise  
n = 18 
Control 
 n = 22 
Age (yr) 20.4 ± 2.1 22.9 ± 4.7  * 
Weight (kg) 82.1 ± 11.3 82.1 ± 13.9 
Height (cm) 177.2 ± 7.7 176.2 ± 5.6 
BMI 26.1 ± 3.4 26.8 ± 5.5 
Body Fat % 20.4 ± 6.4 24.4 ± 8.8 
Fat Mass (kg) 17.3 ± 7.4 20.3 ± 11.6 
Fat Free Mass (kg) 64.8 ± 6.1 61.9 ± 5.9 
Reg. Caffeine Consumption (%) 55.0 45.5 
Reg. Resistance Exercise (%) 25.0 41.0 
* Denotes statistically significant differences between groups, p < 0.05.  BMI Body Mass Index. 
 
Experimental Protocol 
Students currently enrolled in a beginning weight training course and a lecture course at 
Louisiana State University were recruited to participate as the exercise (E) and control (C) 
groups, respectively.  In order to minimize subject variability, at the onset of the study, 
participants were asked to abstain from alcohol and caffeine consumption as well as strenuous 
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physical activity for 48 hours.  Following this time period, participants completed an overnight 
fast and 10 ml of blood was drawn from the cubital vein, height and weight were measured using 
a Detecto medical scale (Cardinal Scale Manufacturing Co., Webb City, MO), body fat was 
measured via the 7-site skinfold technique using Lange skinfold calipers (Beta Technology, Inc., 
Cambridge, MD), and a questionnaire regarding exercise and dietary habits was completed and 
analyzed using My Diet Analysis software (Pearson Education Inc., Upper Saddle River, NJ).  A 
sample questionnaire is provided in Appendix 2.  Regular caffeine consumption was considered 
a combination of any of the following equating to ≥ 5 per week: cups of coffee/tea, 12 oz 
caffeinated sodas, and energy shots/drinks.  Regular aerobic exercise was considered ≥ 150 
minutes of total aerobic exercise per week.  Regular high fat diet was considered ≥ an average of 
35% of total daily caloric intake from fat. 
Exercise Protocol 
As outlined in table 6, following a familiarization phase, the initial strength of each 
participant was determined by one-repetition maximum (1RM) for free weight squat, free weight 
bench press, and free weight deadlift.  Following the exercise intervention, all baseline 
measurements and strength measurements were re-tested.  
Participants completed the twelve-week exercise intervention.  A week-by-week 
description for the exercise intervention is described in table 6.  Resistance training was 
performed three times per week for 40-50 minutes per exercise session.  Each exercise session 
was separated by a minimum of 48 hours.  Participants were required to participate in a 




Table 6 Week-to-week periodization training protocol for the chronic resistance training 
protocol. 
Week Sets Reps Intensity (%1RM) 
1 Familiarization/Baseline Testing N/A 
2 4 3 60 
3 4 6 60 
4 12 2 80 
5 1 RM Testing 1 100 
6 3 8 60 
7 3 6 70 
8 4 2 85 
9 5 5 80 
10 4 4 85 
11 3 12 55 
12 3 6 70 
13 1 RM Testing 1 100 
14 Repeat Baseline Testing N/A N/A 
1RM one-repetition maximum. 
Total work volume varied from week to week, each day consisted of three-to-five 
exercises depending on the number of sets and reps.  Three exercises were used for higher set 
and rep schemes whereas four or exercises were used for lower set and rep schemes.  Specific 
exercises varied from week-to-week and included free weight box squats, back squats, flat bench 
press, incline bench press, conventional deadlifts, Romanian deadlifts, sumo deadlifts, bent over 
rows, upright rows, good mornings, glut/ham raises, pull ups, lat pull downs, and push press.  To 
minimize the risk of overtraining and injury, no single muscle group was targeted on back-to-
back exercise sessions.  Each of the baseline variables were re-assessed at week twelve following 
the baseline testing procedures discussed. 
Plasma Analysis 
At the onset of the study, ten ml of blood was drawn from the cubital vein to determine 
initial plasma adiponectin values.  Following a 48-hour rest period, in which participants 
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abstained from vigorous exercise, caffeine, and alcohol for 48 hours, an additional ten ml of 
blood was drawn from the same location to determine post-exercise intervention plasma 
adiponectin levels.  Blood was collected into sodium heparin vacutainers and immediately 
centrifuged.  Plasma was then separated and stored at -80 degrees Fahrenheit until further 
analysis.  All plasma samples were analyzed to determine the concentration of total plasma 
adiponectin via western blot. Protein was quantified for each sample, as determined by 
bicinchoninic acid (BCA) assay (Sigma-Aldrich, St. Louis, MO), and equal amounts of protein 
from each sample were subjected to electrophoresis.  Proteins were separated in 7.5% 
polyacrylamide (acrylamide from National Diagnostics) gels containing sodium dodecyl sulfate 
(SDS) and transferred to nitrocellulose membrane in 25 mM Tris, 192 mM glycine, and 20% 
methanol. Following transfer, the membrane was blocked overnight in 4% milk at 4°C then 
probed with human-anti-adiponectin (1:1000 in 1% BSA in 1X Tris-buffered saline-tween). 
Results were visualized with horseradish peroxidase (HRP)-conjugated mouse-anti-human 
secondary antibody (1:1000 in 1% nonfat milk in 1X Tris-buffered saline-tween) and enhanced 
chemiluminescence.  Each membrane was probed with anti- α Tubulin as a loading control 
(1:1000 in 1% BSA in 1X Tris-buffered saline-tween) and densitometric analysis of blots was 
performed using Image J software.  
Statistical Analysis 
 All data were analyzed using repeated-measures ANOVA and paired t-tests where 
appropriate.  Correlations of co-variables were tested using simple linear regression and 
significant differences were identified using Tukey post-hoc tests.  p < 0.05 was considered 
significant.  All values are presented as mean ± SD.  All statistical analysis was completed using 
SAS v9.2 (SAS Institute, Inc. Cary, NC). 
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2.5 Acute Stretching Exercise 
Subjects 
Recreationally active, healthy men age 18-35 with a body mass index (BMI) of less than 
25 were recruited to participate in the study.  All participants were non-smokers, were not taking 
any medication, and did not regularly participate in vigorous exercise more than one time per 
week.  Subject characteristics are shown in table 7.  All participants were healthy as indicated by 
the Physical Activity Readiness Questionnaire (PAR-Q).  Informed consent was obtained from 
all participants prior to the onset of the first exercise trial and the study protocol was approved by 
the Institutional Review Board of Louisiana State University. 
Table 7. Subject characteristics for the acute stretching exercise protocol. 
Subject Characteristics Men  
n = 23 
Age (yr) 22.5 ± 4.3 
Weight (kg) 78.8 ± 11.4 
Height (cm) 177.9 ± 5.7 
BMI 25.0 ± 3.9 
Body Fat % 16.2 ± 5.9 
Fat Mass (kg) 13.4 ± 6.5 
Fat Free Mass (kg) 65.5 ± 7.1 
Reg. Caffeine Consumption (%) 30.0 
Reg. Resistance Exercise (%) 48.0 
Reg. Aerobic Exercise (%) 65.0 




Each participant completed a total of four trials.  Participants were asked to abstain from 
caffeine and alcohol consumption 48 hours prior to each trial.  In addition, participants came into 
the lab a minimum of three hours postprandial and were asked to consume the same meal (60% 
CHO, 15% protein, 25% fat) prior to each trail to ensure consistent results across all participants 
40 
 
and between each trial.   Upon arrival to the research site, height and weight were measured 
using a Detecto medical scale (Cardinal Scale Manufacturing Co., Webb City, MO), body fat 
was measured via the 7-site skinfold technique using Lange skinfold calipers (Beta Technology, 
Inc., Cambridge, MD), and a questionnaire regarding exercise and dietary habits was completed 
and analyzed using My Diet Analysis software (Pearson Education Inc., Upper Saddle River, 
NJ).  A sample questionnaire is provided in Appendix 2.  Regular caffeine consumption was 
considered a combination of any of the following equating to ≥ 5 per week: cups of coffee/tea, 
12 oz caffeinated sodas, and energy shots/drinks.  Regular aerobic exercise was considered ≥ 150 
minutes of total aerobic exercise per week.  Regular high fat diet was considered ≥ an average of 
35% of total daily caloric intake from fat. 
Supplement dosage 
Following baseline measurements, participants were administered a methylcellulose 
placebo or melatonin (6mg) supplement, utilizing a counterbalanced randomized double blind, 
crossover design.  This ensured that each participant was administered each supplement twice 
over the course of the four exercise trials, one placebo and one melatonin supplement for each of 
the exercise trials, and one placebo and one melatonin supplement for each control trial.  At the 
onset of each trail and for the duration of each trial, respiratory gases were monitored using 
indirect calorimetry.  This was done to determine changes in substrate utilization during the 
exercise protocol. 
Exercise Protocol 
Two exercise trials consisted of a 30 minute passive resistance stretching protocol, the 
other two trials consisted of a 30 minute mock stretching protocol, meaning no tension was 
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applied to the muscle, but participants went through the same motions as the passive resistance 
protocol.  The order of the trials was randomized and balanced for each participant.  Each 
exercise trial was separated by a minimum of one week.   
The passive resistance stretching exercise protocol was done in the following order: 
Hamstring stretch, quadriceps stretch, shoulder stretch, triceps stretch, hip adductor stretch, and 
hip flexor stretch.  Each stretch was held for 30 seconds followed by 20 seconds rest, then 
repeated 2 more times (three sets of 30 seconds for each exercise per leg/arm).  6 exercises X 2 
limbs X 2.5 minutes/exercise = a total time of 30 minutes.  The details of each exercise are 
outlined and diagramed below, however some of these stretches were modified to have the 
participants lying in the supine position.  This allowed for more accurate measurements of the 
respiratory gases.  For each exercise, the range of motion was increased until the participant 
acknowledged a stretch-induced mild tightness in the muscle similar to that normally felt during 
a stretching activity.  For the control trials, participants completed these same motions for the 
same period of time, but no tension will be applied to the muscle. 
Stretching Illustrations and Descriptions 
Hamstring stretch:  Participants were in a supine position on a table with one leg fully 
extended. The other leg was flexed at the hip (45 degrees), with the knee fully extended.  From 
this position, the extended leg was raised (hip flexion) to the vertical position or beyond to the 
point of stretching.  During the stretch, the buttocks remained in complete contact with the 




Quadriceps stretch:  Participants were in a supine position with one leg hanging off the 
edge of the table and knee flexed at approximately 90 degrees.  The hip was then hyperextended 
by pushing down on the thigh and the foot was pushed upward to increase tension on the 
quadriceps muscle.  This was done to the point of stretching. 
 
Shoulder stretch: Participants were in a supine, anatomical position on a table.  The 
shoulder was then adducted; the arm was rotated to a pronated position.  The arm was then 
hyperextended to the point of stretching, keeping the opposite shoulder flat on the table. 
Chest stretch:  Participants were in a supine, anatomical position on a table.  The 
shoulder was then adducted and the arm remained in a supinated position.  The arm was then 




Glutes stretch: Participants were in a supine position on a table with one leg flexed at the 
knee (90 degrees) and the hip (45 degrees), with the foot placed firmly on the table.  The ankle of 
the opposite leg was placed on the knee of the flexed leg.  From this position, the hip of the first 
leg was flexed back to the point of stretching in the gluteus maximus muscle. 
Low back stretch:  Participants were in a supine position on a table with one leg fully 
extended. The other leg was flexed at the knee (90 degrees) and the hip (45 degrees), with the hip 
placed firmly on the table.  From this position, the flexed leg was adducted and brought across 
the body.  The leg was then pushed upward toward the head until the point of stretching in the 
low back. 
Plasma Sample Analysis 
For each trial, the participant sat quietly for 30 minutes after ingesting the supplement, 
after which ten ml of blood was drawn from the cubital vein to determine initial plasma 
adiponectin values.  Immediately following the completion of each exercise trial, an additional 
ten ml of blood was drawn from the same location to determine post-exercise plasma adiponectin 
levels.  Blood was collected into sodium heparin vacutainers and immediately centrifuged.  
Plasma was then separated and stored at -80 degrees Fahrenheit until further analysis.  All 
plasma samples were analyzed to determine the concentration of total plasma adiponectin via 
western blot. Protein was quantified for each sample, as determined by bicinchoninic acid (BCA) 
assay (Sigma-Aldrich, St. Louis, MO), and equal amounts of protein from each sample were 
subjected to electrophoresis.  Proteins were separated in 7.5% polyacrylamide (acrylamide from 
National Diagnostics) gels containing sodium dodecyl sulfate (SDS) and transferred to 
nitrocellulose membrane in 25 mM Tris, 192 mM glycine, and 20% methanol. Following 
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transfer, the membrane was blocked overnight in 4% milk at 4°C then probed with human-anti-
adiponectin (1:1000 in 1% BSA in 1X Tris-buffered saline-tween). Results were visualized with 
horseradish peroxidase (HRP)-conjugated mouse-anti-human secondary antibody (1:1000 in 1% 
nonfat milk in 1X Tris-buffered saline-tween) and enhanced chemiluminescence.  Each 
membrane was probed with anti- α Tubulin as a loading control (1:1000 in 1% BSA in 1X Tris-
buffered saline-tween) and densitometric analysis of blots was performed using Image J 
software.  
Statistical Analysis 
 All data were analyzed using repeated-measures ANOVA and paired t-tests where 
appropriate.  Correlations of co-variables were tested using simple linear regression and 
significant differences were identified using Tukey post-hoc tests.  p < 0.05 was considered 
significant.  All values are presented as mean ± SD.  All statistical analysis was completed using 










CHAPTER 3. RESULTS 
 3.1 Acute Aerobic Exercise 
In males, the niacin treatment had significantly higher (p < 0.05) respiratory exchange 
ratio (RER) compared to the placebo and caffeine treatments (N = 0.95 ± 0.05, P = 0.88 ± 0.05, 
C = 0.88 ± 0.06) (mean ± SD.) (Fig. 1.1a).  Females, however, did not demonstrate significant 
differences in RER when given the niacin treatment compared to the placebo treatment, while 
the caffeine treatment yielded a significantly lower RER compared to the placebo treatment (C = 
0.84 ± 0.09, P = 0.88 ± 0.04) (Fig. 1.1b).  Males demonstrated a significantly higher RER when 
given niacin compared to females (males = 0.95 ± 0.05, females = 0.85 ± 0.08).  When all 
exercise trails were combined, fat utilization did not significantly differ between males and 
females for stages one and two of exercise; however, the utilization of fat at the third stage of 
exercise was significantly lower in males (males = 0.97 ± 0.06, females = 0.90 ± 0.08). 
In males, the percentage of carbohydrate (CHO) utilization was higher for the niacin 
treatment compared to placebo and caffeine treatments (N = 80% ± 13, P = 61% ± 17, C = 62% 
± 20) (Fig. 1.2a) while there were no significant differences in CHO utilization in females (Fig. 
1.2b).  Similar to absolute RER, males demonstrated a significantly higher %CHO utilization 
when given niacin compared to females (males = 80% ± 13, females = 51% ± 26) and when all 
exercise trails were combined, %CHO during the third stage of exercise was significantly higher 
in males (males = 85% ± 14, females = 60% ± 27), while there were no significant differences in 
%CHO utilized during stages one and two. 
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Time to exhaustion was significantly different for all three trials for both males (N = 24.4 
± 3.8, P = 25.5 ± 3.1, C = 27 ± 3.4) (Fig. 1.3a) and females (N = 29.7 ± 5.6, P = 31.3 ± 5.0, C = 
32.8 ± 5.1) (Fig.1.3b).  
The caffeine and niacin supplements did not significantly alter plasma adiponectin pre-
exercise compared to the placebo trial. (Fig. 1.4)  Exercise did not significantly alter plasma 
adiponectin in the placebo or caffeine trials, however, plasma adiponectin significantly decreased 
following the niacin trial (Pre = 1.00 AU, Post = 0.74 AU). (Fig. 1.5). 
Simple linear regression was used to determine correlations between average plasma 
adiponectin concentration (Adpn) and: first degree family history of type 2 diabetes mellitus 
(FH+), regular aerobic exercise (Reg. Aex), regular resistance training exercise (Reg. Rex), 
regular caffeine consumption (Reg. Caff), body fat percentage (BF%), BMI, and average RER 
during exercise for each subject (Table 8).  Regular aerobic exercise (r = 0.28) and regular 
caffeine consumption (r = .32) were both statistically significant correlations (p < 0.05), no other 
correlates were significant.  No subjects for this intervention were FH+ and therefore no values 















































Figure 1.1. Comparison of respiratory exchange ratio (RER) during three stages of exercise for 
niacin, placebo, and caffeine exercise trials (means ± SD) for males (A) and females (B).            
* p < 0.05 compared to placebo treatment.  # p < 0.05 compared to caffeine treatment.       
(Males: N = 0.95 ± 0.05, P = 0.88 ± 0.05, C = 0.88 ± 0.06; Females: N = 0.87 ± 0.07,                  















































Figure 1.2. Comparison of %CHO utilization during three stages of exercise for niacin, placebo, and 
caffeine exercise trials (means ± SD) for males (A) and females (B).  *p > 0.05 compared to placebo 
treatment.  # p > 0.05 compared to caffeine treatment. (Males: N = 80 ± 13%, C = 62 ± 20%,                  
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Figure 1.3. Comparison of time to exhaustion for niacin, placebo, and caffeine exercise trails in 
minutes (min) (mean ± SD) for males (A) and females (B).  *p < 0.05 compared to placebo 
treatment.  # p < 0.05 compared to caffeine treatment. (Males: N = 24.4 ± 3.8 vs. P = 25.5 ± 3.1 























Placebo                          Niacin                                    Caffeine 









Figure 1.4. Acute Aerobic Exercise.  Western blot comparison of plasma adiponectin (~ 31 
kda) for placebo, niacin, and caffeine exercise trials pre- and post- exercise for subject 2. α-






















Figure 1.5. Quantitative comparison of plasma adiponectin for placebo, niacin, and caffeine 
exercise trials.  Area under the curve for each plasma sample was calculated and normalized 
against the loading control.  Results are given in arbitrary units (mean ± SD) for all male subjects 
(n = 17). (P Trial: Pre = 0.91 ± 0.28, Post = 0.87 ± 0.48; N Trial: Pre = 1.01 ± 0.44, 0.74 ± 0.36, 
C Trial: Pre = 0.99 ± 0.43, Post = 0.78 ± 0.25). 
α- Tubulin   
Adiponectin 
Placebo                            Niacin                               Caffeine 
       -                  +                  -                  +                    -                   + Subject 2 
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Table 8. Acute Aerobic Exercise.   
Adiponectin Correlations 
FH+ - - 
Reg. AEX.   r = .28  p = 0 .05 
Reg. Rex r = -.08 NS 
Reg. Caff.    r = .32  p = 0.03 
BF%   r = -.14  NS 
BMI   r = -.06  NS 
RER   r = -.14  NS 
Average plasma adiponectin concentration compared to various correlates.  Reg AEX. Regular 
Aerobic Exercise; BMI Body Mass Index; RER Respiratory Exchange Ratio; Reg. Caff. Regular 
Caffeine Consumption; NS non-significant; statistics represent data from all subjects (n = 17). 
 
 
 3.2 Chronic Aerobic Exercise 
There were no significant differences among the groups for any of the measured 
parameters at baseline.  Significant improvements were observed for estimated VO2max  in the E 
group (37.38 ± 2.39 ml/kg/min pre-intervention to 42.32 ± 7.67 ml/kg/min post-intervention) 
(mean ± SD) p = 0.02, but not the C group (36.85 ± 2.98 ml/kg/min pre to 39.79 ± 4.46 
ml/kg/min) (Fig 2.1).  The 1.5 mile run time changed 8.5% from 13.57 ± 1.3 to 12.41 ± 2.7 
minutes (mean ± SD), and the C group changed from 14.24 ± 1.7 to 13.31 ± 2.0 minutes (mean ± 
SD) neither of which reached significance (p > 0.05).   
The E group decreased body fat significantly from 29.4% ± 8.3 to 27.7% ± 8.7 (mean ± 
SD) p = 0.04 (Fig. 2.2). The percent change for this reduction in body fat was 1.7%; however, 
the reduction in total body weight was not significant.  There was no significant change in body 
fat for the C group.  The C group and E group had no significant changes in lean tissue mass pre- 

























Plasma adiponectin was not significantly different pre- to post-intervention in the E group 
or the C group (Fig 2.3), however, plasma adiponectin was significantly lower in the C group for 
both pre- and post-intervention time points p = 0.05 (Fig 2.4).  
Simple linear regression was used to determine correlations between average plasma 
adiponectin concentration (Adpn) and: VO2max, waist-to-hip ratio (WHR), body fat percentage 
(BF %), BMI, android percent fat (And.), and gynoid percent fat (Gyn.) for each subject (Table 
9).  No correlates were found to be significant (p > 0.05). 
Figure 2.1. Comparison of estimated VO2max pre- to post-exercise between C and E groups 
(mean ± SD). * p = 0.02 compared to pre-exercise intervention.  (E Group: pre = 37.38 ± 2.39 
ml/kg/min, post = 42.32 ± 7.67 ml/kg/min; C Group: pre = 36.85 ± 2.98 ml/kg/min, post = 39.79 






























Figure 2.2. Comparison of body fat percentage pre- to post-exercise between C and E groups 
(mean ± SD). * p = 0.04 compared to pre-exercise intervention. (E Group: pre = 32.36 ± 5.09, 












Figure 2.3. Chronic Aerobic Exercise.  Western blot comparison of plasma adiponectin           
(~ 31 kda) for pre- and post- exercise time points for subject 25, 19, and 2. α-Tubulin (~ 55 kda) 
served as a loading control.  - Pre-Exercise Intervention; + Post-Exercise Intervention. 
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Figure 2.4. Quantitative comparison of plasma adiponectin for C and E group pre- and post-
intervention.  Area under the curve for each plasma sample was calculated and normalized 
against the loading control.  Results are given in arbitrary units (mean ± SD) for all subjects      
(n = 11 for both groups). * p = 0.04 compared to control group. (E Group: pre = 1.41 ± 0.66,   




Table 9. Chronic Aerobic Exercise.   
Adiponectin Correlations 
VO2max r = .17 NS 
WHR r = -.21 NS 
BMI r = -.12 NS 
BF % r = .09 NS 
And. r = -.15 NS 
Gyn. r = -.15 NS 
Average plasma adiponectin concentration compared to various correlates.  WHR Waist-to-hip 
ratio; BMI Body Mass Index; BF% Body Fat Percentage; And. Android percent fat; Gyn. 
Gynoid percent fat; NS non-significant; statistics represent data from all subjects (n = 22). 
 
 
3.3 Acute Resistance Exercise 
 Blood glucose significantly increased pre-to post-exercise (pre = 4.72 mmol/l ± 0.45,  




10.4 %.  There was no significant difference in blood glucose 24-hours post-exercise compared 
to pre-exercise levels (24 = 4.71 mmol/l ± 0.43) (Fig. 3.1).  The control trial did not yield any 
significant differences in blood glucose from pre- to immediately post- or 24 hours post-exercise 
(pre = 4.70 mmol/l ± 0.41, post = 4.70 mmol/l ± 0.44 vs. 24 = 4.72 mmol/l ± 0.45) (mean ± SD). 
Despite apparent changes in glucose utilization, plasma adiponectin was not significantly 
different pre- to post-intervention for the exercise trial nor was adiponectin significantly different 
24 hours post-exercise or between pre- post- and 24 hours post-control trial (Fig 3.2).   
Simple linear regression was used to determine correlations between average plasma 
adiponectin concentration (Adpn) and: resting blood glucose, relative strength (RS), body mass 
index (BMI), body fat percentage (BF%), regular caffeine consumption (Reg. Caff), regular 
aerobic exercise (Reg. Aex), regular resistance exercise (Reg. Rex), and first degree family 
history of type 2 diabetes mellitus (FH+).  Reg. Aex (r = 0.44) and RS (r = 0.43) were 
significantly correlated with average plasma adiponectin (p < 0.01) and FH+ (r = -0.56) was 
significantly inversely correlated with average plasma adiponectin (p < 0.01).  No other 



































Figure 3.1 Blood glucose concentration pre-exercise, immediately post-exercise, 24 hours post 
intervention. * p < 0.01 compared to the pre-exercise time point. (E Trial: pre = 4.72 ± 0.45, post 









Figure 3.2. Acute Resistance Exercise.  Western blot comparison of plasma adiponectin          
(~ 31 kda) for pre-, post-, and 24 hours post- exercise time points for subject 3 and 9. α-Tubulin 
(~ 55 kda) served as a loading control.  - Pre-Exercise Intervention; + Post-Exercise Intervention; 
24 24 hours-post intervention. 
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Figure 3.3. Quantitative comparison of plasma adiponectin for pre- post- and 24 hours post- 
intervention.  Area under the curve for each plasma sample was calculated and normalized 
against the loading control.  Results are given in arbitrary units (mean ± SD) for all subjects      
(n = 17).  (E Trial: pre = 0.69 ± 0.43, post = 0.75 ± 0.51, 24 = 0.72 ± 0.45; C Trial:                   
pre = 0.74 ± 0.39, post = 0.76 ± 0.48, 24 = 0.81 ± 0.46 AU). 
 
Table 10. Acute Resistance Exercise.   
Adiponectin Correlations 
RBG r = -.03 NS 
RS r = .42 p < 0.01 
BMI r = -.12 NS 
BF% r = -.20 NS 
Reg. Caff. r = .45 p < 0.01 
Reg. Aex. r = .22 NS 
Reg. Rex r = .18 NS 
FH+ r = -.56 p < 0.01 
Average plasma adiponectin concentration compared to various correlates.  RBG Resting Blood 
Glucose; RS Relative Strength; BMI Body Mass Index; BF% Body Fat Percentage; Reg. Caff. 
Regular Caffeine Consumption; Reg Aex. Regular Aerobic Exercise; Reg. Rex Regular 
Resistance Exercise; FH+ First Degree Family History of Type 2 Diabetes Mellitus; NS non-






3.4 Chronic Resistance Exercise 
Strength, as measured by 1RM increased significantly following training (Fig 4.1).  
Bench press increased from 97.7±18.4 kilograms (kg) to 101.8±16.2 kg, an 8.2% increase.  Squat 
increased from 129.6±30.3 kg to 143± 28.3 kg, a 13.4% increase.  Deadlift increased from 
126.3±35.7 kg to 137.2±33.2 kg, a 12.2% increase. 
Resting blood glucose did not change significantly in the E group (pre = 4.87 ± 0.34 
mmol/l, post = 4.84 ± 0.36 mmol/l) or the C group (pre = 4.94 ± 0.43 mmol/l, post = 4.83 ± 0.42 
mmol/l) (Fig 4.2). 
Body fat percentage did not change significantly in the E group (pre = 18.38 ± 4.94%, 
post = 17.73 ± 5.42%) or the C group (pre = 21.49 ± 2.02, post = 21.19 ± 3.04) and neither group 
had significantly different body fat percentage at the pre- nor post-intervention time points (Fig. 
4.3). 
Plasma adiponectin did change significantly in the E group (pre = 0.90 ± 0.48 AU, post = 
1.00 ± 0.59 AU) but not the C group (pre = 1.04 ± 0.37, post = 1.15 ± 0.53 AU) and neither 
group had significantly different concentrations of plasma adiponectin at the pre- or post-
intervention time points (Fig. 4.4). 
Simple linear regression was used to determine correlations between average plasma 
adiponectin concentration (Adpn) and: resting blood glucose (RBG), relative strength (RS), body 
mass index (BMI), body fat percentage (BF%), regular caffeine consumption (Reg. Caff), regular 
aerobic exercise (Reg. Aex), regular resistance exercise (Reg. Rex), and first degree family 

























Bench                                       Squat                                    Deadlift 
Chronic Resistance Exercise: 1RM 
* 
* * 
average plasma adiponectin (p < 0.05) and FH+ (r = -0.58) was significantly inversely correlated 









Figure 4.1. Absolute weight lifted in kilograms (kg) for a one-repetition maximum lift effort 
(1RM) (means ± SD). * P < 0.01 vs. baseline measurements. Dark bars, pre-intervention; Light 
































































Figure 4.2. Comparison of resting blood glucose between E and C groups pre- and post-
intervention.  There were no significant differences pre- to post-exercise for the E or C group and 













Figure 4.3. Comparison of body fat percentage between E and C groups pre- and post-
intervention.  There were no significant differences pre- to post-exercise for the E or C group and 




































Figure 4.4. Chronic Resistance Exercise.  Western blot comparison of plasma adiponectin (~ 
31 kda) for pre- and post-exercise time points for subjects 15, 16, and 20.  α-Tubulin (~ 55 kda) 








Figure 4.5. Quantitative comparison of plasma adiponectin for pre- and post-intervention.  Area 
under the curve for each plasma sample was calculated and normalized against the loading 
control.  Results are given in arbitrary units (mean ± SD) for all subjects (n = 36).  *p < 0.05 
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Table 11. Chronic Resistance Exercise.   
Adiponectin Correlations 
RBG r = .14 NS 
RS r = .27 NS 
BMI r = -.08 NS 
BF % r = .08 NS 
Reg. AEX. r = .36 p = 0.02 
Reg. Caff. r = .25 NS 
FH+ r = -.58 p < 0.01 
Average plasma adiponectin concentration compared to various correlates.  RBG Resting Blood 
Glucose; RS Relative Strength; BMI Body Mass Index; BF% Body Fat Percentage; Reg. Caff. 
Regular Caffeine Consumption; Reg Aex. Regular Aerobic Exercise; Reg. Rex Regular 
Resistance Exercise; FH+ First Degree Family History of Type 2 Diabetes Mellitus; NS non-
significant; statistics represent data from all subjects (n = 18). 
 
 3.5 Acute Stretching Exercise 
Stretching did significantly increase RER.  Post-hoc analysis revealed that 
supplementation did not significantly affect RER, regardless of whether subjects were stretching 
or not.  The average RER for the placebo stretching trial was 0.72, average RER for the 
melatonin stretch trial was 0.70, average RER for the placebo control trial was 0.66, and average 
RER for the melatonin control trail was 0.64 (Fig 5.1). 
Plasma adiponectin did not change significantly as a result of supplementation pre- or 
post-exercise, (M Trial: 0.99 ± 0.37; P Trial: 1.01 ± 0.38 AU) (Fig. 5.2 & 5.3a) nor as a result of 
exercise (pre = 0.99 ± 0.40; post = 1.02 ± 0.36 AU) (Fig 5.3b) and there was no interaction effect 
for supplement and exercise on plasma adiponectin concentration (p = 0.25). (PC Trial: Pre = 
0.91 ± 0.47, Post = 1.18 ± 0.34; PS Trial: Pre = 0.90 ± 0.76, Post = 0.74 ± 0.59; MC Trial: Pre = 




















Acute Stretching Exercise: RER 
Simple linear regression was used to determine correlations between average plasma 
adiponectin concentration (Adpn) and: respiratory exchange ratio (RER), body mass index 
(BMI), body fat percentage (BF%), regular caffeine consumption (Reg. Caff), regular aerobic 
exercise (Reg. Aex), regular resistance exercise (Reg. Rex), and first degree family history of 
type 2 diabetes mellitus (FH+).  FH+ (r = -0.14) was significantly inversely correlated with 
average plasma adiponectin (p = 0.04).  No other correlates were significant (Table 12).  No 
participants regularly consumed caffeine and therefore, no values are provided for the variable. 
 
Figure 5.1. Respiratory exchange ratio (RER) measured via indirect calorimetry (means ± SD) 
for placebo and melatonin trials (n = 21). *p < 0.05 vs. control trial. PS, placebo stretch trial; PC, 






























Acute Stretching Exercise: Quantification of 








Figure 5.2. Acute Stretching Exercise. Western blot comparison of plasma adiponectin (~ 31 
kda) for pre- and post-exercise time points for subjects for PS, PC, MS, and MC trials.  α-









A. Figure 5.3. Comparison of plasma adiponectin between supplements (A).  No significant 
differences were found for supplement. M Melatonin; P placebo; statistics represent data from all 
subjects (n = 21). 
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Acute Stretching Exercise: Quantification of 

















Acute Stretching Exercise: Plasma 



















Figure 5.3. Comparison of plasma adiponectin between supplements (A), pre- to post-exercise 
(B), and the interaction effect of supplement and exercise (C).  No significant differences were 
found for supplement, exercise, or interaction. - Pre-Exercise Intervention; + Post-Exercise 
Intervention; S Stretch; C Control; M Melatonin; P placebo; statistics represent data from all 




Table 12. Acute Stretching Exercise.   
Adiponectin Correlations 
RER -0.19 NS 
BMI -0.11 NS 
BF % -0.15 NS 
Reg. Caff - - 
Reg. Aex 0.24 NS 
Reg. Rex -0.20 NS 
FH+ -0.14 p = 0.04 
Average plasma adiponectin concentration compared to various correlates.  RER Respiratory 
Exchange Ratio; BMI Body Mass Index;  BF% Body Fat Percentage; Reg. Caff. Regular 
Caffeine Consumption; Reg Aex. Regular Aerobic Exercise; Reg. Rex Regular Resistance 
Exercise; FH+ First Degree Family History of Type 2 Diabetes Mellitus; NS non-significant; 














CHAPTER 4. DISCUSSION 
 4.1 Substrate Metabolism and Adiponectin  
Changes in substrate utilization during exercise do not appear to directly regulate plasma 
adiponectin concentration.  Despite significant changes in substrate metabolism, measured via 
RER and BG, during and immediately following exercise, plasma adiponectin concentration was 
largely unaltered.  It is worth noting that changes in metabolism may still alter plasma 
adiponectin but not immediately post-exercise.  Previous research has demonstrated that niacin 
supplementation suppresses lipolysis in adipocytes (103), mitigates plasma FA, and increases 
plasma adiponectin (96).  The current study did not yield any significant increases in adiponectin 
following niacin supplementation; in fact, the combination of niacin and aerobic exercise 
significantly attenuated plasma adiponectin post-exercise.  The aforementioned study was 
performed on mice and the dosage of niacin was 30 mg/kg of body weight, which was 
approximately twice the dosage administered in the current study.  It is likely if a higher dose of 
niacin had been administered, adiponectin would have significantly increased.   
Niacin supplementation negatively affected acute aerobic exercise performance in the 
current study, which may be partially attributed to changes in substrate utilization, as indicated 
by changes in RER, though there are clearly other factors, such as catecholamine release 
involved as well.  Carlson et al. (103) suggested that niacin supplementation does not directly 
affect free fatty acid (FFA) uptake or oxidation, rather it inhibits norepinephrine from binding at 
its receptor site, which in turn, inhibits FFA mobilization.  Therefore, niacin has directly 
opposing mechanisms to those of caffeine to alter substrate utilization, as discussed below.  
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Taken together, these results suggest that even for high-intensity aerobic exercise lasting less 
than 30 minutes, impaired lipid metabolism negatively affects exercise performance. 
The reasons for the significant attenuation in plasma adiponectin following niacin 
supplementation post-exercise in the current study are not readily apparent, but may have been 
due to decreased lipid oxidation or increased plasma glucose concentration.  During the niacin 
trial, RER was significantly higher compared to the placebo trial, which suggests decreased lipid 
utilization and increased glucose utilization.  Increased plasma lipids are a likely candidate for 
decreasing the expression of adiponectin.  In addition, increased plasma glucose is a major 
characteristic of insulin resistant and diabetic populations expressing low levels of plasma 
adiponectin (69).  Thus, a combination of these two factors may have driven down the 
expression of adiponectin.  Although high-intensity exercise elicits significant increases in 
growth hormone and glucocorticoids, the placebo and caffeine trials did not yield significant 
changes in plasma adiponectin.  These findings support previous research which suggests 
adiponectin is not directly regulated by endocrine responses (77, 81).   
In contrast to the effects of niacin, previous research has indicated that caffeine augments 
lipolysis and possibly lipid oxidation as well (89, 93).  Caffeine supplementation has been shown 
to elicit a greater benefit for aerobic performance compared to placebo in the current and 
previous studies (94, 104), as measured by time to exhaustion.  A study by Graham & Spriet 
(89), suggested that 6 mg/kg of body weight of a caffeine supplement improved exercise 
performance and increased plasma epinephrine concentration.  Epinephrine acts to increase both 
lipid and glucose substrate availability; although, epinephrine seems to have a greater effect on 
lipolysis than glycogenolysis (105).  Previous studies have also demonstrated that caffeine 
supplementation increased FFA mobilization from adipose tissue, lowered RER, and spared 
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muscle glycogen during submaximal acute exercise lasing 30-60 minutes (89). Since plasma 
lipid metabolites were not elevated in the study by Grahm & Spriet (89), it is likely that FFA 
mobilization as well as uptake and oxidation were up-regulated.  Compared to the placebo trial, 
the caffeine trial of the current study did not demonstrate significantly lower RER values during 
exercise, which suggests that caffeine increases lipolysis, but not necessarily lipid oxidation.  
These results may also explain why plasma adiponectin did not significantly change post-
exercise for the caffeine trial.  These conflicting results are likely due to differences in exercise 
intensity.  The current study incorporated higher intensity exercise compared to previous studies.  
Untrained individuals primarily oxidize glucose at high exercise intensities and therefore, the 
effects of increased catecholamines may have been overridden by other factors such as lactate 
accumulation and decreased blood flow to adipose tissue, thereby limiting lipid oxidation. 
The current study revealed that regular caffeine consumption was significantly correlated 
with adiponectin.  This is in agreement with a previous research study involving both diabetic 
and non-diabetic women which found habitual coffee consumption correlated with higher levels 
of adiponectin (106).  This is an interesting finding given that caffeine increases lipolysis but not 
necessarily lipid oxidation (91).  Although the cellular mechanisms responsible for increased 
expression of adiponectin with caffeine consumption are currently unknown, it has been 
suggested that regular consumption of caffeine may act to down-regulate inflammatory markers 
associated with low levels of adiponectin (107).  It is also possible that habitual caffeine 
consumption may down-regulate β-adrenergic receptor sensitivity, and consequently attenuate 




Melatonin supplementation has been shown to decrease plasma glucose, increase glucose 
transport, and increase glucose oxidation during and post-exercise (98, 108).  Melatonin has also 
been shown to decrease plasma adiponectin in rats given a high fat diet (99).  Therefore it seems 
feasible that melatonin may decrease lipid uptake and oxidation, thereby decreasing plasma 
adiponectin.  The current study; however, did not demonstrate any significant changes in plasma 
adiponectin following melatonin supplementation nor did the combination of exercise and 
melatonin have any significant effect on plasma adiponectin.  The discrepancies in these findings 
may be explained by the lack of a high fat diet in the current study, which may have eliminated 
any detectible changes in plasma adiponectin.  Interestingly, melatonin supplementation did not 
significantly affect RER in the current study, suggesting that substrate utilization was not altered 
following the administration of this supplement.  Since previous melatonin supplement research 
has revealed changes in substrate utilization during and following exercise, it seems likely that 
the stretching exercise modality was not metabolically challenging enough to elicit any 
significant changes in substrate utilization.  Whether or not other exercise modalities, in 
combination with melatonin supplementation, are sufficient to alter plasma adiponectin 
concentrations remains to be determined.  
4.2 Effects of Chronic Exercise Modalities 
During exercise, substrate metabolism is primarily dependent upon training status, 
exercise intensity, and duration (39); however, the current study suggests that substrate 
metabolism following chronic training is affected, at least to some extent, by exercise modality 
as well.  Plasma adiponectin concentration following chronic training also appears to be 
somewhat dependent on exercise modality, although the link between substrate metabolism and 
adiponectin remains unclear. 
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The current study revealed that chronic resistance training significantly increased plasma 
adiponectin concentration whereas chronic aerobic training did not significantly increase 
adiponectin.  Combined, these results further suggest that substrate metabolism does not directly 
regulate plasma adiponectin concentration.  Chronic exercise modality; however, does have a 
significant effect on substrate utilization.  The present study did not reveal any significant 
changes in resting blood glucose; however, the participant population for both the E and C 
groups were young, active, and insulin sensitive, therefore detecting significant changes in this 
variable was difficult.  Although not directly measured for this exercise modality, it is likely that 
glucose utilization during exercise was up-regulated following chronic training.  Previous studies 
have demonstrated that resistance-trained individuals appear to have a high percentage of type II, 
glycolytic fibers, and thus few mitochondria and a low capacity to oxidize fatty acids (61), but 
increased glycolytic enzyme activity (12) and capacity to oxidize carbohydrates (60).   
Conversely, endurance-trained individuals demonstrate a high percentage of type I, 
oxidative fibers, and thus, an increased size and number of mitochondria and an elevated 
capacity to oxidize fatty acids (14).  However, unlike resistance training, which exclusively 
increases the body’s ability to utilize carbohydrate sources for energy, endurance training 
increases the body’s ability to use all substrates.  Following endurance training, GLUT-4 (109) 
and hexokinase (110) activity increase, gluconeogenic capacity has been shown to increase in rat 
liver (111), and glycogen is spared to a greater extent compared to sedentary controls (39).  It has 
been suggested that this glycogen sparing in endurance-trained individuals is due to increased 
blood glucose availability and uptake, not increased lipid utilization and that catecholamines and 
glucagon raise less while insulin falls less following training, thereby sparing glycogen by 
increasing blood glucose utilization at low exercise intensities (39). 
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Despite the increased blood glucose utilization, lipid oxidation has been shown to 
significantly increase following chronic aerobic training (14).  Lipid oxidation has also been 
shown to increase during long duration (> 1 hour) aerobic exercise (30).  Participants for the 
current study’s chronic aerobic training modality were training for a marathon and therefore, 
one-to-two sessions per week were greater than an hour in duration, on average.  Although 
duration is a confounding variable for the present study, several studies have shown that chronic 
aerobic training of less than one hour elicits an up-regulation in lipid metabolism (16), thus, a 
chronic aerobic exercise training modality will increase the body’s dependence on lipid 
metabolism during exercise.  It is likely that this shift in lipid metabolism may partially account 
for the observed significant reduction in body fat following the chronic aerobic exercise 
modality, despite the lack of overall body weight reduction in the present study.  While a shift in 
energy balance will result in total body weight reduction, body fat reduction in the absence of 
weight loss may be dependent on increased lipid oxidation.   
In the present study, regular aerobic exercise weakly, but significantly correlated with 
adiponectin, which may suggest that this type of exercise limits plasma lipid concentration via 
increased lipid transport and storage, as previous research has suggested (69).  Specifically, there 
may be increased lipid synthesis in the form of IMCL, given that this form of lipid storage is 
increased following endurance exercise (22).  Further research examining lipogenic enzymes and 
transporters concomitantly with plasma adiponectin is needed. 
Despite the correlation with regular aerobic exercise and plasma adiponectin, the chronic 
aerobic exercise intervention did not significantly increase adiponectin.  Conversely, regular 
resistance training exercise did not significantly correlate with plasma adiponectin, whereas the 
chronic resistance training intervention did significantly increase adiponectin.  The reasoning for 
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this apparent disconnect is likely due to both training status as well as exercise intensity and is 
consistent with the literature which shows an augmentation in adiponectin following some 
chronic exercise studies (87), but no changes in adiponectin following other chronic exercise 
studies (88).  The less trained an individual and the higher the exercise intensity, the more likely 
it is that adiponectin will significantly increase as a result of training.  In the present study, the 
chronic aerobic training modality was high-intensity marathon training; however, all participants 
were previously engaged in habitual, recreational aerobic exercise, and therefore these 
participants exhibited significantly higher levels of plasma adiponectin compared to the control 
group both at the onset of the study and following the exercise intervention, limiting the degree 
of change in this hormone as a result of exercise.  Conversely, participants for the chronic 
resistance training modality did not engage in habitual physical activity prior to the exercise 
intervention.  The chronic resistance training modality was high-intensity, well above the typical 
intensity for individuals that regularly engage in this type of exercise.  Combined, these variables 
readily explain why plasma adiponectin increased following chronic resistance, but not aerobic 
training.  The mechanisms for this change remain unknown.  Further research examining 
lipogenic or glycogenic enzymes and plasma adiponectin in sedentary individuals may reveal 
specific mechanisms responsible for the changes in adiponectin concentration. 
4.3 Effects of Acute Exercise Modalities 
It should be noted that most studies examining complete substrate utilization during and 
following acute exercise consist of protocols that are upwards of two hours in duration (30, 47, 
112) yet most individuals that participate in regular exercise for health purposes are not likely to 
engage in any type of exercise activity exceeding an hour in length in a given day.  Thus, it was 
important to examine substrate utilization during and following less than one hour of activity. 
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Similar to chronic exercise modalities, the present study demonstrated that substrate 
metabolism during and following acute exercise modalities was primarily dependent upon 
intensity and habitual training modality.  In contrast to chronic exercise modalities, acute 
exercise modality did not appear to have any effect on substrate utilization.  The acute aerobic, 
acute resistance, and acute stretching modalities for the current study were similar in duration 
(approximately thirty minutes each) and the intensity for each modality was considered high-
intensity, according to the 2011 American College of Sports Medicine (ACSM) position stand 
for exercise guidelines (113).  This approach minimized potential confounding variables. 
As expected, the acute aerobic exercise modality revealed that as exercise intensity 
increases, the body’s dependence on glucose oxidation increases while the body’s dependence on 
lipid oxidation decreases.  Independent of the addition of supplements, this change in substrate 
metabolism as a result of exercise did not significantly change plasma adiponectin concentration.  
Previous acute aerobic exercise studies have shown decreases in plasma adiponectin (67), 
increases in HMW adiponectin (35), and no change in plasma adiponectin (86).  However, 
decreases in total adiponectin were seen in elite athletes immediately post-exercise, increases in 
HMW adiponectin were seen in obese individuals, and no changes in total adiponectin were seen 
in healthy, untrained individuals.  Therefore, the current results support the existing research on 
plasma adiponectin responses to acute aerobic exercise and further suggest that acute changes in 
adiponectin may be dependent on plasma lipid content, which is elevated in elite endurance 
athletes immediately post-exercise and is suppressed in sedentary, obese individuals immediately 
post-exercise. 
The incorporation of supplements in concert with acute aerobic exercise revealed that 
caffeine enhances aerobic performance while niacin negatively affects aerobic of performance.  
75 
 
The underlying cause for this response is partially attributed to changes in substrate utilization as 
previously suggested, though the current study suggests that these changes are different between 
males and females.  Previous studies have also demonstrated greater fat oxidation and higher β 
oxidative enzyme content in female skeletal muscle compared to male counterparts (114).  
However, the study also revealed that there were no significant differences between males and 
females for the transcription factor PPAR, which plays a major role in several genes involved in 
lipid metabolism and the regulation of adiponectin.  Interestingly, females have exhibited higher 
plasma HMW adiponectin concentration (53) as well as total plasma adiponectin concentration 
(115) compared to males matched for BMI.  It is likely that increased lipid oxidation in females 
may be partially responsible for the gender differences in adiponectin; therefore further research 
is warranted to investigate these issues. 
The acute stretching exercise modality of similar duration and intensity (30 minutes at 
high-intensity) significantly increases RER compared to the control trials; however, plasma 
adiponectin did not significantly change post-exercise.  This appears to be the first study to 
examine the effects of passive resistance stretching on adiponectin.  Similar to acute aerobic 
exercise, it seems that even in the presence of substrate shift, plasma adiponectin is unaffected in 
young, healthy populations.  The increase in RER and subsequent increase in glucose oxidation 
is likely due to increased muscle contraction.  Increased muscle contraction alone does improve 
insulin sensitivity (40), although this improvement appears to be independent of adiponectin.  
Therefore, it may be suggested that while improvements in insulin sensitivity as a result of 
chronic exercise training are partially due to increased plasma adiponectin, improvements in 
insulin sensitivity as a result of acute exercise appear to be independent of plasma adiponectin.  
Acute high-intensity, passive-resistance stretching exercise will result in only minimal increases 
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in overall energy expenditure and elevation in metabolism as seen in the present study; therefore; 
further research investigating the effects of chronic stretching exercise on plasma adiponectin in 
sedentary populations may be useful given that habitual exercise is correlated with increased 
insulin sensitivity and increased adiponectin.  This exercise modality could be an attractive 
alternative form of exercise for individuals unwilling or unable to engage in aerobic exercise 
modalities. 
The acute resistance exercise modality of the present study was similar in duration and 
intensity to both the acute aerobic and acute stretching modalities (30 minutes, high-intensity) 
and resulted in significantly increased blood glucose immediately post-exercise.  Not 
surprisingly, blood glucose levels 24-hours post-exercise were similar to those seen at baseline.  
An augmentation in hepatic glycogenolysis, and to a lesser extent, gluconeogenesis, are 
responsible for the observed increases in blood glucose immediately post-exercise (39), 
indicating that glucose utilization is up-regulated following an acute resistance exercise regimen.  
The increased utilization of glucose; however, was not associated with any changes in plasma 
adiponectin immediately post-exercise.  Previous research has indicated that acute resistance 
training leads to an up-regulation of lipolysis from adipose tissue post-exercise (116) and an 
increase in lipid oxidation for up to 24 hours post-exercise (26).  Importantly, immediately 
following exercise, the activation of lipolysis is delayed in obese populations compared to lean 
populations and fat oxidation during acute resistance exercise is lower.  This may help to clarify 
why sedentary or obese populations continually demonstrate improvements in plasma 
adiponectin following acute exercise while lean populations do not.  Limited lipolysis and 
consequently, limited plasma lipids may up-regulate plasma adiponectin immediately following 
exercise.  To date, no studies have examined plasma adiponectin responses to acute resistance 
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exercise.  It seems likely that, similar to other acute exercise modalities, changes in adiponectin 
are more likely to occur in sedentary or obese populations.  Further research is needed to 
examine plasma adiponectin responses to acute resistance exercise in these populations. 
It should be noted that plasma adiponectin concentration is lower in patients with 
coronary artery disease as well as patients with type 2 diabetes, and is inversely correlated with a 
poor lipid profile (117) and elevated inflammatory markers such as TNF-α (118).  Acute aerobic 
exercise has been shown to increase TNF-α in healthy populations without any concomitant 
increase in plasma adiponectin (86).  Combined, these results suggest that inflammatory markers 
do not regulate adiponectin, but rather they are a likely byproduct of chronic elevated plasma 
lipids, which as suggested by the current study, acts to drive down the expression of adiponectin.  
Also, while plasma lipids are controlled in large part by diet and exercise, genetic predisposition 
to high plasma TAG levels, high LDL, or low HDL may contribute to lower levels of plasma 
adiponectin (119) and may help explain why some individuals are more susceptible to the 
development of insulin resistance and type 2 diabetes. 
The most significant and striking correlation of the current study was the strong inverse 
correlation between plasma adiponectin and first degree family history of type 2 diabetes.  This 
finding further suggests genetic predisposition to the development of insulin resistance may be a 
direct result of low levels of adiponectin.  Elevated plasma lipids likely drive down the 
expression of plasma adiponectin via down-regulated expression of mRNA in the adipocyte (82).  
It has also been suggested that adiponectin mRNA is directly regulated by insulin (79).  The 
specific regulation of various gene transcription factor activation is beyond the scope of this 
study, but this area of investigation can potentially provide more in-depth explanations for the 
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link between first degree family history of type 2 diabetes and low expression of plasma 
adiponectin.  
Previous findings combined with the current findings on adiponectin and exercise 
indicate that exercise-mediated improvements in insulin sensitivity following chronic training 
may be partially due to increased plasma adiponectin; however, short-term improvements in 
insulin sensitivity are likely due to other factors.  It is worth investigating substrate utilization 
and plasma adiponectin several hours post-exercise as lipid oxidation and lipid storage both 
increase following exercise (22) while plasma lipids decrease, potentially leading to an up-
regulation in adiponectin. 
4.4 Limitations 
The participant population for the current study was young, active, and insulin sensitive.  
It is likely that this population had high levels of adiponectin at the onset of the study; therefore, 
eliciting significant changes in this hormone may have been compromised in this population.  If 
sample sizes for both of the chronic exercise modalities had been larger, it would have been 
useful to stratify participants based on percent decrease in body fat pre- to post-exercise to 
determine potential correlations with changes in adiponectin and total body fat percentage.  
Studies have shown that plasma adiponectin concentration significantly increases following 
weight loss (118), however the number of participants in the current studies that demonstrated 
significant decreases in percent body fat following exercise intervention were too few to 
determine statistical significance.  Additionally, relative concentration of plasma adiponectin was 
measured using a western blot technique, as opposed to the measurement of absolute 
concentration of adiponectin via enzyme-linked immunosorbent assay (ELISA) or 
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radioimmunoassay (RIA).  While specific concentration cannot be determined from a western 
blot technique, it does account for plasma volume shift which is not accounted for in numerous 
exercise studies involving plasma adiponectin.  Also, plasma adiponectin concentration in 
humans varies considerably in healthy populations.  Some studies report concentrations as low as 
6 µg/ml (88) while other studies report concentrations as high as 20 µg/ml (86).  Thus the current 
study eliminated this issue by determining relative change. 
The current study did not incorporate muscle or adipose tissue biopsies. While muscle 
biopsies would have provided useful information in regards to changes in adiponectin mRNA, 
AdipoR1, and AdipoR2 receptor expression, the use of biopsies were beyond the scope of the 
current study and likely would have compromised the number of study participants.  In addition, 
skeletal muscle fiber composition, and likely receptor expression, at the origin may be different 
than at the insertion (120), making it difficult to determine which changes are truly due to the 
training adaptation. 
Lastly, the HMW isoform of adiponectin, which has been correlated more strongly with 
insulin sensitivity than total serum adiponectin (64), was not measured in the current study.  
However, all subjects were insulin sensitive and  the HMW form has not been shown to change 
following exercise in lean, healthy individuals (65).  Furthermore, this isoform is not associated 
with acute improvements in insulin-sensitivity (66) whereas total adiponectin has been shown to 
change following exercise in some studies involving lean, healthy individuals (67).  Thus, the 
focus of this dissertation was to determine if changes in substrate utilization directly affected 




CHAPTER 5. CONCLUSIONS 
The current study demonstrates that changes in substrate utilization during and following 
exercise are not directly related to changes in plasma adiponectin.  Furthermore, while both 
chronic and acute exercise modalities affect substrate utilization during exercise, only high-
intensity chronic exercise appears to increase plasma adiponectin concentration.  Substrate 
oxidation may not be responsible for the shift in plasma adiponectin concentration following 
chronic exercise training; rather the increase seen in the present and previous studies may be due 
to increased lipid clearance from the plasma, as was evident following niacin supplementation.   
Inducing significant changes in adiponectin via exercise appears to be dependent on 
habitual activity as indicated by the lack of prior physical activity in the participants in the 
chronic resistance training modality, which demonstrated significant augmentation in plasma 
adiponectin post-exercise.  On the other hand, the higher levels of prior physical activity in the 
participants in the chronic aerobic training modality minimized improvements in plasma 
adiponectin post-exercise, but demonstrated significantly higher plasma adiponectin compared to 
the less active control group at both time points. 
The results of this study provide important implications for exercise prescription to both 
improve insulin sensitivity and increase plasma adiponectin.  While high-intensity exercise 
increases the body’s dependence on glucose oxidation acutely, lipid clearance appears to 
improve following this type of training both acutely and chronically.  Thus, engaging in high-
intensity exercise may provide greater benefits in improving insulin sensitivity compared to low-
or moderate-intensity exercise.   
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Whether or not aerobic or resistance training exercise elicits greater improvements in 
plasma adiponectin remains to be determined.  While aerobic exercise clearly has its benefits, if 
patients do not regularly adhere to this type of exercise throughout their lives, plasma 
adiponectin and overall health status is not likely to improve.  With a limited aerobic capacity in 
these patients, especially in the early stages of training, engaging in resistance training appears to 
offer an attractive alternative to possibly help combat obesity and the development of insulin 
resistance and type 2 diabetes; however, much more research is needed to establish specific 
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CHAPTER 1:  The problem with excess energy intake/insufficient energy expenditure 
 
Introduction 
Diabetes is a chronic disease that is characterized by elevated blood glucose levels.  In 
2005, the centers for disease control (CDC) estimated that approximately 20.8 million people 
were suffering with diabetes, and of those, 90-95% had non-insulin dependent Diabetes Mellitus 
(NIDDM or Type 2 Diabetes).  The CDC also states that this disease leads to a variety of 
secondary health problems including heart disease, stroke, hypertension, blindness, kidney 
disease, nervous system damage, amputations, and dental disease.  
 Although the etiology of diabetes is far from being fully understood, there are several 
known factors that contribute to the development of diabetes including genetics, lifestyle factors, 
and levels of adiposity (18, 121), all of which must be taken into consideration when examining 
this disease.  Substantial evidence over the years has indicated that the one of the major 
predictive causes of type 2 diabetes is obesity, the prevalence of which has increased 
dramatically over the past 20 years (122) and is likely to continue to increase primarily due 
modern lifestyle factors including an overconsumption of calories and lack of physical activity.  
Therefore, gaining further insight into the development and prevention of diabetes is of high 
importance to help minimize the prevalence of this disease.  Research has overwhelmingly 
indicated that type 2 diabetes is preceded by several years of insulin resistance, hyperglycemia, 
and hyperlipidemia both in skeletal muscle and in the liver.  In this review, the main focus for the 
development of type 2 diabetes will revolve around this concept.  The main focus for the 
prevention of type 2 diabetes will be centered on various forms of acute and chronic exercise 
given that numerous studies have shown that insulin resistance can be reversed with the addition 
of acute or chronic exercise (15, 22). 
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Insulin, which is one of the hormones responsible for maintaining blood glucose 
homeostasis, is released at an elevated rate following feeding.  Insulin signals skeletal muscle 
and adipose tissue to uptake the circulating glucose, which is either stored in the form of 
glycogen or it can be oxidized and used for energy (7).  In either case, blood glucose levels are 
maintained following feeding via insulin signaling.  When an individual becomes insulin 
resistant, the tissue’s ability to uptake glucose from the blood becomes impaired, resulting in 
chronic elevated blood glucose levels.  From a mechanistic standpoint, hepatic, adipose, and  
skeletal muscle tissue insulin resistance do not develop following identical signaling pathways 
nor is this insulin resistance reversed following the same pathways (34).  This notion is 
extremely important must be considered when examining the various mechanisms involved in 
insulin resistance.  
Although the liver and adipose tissue play critical roles in energy homeostasis and whole-
body insulin sensitivity, the focus of this review will be on the role of skeletal muscle.  There are 
two critical reasons for this.  The first is that skeletal muscle has a large relative mass which 
requires a high amount of energy to maintain.  In addition, skeletal muscle is responsible for all 
mechanical work, and is thus metabolically active tissue with high energy demands.  In fact, 
when the body is at a relatively stable balance, the majority of ingested carbohydrates are either 
stored in skeletal muscle or oxidized in skeletal muscle to provide immediate energy (123).  The 
second reason for investigating skeletal muscle in greater detail is that skeletal muscle plays a 
critical role in fatty acid oxidation.  At rest, approximately 60-80% of muscle energy production 
is provided by fat oxidation (124).  During exercise, there is a shift of substrate utilization and 
the body becomes more dependent on glucose oxidation.  Clearly, energy homeostasis is largely 
dependent on the metabolic state of skeletal muscle.  When the metabolism of skeletal muscle 
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becomes impaired, fat oxidation is compromised and insulin resistance can result.  Indeed, the 
development of insulin resistance has been linked to impaired lipid metabolism in skeletal 
muscle, although the mechanisms remain somewhat unclear. 
Therefore, the purpose of this review is to address lipid metabolism in skeletal muscle, its 
links to insulin resistance, and how this insulin resistance can be reversed with the addition of 
exercise training or calorie restriction.  Since there are numerous interacting factors that could 
possibly contribute to insulin resistance, the first chapter will briefly address some of the current 
major focus areas relating to lipid metabolism and cellular signaling.  The second and third and 
chapters will address lipogenesis and lipolysis, respectively, in healthy and insulin resistant 
individuals.  This will identify possible cellular mechanisms that may be responsible for 
impaired insulin signaling as a result of lipid accumulation and lipid intermediate accumulation.  
The fourth chapter will discuss the effects of exercise on lipid synthesis and degradation to 
identify mechanisms that may be responsible for improved insulin signaling following exercise.  
Based on these findings, the fifth and final chapter will offer future directions for this area of 
research. 
Energy Imbalance   
During periods of starvation, the human body will readily break down energy stores, 
mainly energy stores in the form of lipids, in order to sustain normal function.  Similarly, during 
periods of food abundance, the human body has an astounding ability store excess energy, 
mostly in the form of triacylglycerols (TAG) in white adipose tissue (WAT) (125), which once 
again can be used as an energy source during periods of starvation.  This ability has been critical 
to the survival of our species during times of famine.  However, in more developed countries in 
modern times, a combination of technology and societal norms has encouraged sedentary 
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behavior and overconsumption (126).  Thus, the body’s efficient ability to store excess energy 
has recently lead to a wide range of health disparities.  Over an extended period of time, 
excessive physical inactivity in combination with overconsumption of food can result in an array 
of chronic diseases including obesity, cardiovascular disease, and diabetes (127).  As will be 
discussed in detail in chapter four, many of these abnormalities can be reversed with the addition 
of exercise although the mechanisms for these adaptations remain unclear.   
It will become evident throughout this review that although many of the cellular 
mechanisms responsible for changes in insulin sensitivity are currently unknown, the human 
body will adapt regardless of the stress placed on the body in order to maintain a homeostatic 
state.  Much like the body becomes trained to utilize fats as a primary fuel following chronic 
endurance training, in the case of chronic energy abundance, the body becomes trained to store 
rather than oxidize excess fat.  With a decreased ability to oxidize fats, the body must primarily 
rely on glucose oxidization, even in a fasted state, to provide energy.  This is what has been 
observed in obese human subjects.  A study by Kelley et. Al (55) revealed that when the 
respiratory quotient (RQ) was measured across the leg muscles of obese subjects, RQ averaged 
0.90 in a fasted state, indicating glucose was the primary fuel source.  On the other hand, fasted 
lean subjects had an RQ of 0.82 indicating a greater reliance on fatty acids for fuel (55).  This 
increased reliance on glucose for fuel has been linked to hyperlipidemia and metabolic 
dysfunction.  This makes sense given that if fat is not utilized for fuel, it will remain in the 
circulation, raising lipid levels, or will be stored in adipose tissue which seemingly has no 
maximal storage capacity.  Conversely, although glucose can be stored to some extent in skeletal 
muscle and liver in the form of glycogen, there is a limit to how much of this can be stored.  
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Thus, the body may preferentially oxidize excess glucose first, while only minimally oxidizing 
lipids, storing the rest in adipose, skeletal, and hepatic tissue. 
It is likely that excess lipid storage, not only in adipose tissue, but also in skeletal muscle 
and around organs such as the heart, liver, and kidneys can lead to metabolic dysfunction (8).  
However, the exact mechanism(s) responsible for this abnormal metabolic regulation is not fully 
understood.  There are several current hypotheses to explain the development of insulin 
resistance, many of which are interconnected as seen in figure A1. 
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Excess lipid storage in adipose


























utilization of lipids as 
fuel source
Lack of physical activity
↓ Skeletal muscle 
oxidative capacity
↓G6P concentration
↑ Hepatic glucose 
production
 
Figure A1.  A general overview of some of the proposed mechanisms linked to the development 
of diabetes.  G6P= glucose-6 phosphate; ER= endoplasmic reticulum; IRS-1= insulin receptor 
substrate-1; DAG= diacylglycerol. 
Recent research has suggested that specific peptide hormones and inflammatory 
cytokines, specifically adipokines, which control the communication between various 
metabolically active tissues and organs, including the liver, skeletal muscle, and fat (128) may 
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play a role in regulating insulin sensitivity.  Adipocyte signaling can greatly affect the 
development of skeletal muscle insulin resistance and will be addressed briefly here.   
Adipocyte-derived hormones 
 Peptide hormones including leptin, adiponectin (ACRP30), retinol-binding protein 
(RBP4), and resistin have all been implicated in the development of insulin resistance (18).  Each 
of these hormones are secreted by adipocytes and play an active role in lipid storage and 
mobilization.  In healthy, normal-weight individuals, adiponectin and leptin act to regulate 
energy storage and energy expenditure.  As leptin levels increase, metabolism increases and 
appetite decreases (129).  However, as a result of obesity, individuals become leptin resistant, 
resulting in higher levels of circulating leptin.  This mechanism is similar to that seen in insulin 
resistance, in which hormone signaling is impaired despite increased circulating levels.  
Conversely, adiponectin, which plays a critical role in glucose and lipid metabolism, has been 
shown to decrease with obesity (71).  Since these two hormones appear to have complementary 
actions and it has been suggested that both act to decrease TAG synthesis, increase β-oxidation, 
and activate 5’-AMP-activated protein kinase (AMPK).  Thus, they are said to be insulin-
sensitizing hormones, which are secreted preferentially from small adipocytes.  RBP4 and 
resistin on the other hand, have been deemed insulin-desensitizing and are secreted preferentially 
from large adipocytes (8).  RBP4 and resistin act to decrease glucose uptake and encourage 
gluconeogenesis, which during fasting, helps maintain normal glycemic levels in the blood.  
However, in a state of chronic overfeeding, the protective action of these hormones becomes a 
plausible contributor to the development of insulin resistance and type 2 diabetes (128).   
It has been demonstrated that fasting can lead to a down-regulation of adipose GLUT-4 
mRNA expression in rats, (130) and several studies have shown that lower GLUT-4 levels are 
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linked to the development of insulin resistance (131).  Although there are several tissue-specific 
glucose transporters, GLUT-4 is the primary transporter in skeletal muscle and adipose tissue 
and appears to be the only one which is insulin-dependent (132).  Thus, it is possible that chronic 
depressed levels of the GLUT-4 protein in adipose tissue as a result of fasting can lead to 
hyperinsulinaemia and eventual insulin resistance, although further research is still needed to 
support these ideas.    This may seem counterintuitive considering that overwhelming evidence 
points to overconsumption leading to insulin resistance.  However, consider that in a fasted state 
plasma insulin levels are low.  In turn, to prevent hypoglycemia, GLUT-4 expression will be 
down-regulated.  This concept has been supported by adipose GLUT-4 knockout (KO) mouse 
models, which demonstrate decreased glucose uptake into the cell and increased insulin 
resistance in skeletal muscle and liver despite normal GLUT-4 function in these tissues (131).   
It should be noted that excess body fat does not cause insulin resistance per se.  Though 
adipose tissue appears to have a limitless capacity, the formation of adipocytes is highly 
regulated and it has been suggested by some that adipose tissue storage capacity is limited via 
TNF-α or other inflammatory cytokine signaling molecules (133).  Some researchers have 
suggested that once this storage capacity is reached, excess lipids are forced to be stored in and 
around organs that do not normally accumulate high lipid levels, this in turn, makes the organs 
more susceptible to lipotoxicity and local insulin resistance (128).  Therefore in theory, a 
therapeutic strategy to combat insulin resistance could involve the expansion in the storage of 
lipids in subcutaneous adipose tissue, blunting the metabolic deficiencies that are normally 
associated with obesity, as long as lipid overflow into other tissues and organs is limited.   The 
problem with this idea, however, is that adipose tissue, as previously mentioned, is an endocrine 
organ which secretes hormones and adipokines.  In the presence of expanding adipose tissue, 
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specific signaling molecules are likely to lead to systemic insulin resistance, similar to what has 
been seen in mouse models (131). 
Based off these findings, it is apparent that adipose tissue is a metabolically active 
endocrine organ that responds to changes in energy demands.  Excess energy intake results in 
adipogenesis, however, this is not a passive process, rather it requires energy, is highly regulated, 
and involves a complex array of transcriptional activation as well as inter- and intracellular 
signaling (128) through hormones, as previously discussed, as well as adipokines. 
 
Inflammatory Cytokines   
While there are several pro-inflammatory cytokines that may be linked to obesity and 
insulin resistance, tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6) are two of the 
most studied and will be addressed briefly here.  TNFα is involved in the regulation of immune 
cells, it can induce apoptosis, inhibit tumor growth, and induce inflammation (134).  However, 
this cytokine has also been implicated in the development of insulin resistance.  Over-expression 
of this cytokine acts to inhibit insulin action and was demonstrated in obese mouse and human 
models (135).  TNFα also activates the c-Jun amino terminal kinases (JNKs), which promotes 
the phosphorylation of the serine residue on insulin receptor supstrate-1 (IRS-1), which has been 
shown to induce insulin resistance (136).  Interestingly, TNFα also acts to promote lipolysis as 
well as inhibit adipogenesis and adipocyte differentiation (133).  Although this may seem 
contradictive given that insulin resistance is highly correlated with excess lipid storage, as will 
be discussed in chapters two and three, incomplete synthesis and degradation of lipids via TNF-α 
or otherwise, is a plausible underlying mechanism which contributes to insulin resistance.  
Increased lipids in the circulation due to increased lipolysis and decreased adipogenesis may also 
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be partially responsible for impaired insulin signaling.  Furthermore, inhibition of adipogenesis 
also suggests that TNF-α may act to limit the storage capacity of adipose tissue.  Thus as an 
oversupply of calories continues, this creates a need for excess lipids to be stored in other organs 
such as skeletal muscle and liver.  As a result, lipotoxic intermediates such as diacylglycerol 
(DAG) and ceramides are formed.  The deleterious effects of these metabolites on the insulin 
signaling cascade is well established (56) and will be discussed further in the next section of this 
chapter.   
IL-6, which much like TNFα, acts to stimulate immune response to injury, is another pro-
inflammatory cytokine that has also been shown to induce insulin resistance.  The accumulation 
of fat deposits around organs appears to be responsible for this outcome through activation of the 
transcription factor NF-κB, which is responsible for the production of several cytokines, 
including IL-6 and TNFα (137).  It is likely that these and other cytokines have additive effects; 
however, the relative contribution of each of these cytokines is not readily apparent.  What is 
apparent is that adipokines play a significant role in the development of insulin resistance and 
that there is a link between these adipokines and lipid accumulation in organs such as skeletal 
muscle and the liver.  The question becomes whether these cytokines are a cause or an effect of 
abnormal lipid storage.  The nature of cytokines would suggest the latter; however, further 
research is still needed to support this notion. 
The treatment of chronic inflammation has been targeted as a potentially novel strategy in 
the prevention and treatment of type 2 diabetes.  Non-steroidal anti-inflammatory drugs 
(NSAID), particularly aspirin, which is an acetylated salicylate drug, has been shown to reduce 
inflammation by irreversibly modifying the active site on cyclooxygenase (COX) 1 and 2 and in 
turn, inhibiting prostaglandin formation.   High doses of salicylates have also been shown 
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directly lower blood glucose levels and improve insulin sensitivity in diabetic patients by direct 
inactivation of IKKβ (138).  When activated, IkB kinase-β (IKKβ) will activate NF-kB, which 
produces pro-inflammatory markers such as IL-6, TNF-α, and resistin, which as mentioned in 
chapter one, have been linked to insulin resistance.  Also, macrophages may amplify this signal, 
which demonstrates that the development of IR may have similar/parallel mechanisms to other 
inflammatory diseases such as atherosclerosis.  However, it is important to note that it is 
assumed that adipocytes, not skeletal muscle cells, initiate inflammation-mediated IR since 
accumulated lipid stores are predominantly in these types of cells (139).  The inflammatory 
cascades seen in adipose and liver cells from increased adiposity are not seen in skeletal muscle, 
there is no activation of IKKβ/NF-kB or increases in macrophages.  Inflammation in skeletal 
muscle is only seen in lipid infusion models, which indicates again that skeletal muscle IR does 
not cause inflammatory responses, rather skeletal muscle IR occurs as a result of inflammatory 
responses. 
Though a link appears to be established between insulin resistance and lipid accumulation 
around organs, rather than in subcutaneous adipose tissue, the exact mechanism(s) responsible 
for this dysregulation is currently a matter of debate and clearly requires further investigation.  
There are two opposing theories, one suggesting decreased β oxidation, and the other suggesting 
increased, but incomplete β oxidation, both of which will be addressed here.   
Decreased β oxidation  
The rationale for the popular theory which suggests reduced β oxidation leads to insulin 
resistance follows a seemingly intuitive and logical line of reasoning.  Feeding stimulates the 
conversion of acetyl CoA to malonyl CoA by acetyl-CoA carboxylase (ACC).  Malonyl CoA is 
responsible for the inhibition of carnitine palmitoyltransferase 1 (CPT1), which controls entry of 
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fatty acids into the mitochondria for β oxidation (18).  Immediately following feeding, the 
oxidation of fat stores is no longer necessary to provide energy.  Thus, long chain acyl CoAs 
(LC-CoAs) which are partitioned toward mitochondrial oxidation in a fasted state, are redirected 
toward the synthesis of TAG, diacylglycerol (DAG), and ceramides in a fed state (140).  Chronic 
overfeeding, therefore, leads to decreased β oxidation and an accumulation of lipid 
intermediates, particularly DAG, which phosphorylates several kinases, including several protein 
kinase C (PKC) isoforms (54).  This in turn, phosphorylates serine kinases on insulin receptor 
substrate-1 and -2 (IRS-1 and IRS-2), which again, have been shown to negatively influence 
insulin-induced glucose uptake (136).  This is likely due to  a decrease in GLUT-4 translocation 
via a signaling cascade described elsewhere (54). 
In addition, it has been demonstrated that patients with type 2 diabetes have smaller and 
fewer number skeletal muscle mitochondrial as well as decreased mitochondrial enzyme activity 
compared to healthy controls (141), thus the rate of oxidative phosphorylation is significantly 
reduced, causing lipid accumulation within the muscle.  However, it should be noted that in this 
study, the diabetic subjects were approximately ten years older than the control subjects.  It has 
been shown that mitochondrial density and mitochondrial adenosine triphosphate (ATP) 
synthesis are reduced with age (142), therefore it is possible that age may have influenced these 
results and must be taken into consideration.  However, other studies have revealed similar 
results which point toward overall reduced fat oxidation in skeletal muscle of fasted insulin 
resistant subjects (143).  The activity of citrate synthase (CS) and cytochrome c oxidase, which 
are thought to be the rate-limiting enzymes involved in the tricarboxcylic acid (TCA) cycle and 
Electron Transport system (ETS), respectively were also down-regulated in insulin resistant, 
obese subjects (144).  It has also been shown that the expression of hormone sensitive lipase 
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(HSL) and adipose triglyceride lipase (ATGL), both of which hydrolyze triglyceride stores, are 
down-regulated in insulin resistance (145).  Together, these results suggest that not only is β 
oxidation decreased, but fatty acid hydrolysis may be down regulated as well.  The extent of lipid 
breakdown in insulin resistant individuals is yet to be determined and warrants further 
investigation as will be discussed further in chapter three. 
Another reason that decreased fatty acid oxidation is a popular theory to explain the 
connection between lipid accumulation in skeletal muscle and insulin resistance is because of 
changes in fatty acid transport and translocation.  Initially, it may seem logical that decreases in 
oxidative enzymatic activity as well as decreased expression of the fatty acid translocation 
protein (FAT/CD36) could explain the lack of fat utilization as seen in some studies (9) (146).  
However, given that insulin resistant individuals have elevated levels of intramyocellular lipids 
(IMCL), more recent studies have shown that CD36 expression is actually increased in type-2 
diabetics, yet the translocation of CD36 to the plasma membrane is impaired.  This results in 
increased fatty acid uptake, but decreased oxidation due to the decreased transport of fatty acids 
to the mitochondria (147).  Indeed, CD 36 KO mice have shown improvements in insulin 
sensitivity in skeletal muscle (148).  This is likely due to the lack of lipid accumulation in the 
muscle; however, these KO mice had decreased insulin sensitivity in the liver.  This was likely 
due to increased lipid accumulation in the liver and suggests tissue-specific mechanisms 
involved in the development of insulin resistance.  It also suggests that there are significant 
differences between the regulation of glucose versus lipid transporters.  While increased lipid 





Incomplete β oxidation 
In contrast to the theory of decreased β oxidation, recent studies have suggested that 
insulin resistance leads to increased, but incomplete, β oxidation.  No matter what type of stress 
placed on the body, under normal conditions, the human body will adapt to better handle the 
stress and maintain a homeostatic state, beginning with changes at the molecular level.  Thus, the 
theory of incomplete β oxidation is as follows: 
Much like the changes seen in gene expression following chronic exercise training, 
chronic exposure to elevated lipids in skeletal muscle up-regulates various genes involved in β 
oxidation to compensate for this constant stress.  However, unlike the changes seen with 
exercise,  exposure to high levels of lipids appears to have no effect on the TCA cycle or ETS 
(140).  This results in an accumulation of acetyl CoA, which is the end product of β oxidation.  
When energy supply is greater than energy demand, these accumulated acetyl CoAs are 
converted to acylcarnitines (8).  A recent study demonstrated that high-fat feeding in mice 
induces similar increases in even-chain acylcarnitines in skeletal muscle to those seen in fasted 
standard chow-fed mice, however, acylcarnitine levels significantly decreased following feeding 
in standard chow mice whereas they remained elevated in the high-fat fed mice (149).  This 
gives rise to two important outcomes.  The first is that the mitochondria in high-fat fed mice are 
unable to adapt to changes in fuel sources, this has recently been deemed “metabolic 
inflexibility”.  Studies have shown that there are direct links to metabolic inefficiency, 
particularly in fat utilization in insulin resistant individuals (150, 151).  Essentially what these 
studies indicate is that insulin resistant individuals may not be able to switch from fat utilization 
to glucose or vice versa under stress conditions, which leads back to mitochondrial dysfunction 
or mitochondrial overload, which will be discussed further in chapter four. 
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The second outcome from the acylcarnitine study indicates that both high fat feeding and 
prolonged starvation can lead to incomplete β oxidation.  These results were further supported by 
examining malonyl-CoA decarboxylase (mcd) KO mice.  As previously mentioned, malonyl-
CoA inhibits CPT1 to prevent the import of fatty acids into the mitochondria.  Mcd degrades 
malonyl-CoA, thus reliving the inhibition of CPT1, allowing fatty acid entry into the 
mitochondria for oxidation.  Mcd KO mice have partial inhibition of CPT1 and were in turn, 
protected from glucose intolerance and skeletal muscle remained insulin sensitive when fed a 
high-fat diet (140).  Thus, by limiting β oxidation, the build-up of metabolic byproducts such as 
DAGs, ceramides, acylcarnitine, and non-esterified fatty acids (NEFAs) (121), all of which are 
associated with the development of insulin resistance, are limited.  This is an apparent paradox 
given that these same intermediates accumulate in studies examining incomplete β oxidation and 
decreased β oxidation. 
Experimental Variation  
There may be a wide range of explanations for the conflicting data between decreased β 
oxidation and incomplete β oxidation.  The most likely of these is tissue specificity.  A recent 
study showed that this incomplete β oxidation was more pronounced in white muscle compared 
to red muscle in high-fat fed mice (140).  This is likely due to the intrinsic properties of white 
muscle, which has a much lower oxidative capacity than red muscle, and therefore fewer 
mitochondria, leading to higher levels of incomplete oxidation.  It should be noted here that 
many insulin resistant individuals have a higher percentage of white, glycolytic fibers compared 
to their insulin-sensitive counterparts (152) which may be attributed to a combination of genetics 
and physical activity level.  Therefore, it seems likely that this is a contributing factor to the 
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development of insulin resistance.  For that reason, when examining various mechanisms of 
insulin resistance, muscle fiber type must be taken into consideration.   
The examination of other tissues must also be considered.  The previously mentioned 
study which elicited changes in the skeletal muscle of mcd KO mice had no changes in β 
oxidation in the liver.  Likewise, CD36 KO mice were insulin sensitive in skeletal muscle, but 
insulin resistant in the liver.  Thus, insulin resistance appears to be tissue specific.  Interestingly, 
some of the currently investigated mechanisms involving LC-CoA’s, DAG’s, endoplasmic 
reticulum (ER) stress, and inflammation have shown changes in hepatocytes while they have 
shown little or no changes in myocytes.  For example, acetyl-CoA carboxylase (ACC2) null mice 
have lower levels of malonyl-CoA and are in turn, resistant to diet-induced diabetes.  However, 
these changes occur only in liver while adjustments in muscle lipid metabolism were minor 
(153).  This may suggest that the liver is the site of initiation of insulin resistance, whereas 
skeletal muscle is a secondary target, or responder to insulin resistance (139).  
Other factors, such as cell cultures versus animal models versus human models must also 
be taken into consideration as cells behave differently in vitro compared to in vivo; likewise, 
mouse models do not always respond in the same manner as human models.  In the study by 
Koves et al. (133), cell cultured myotubes exposed to insulin increased glycogen synthesis, but 
only minor increases were seen in glucose oxidation.  On the other hand, fatty acid exposure 
decreased both glycogen synthesis and glucose oxidation by 40-50%.  Insulin resistance 
increased with higher exposure to carnitine, indicating fatty acids must enter mitochondria to 
induce insulin resistance.  This leads to the possibility that elevated carnatine levels may 
contribute to insulin resistance.  However, it is also possible that when cultured cells are exposed 
to carnitine, they will preferentially utilize fatty acids rather than glucose due to the absence of 
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systemic conditions and input, and in turn, these cells appear to be more insulin resistant.  In situ, 
body will preferentially oxidize glucose and store fat following feeding, thus it cannot be 
concluded that elevated levels of carnitine alone subsequently increase β oxidation and lead to 
insulin resistance.  More studies done with animal or human models are needed to support these 
outcomes seen in cell cultures.   
Individual diet, total adiposity, and gender are also important considerations and can 
greatly affect the outcome of a study.  These variables, as well as others, will be examined in 
greater detail in the remaining chapters of this review. 
Athlete’s Paradox 
Regardless of what the mechanism may be, it is evident that excess lipid storage, 
especially within skeletal muscle, leads to insulin resistance, and therefore limiting this 
accumulation may improve insulin sensitivity.  Interestingly, insulin sensitive, endurance-trained 
athletes have demonstrated IMCL stores comparable to, or even higher than sedentary, insulin 
resistant individuals (16), which has been deemed the “athlete’s paradox”.  One possible 
explanation may be that these particular insulin sensitive individuals have a high rate of lipid 
turnover as a result of endurance training (22) and store TAGs which consist mostly unsaturated 
fatty acids.  On the other hand, insulin resistant individuals tend to store IMCL as a result of an 
energy surplus, have a low rate of lipid turnover, and store TAGs which consist of a higher 
percentage of saturated fatty acids.  In addition, unlike insulin sensitive individuals, those with 
insulin resistance may not be able to completely synthesize triglycerides within the muscle or 
within adipocytes, thus these lipids may not be fully synthesized TAG, rather they may be partial 
lipid intermediates such as DAG or monoacylglycerol (MAG), which have been linked to 
impaired insulin signaling and glucose transport (22); however, further research is needed to 
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support these hypotheses.  The cause for this dysfunction is still not fully understood and 
warrants further investigation.  Therefore, the remainder of this review will focus on differences 
in lipid synthesis and degradation in healthy and insulin resistant individuals to determine 
plausible mechanistic pathways linking incomplete lipid metabolism to insulin resistance and 





















CHAPTER 2: Lipid synthesis in healthy vs. insulin resistant skeletal muscle  
Since lipid intermediates such as DAG, ceramides, and acylcarnitine appear to have 
deleterious effects on insulin signaling pathways, it is necessary to examine both TAG 
breakdown into FFA, also known as lipolysis, and TAG synthesis from FFA, also known as 
lipogenesis, to determine exactly how these metabolites accumulate.  Currently, both lipolysis 
and lipogenesis within skeletal muscle are poorly understood.  By gaining a better understanding 
of the mechanisms involved in these processes and by understanding differences in lipolysis and 
lipogenesis in healthy skeletal muscle compared to insulin resistant muscle, it may be possible to 
determine more definitive causes that lead to a build-up of these lipid intermediates and 
contribute to insulin resistance. 
As mentioned in chapter one, insulin is a hormone which acts to control blood glucose 
levels.  It is also an anabolic hormone and therefore promotes the synthesis and storage of 
various substrates, including lipids.  Thus, following feeding, insulin is released activating 
various enzymes involved in lipogenesis.  It should be noted that most of the current knowledge 
regarding lipogenesis comes from E.Coli or hepatic cell culture studies though it is assumed that 
similar mechanisms occur in skeletal muscle.  Briefly, the synthesis of fatty acids begins with 
acetyl CoA, which is formed from the enzyme pyruvate dehydrogenase (PDH) (154).  When 
pyruvate is decarboxylated by PDH, the newly formed acetyl CoA can be converted to malonyl 
CoA by acetyl CoA carboxylase (ACC).  The carbon units from this malonyl CoA can then be 
used to synthesize part of a fatty acid chain via the action of an enzyme complex called fatty acid 
synthase (154).  Both PDH and ACC are activated by insulin and as will be discussed, alterations 
to these enzymes or variations in the level of substrate can greatly affect lipid metabolism and in 
turn, insulin sensitivity. 
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Once a fatty acid is formed, it, along with two other fatty acids must attach to a glycerol 
molecule, which is derived from carbohydrate sources, to form TAG (154).   Complete 
lipogenesis involves both the formation of fatty acids and the partitioning of fatty acids into TAG 
molecules.  It should be noted that TAGs can be any permutation of various fatty acid chain 
lengths (14-24 carbon atoms) and saturation level for each of the three fatty acids, thus the rate 
and extent of degradation and esterification of TAGs have a large degree of variation.   
TAG synthesis can result from one of two biochemical pathways, as seen in figure 2.  
The MAG pathway is the predominant pathway following feeding and is likely responsible for 
the storage of TAG in adipose tissue whereas the glycerol-3 phosphate (G3P) pathway is 
responsible for de Novo synthesis of TAG in most tissues.  In both pathways, monoacylglycerol 
acyltransferase (MGAT) and glycerol phosphate acyltransferase (GPAT) act to acetylate the 
substrate with fatty acyl-CoA.  The G3P pathway requires an additional acetylation followed by 
dephosphorylation.  Each pathway produces DAG and thus the final step of converting DAG to 
TAG by diacylglycerol acyltransferase (DGAT) is shared by both pathways and is considered to 





Figure A2. Lipid Synthesis Pathway. (155). MGAT=monoacylglycerol acyltransferase; 
GPAT= glycerol-3-phosphate acyltransferase; LPAAT= lysopophosphatidic acidacyltransferase; 
PAP= phosphatidic acid phosphorylase; DGAT=diacylglycerol acyltransferase; PC= 
phosphatidic choline; PE= phosphatidic ethanolamine. 
 
Variation in Lipid Storage 
Multiple factors such as gender, training status, measurement used, muscle analyzed, and 
most importantly, energy status all affect the synthesis and partitioning of lipids to various 
storage sites.  The storage of lipids in non-adipose tissues may contribute to insulin resistance, 
but an overconsumption of calories will not result in the same gains in adiposity in all 
individuals.  In fact, a study done with overfeeding in twins revealed that there was a large 
variation between pairs of twins in energy expenditure, weight gain, and regional adiposity 
(157), all of which were thought to be due to genetic variation.   These results highlight the 
importance of acknowledging the differences in the expression of genes responsible for the 
partitioning of lipids to adipose versus skeletal muscle.  Further insight is still needed to explain 
how lipids are synthesized within skeletal muscle and how insulin resistance develops as a result 
of excess lipid storage.  More visceral adiposity and lipid storage in and around organs and 
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within skeletal muscle contribute to increased insulin resistance, yet endurance athletes remain 
insulin sensitive despite high IMCL stores (16).   
With that in mind, the question becomes, “what are the primary mechanistic differences 
in lipogenesis between healthy and insulin resistant individuals”?  It is likely that endurance 
athletes store lipids in muscle for quick access to a lipid energy source as a result of training and 
thus, have a high turnover of lipid storage and oxidation within the muscle.  A high 
mitochondrial density and increased oxidative fiber characteristics likely contribute to the lack of 
intermediate metabolites, which may be the reason these athletes remain insulin sensitive(16).  
Another major reason endurance athletes remain insulin sensitive despite high levels of IMCL 
may be due to complete synthesis of triglyceride stores.  NEFAs must be esterified to MAG, 
DAG, and finally TAG by multiple enzymes including glycerophosphate, mitochondrial 
glycerol-3 phosphate, sterol CoA desaturase 1 (SCD1), and DGAT.  If any of these enzymes are 
down-regulated, lipids may not be completely converted into TAG, causing intermediates to 
accumulate and interfere with insulin signaling.  Aside from genetic disturbances, numerous 
dietary and supplemental factors can influence this lipogenesis.  Therefore, some of the major 
factors will be addressed here. 
Following Feeding  
 Lipids within the body are stored in the body primarily as TAGs.  Therefore having a 
firm understanding of how TAGs are formed is critically important.   Once food is ingested, 
there are many enzymatic processes involved in the digestion of various food stuffs and eventual 
transport into the circulation, the details of which are described elsewhere (158).  Once in the 
circulation via very low density lipoproteins (VLDLs) and chylomicrons, TAGs are hydrolyzed 
into free fatty acids (FFAs) via lipoprotein lipase (LPL) (125), which is discussed in further 
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detail in chapter three.  The FFAs are transported into skeletal muscle, adipose, and liver cells 
via fatty acid transport proteins (159).  Once inside the cell, the fate of that fatty acid is highly 
dependent on the cell type.  In adipose tissue, fatty acyl-CoA’s are re-esterified to TAGs, in the 
liver, fatty acids are re-esterified to TAGs or are packaged into VLDLs for export into the 
circulation and eventual storage in adipose tissue as TAGs (8).  In skeletal muscle, which is the 
primary focus of this review, FFA are primarily oxidized to provide energy; however, some FFA 
are stored as TAGs within the muscle cell, which is likely due to an increase in the expression 
and activity of various lipogenic enzymes.  The extent of this activation and expression may be 
partially due to the type of macronutrient consumed.  
Carbohydrate ingestion 
In healthy and insulin resistant individuals, there are numerous factors that will ultimately 
determine whether ingested carbohydrates will immediately be utilized for energy or stored in 
various tissues.  Both the amount and the type of carbohydrate consumed will affect the rise in 
blood glucose concentrations.  Simple carbohydrates as well as high amounts of carbohydrates 
consumed at one time will increase blood glucose more rapidly, and in turn increase the rate of 
insulin release.  In insulin resistant individuals, glucose stimulated insulin secretion (GSIS) is 
impaired, leading to chronic elevated levels of blood glucose (160).  In healthy individuals, 
insulin stimulates uptake of glucose and transport into numerous cell types including, skeletal 
muscle, liver, and adipose (7), but again, this action is impaired in insulin resistant individuals 
(161).  This has major implications for the development of diabetes given that up to 90% of 
insulin-stimulated glucose disposal is accounted for by skeletal muscle (162) which will either 
immediately use the glucose to meet its energy needs, or it will store the glucose in the form of 
glycogen.  In healthy individuals, if skeletal muscle and the liver already have large amounts of 
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glycogen stored, it is likely that this excess glucose will be partitioned toward adipose cells, the 
presence of which stimulates lipogenesis.  However, insulin resistant individuals have an 
impaired ability to synthesize glycogen (161), which means even more lipogenesis is likely to 
occur, further exacerbating signaling impairments associated with excess lipid storage and 
increased reliance on glucose oxidation.   
This is why the RQ  is high in a fasted state in insulin resistant individuals and remains 
that way following feeding (55).  The authors from this study suggest that obese, insulin resistant 
individuals oxidize proportionally more fat than lean individuals following insulin stimulation.  
These conclusions cause a fair amount of confusion, as seen in chapter 1 (increased versus 
decreased β oxidation) and deserve clarification.  It is important to understand that while the RQ 
of obese was approximately 0.91 and the RQ of lean was approximately 0.99 following insulin 
stimulation, the RQ of obese in a fasted state was 0.90 compared to 0.82 in lean.  Clearly the 
obese subjects were metabolically inflexible (0.90 fasted versus 0.91 following insulin 
stimulation), but they do not necessarily metabolize more fat than lean individuals as previously 
suggested, rather they are unable to adapt or respond to insulin stimulation and are in a chronic 
state of elevated glucose oxidation. 
Fat ingestion 
Similar to the ingestion of carbohydrates, the ingestion of fat, in the presence of an 
energy surplus, can lead to increased fat synthesis within skeletal muscle, liver, and adipose 
tissue.  Some studies suggest increased fat oxidation following high fat feeding in insulin 
resistant individuals compensate for the influx of fat while others suggest decreased fat oxidation 
or an inability to adjust with fat overfeeding (163) (164).  Differences are likely attributed to 
skeletal muscle composition as well as dietary fat composition (saturated versus unsaturated) and 
127 
 
total energy expenditure.  Some of these discrepancies may also be due to reporting relative 
changes seen in substrate utilization in insulin resistant individuals compared to lean 
counterparts, not absolute changes in fat oxidation. 
One particular study has suggested that fat over-feeding increases adiposity more so than 
CHO over feeding (164).  The authors showed that isocaloric carbohydrate overfeeding for 14 
days in lean and obese humans led to an increased oxidation of carbohydrates with 75-85% 
excess energy being stored.  Fat overfeeding did not increase fat oxidation and 90-95% excess 
energy was stored, indicating that excess dietary fat increased fat accumulation more so than 
excess dietary carbohydrate.  This seems logical given that glucose is the body’s immediate 
preferred energy source there is a limitation to how much glycogen can be stored in skeletal 
muscle and the liver.  Contrasting results were seen in another study which demonstrated that RQ 
was not significantly different in lean subjects given a high-fat diet compared to a high 
carbohydrate diet or mixed (all isocaloric) on consecutive days, indicating that the metabolism of 
these subjects were unable to immediately respond to changes in macronutrient intake (163).  
Taken together, these results suggest that regardless of macronutrient consumption, continual 
overfeeding will result in increased fat storage; however, unlike excess carbohydrate intake, 
excess fat intake is not compensated for by an increased rate of fat oxidation, thus, lipids 
accumulate and levels of adiposity become elevated.  
Also of interest, in the study by Horton et al, (158), the obese subjects oxidized 
proportionally more carbohydrates and less fat than the lean subjects, regardless of diet 
composition, elucidating to the likelihood of metabolic inflexibility in obese individuals as seen 
in previous studies (55).  In addition, plasma insulin levels increased in carbohydrate overfeeding 
in both lean and obese subjects, but insulin concentration decreased in fat overfeeding in lean 
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subjects while it increased in obese subjects, which could explain why obese individuals often 
exhibit hyperinsulimia.  In contrast to these findings, a recent study demonstrated that muscle 
mitochondrial number increases from a high fat diet in rats, which increases the capacity for fat 
oxidation through post-transcriptional modifications for Peroxisome proliferator-activated 
receptor gamma coactivator 1-alpha (PGC-1α), but insulin resistance increases as well (165).  
This indirectly suggests that decreased mitochondrial content in muscle may not be directly 
responsible for insulin resistance as previously suggested, rather it may be a result of an energy 
imbalance (lack of physical activity) as suggested in chapter one combined with impaired lipid 
transport and increased lipid accumulation.  Chapter four will describe in greater detail how even 
a single bout of physical activity can reverse some of the insulin desensitizing effects of physical 
inactivity. 
Lipid Storage 
 Ingesting a mixed diet, which consists of a percentage of both carbohydrates and fats is 
much more applicable to the general public and does not suggest the preferred storage of one 
substrate over another, especially in an isocaloric diet.  It is likely that lipid storage in skeletal 
muscle for this type of diet is largely dependent on the metabolic state of the muscle (energy 
consumption versus energy expenditure).  However, a recent study also demonstrated that dietary 
fat composition can affect insulin sensitivity.  Male Sprague-Dawly rats given a high-saturated 
fat diet for eight weeks exhibited greater levels of saturated fatty acids incorporated into IMCL 
compared to rats given a high-polyunsaturated diet, which incorporated more unsaturated fatty 
acids into IMCL.  However, IMCL content increased in both high-fat diets compared to the 
control group.  The high saturated fatty acid group also exhibited increased homeostasis model 
assessment of insulin resistance (HOMA-IR) and glucose intolerance  (166).  In addition, L6 
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myotubes treated with saturated fatty acids had decreased insulin-stimulated glucose uptake and 
increased DAG and ceramide accumulation.  On the other hand, myotubes treated with 
polyunsaturated fatty acids had no changes in insulin-stimulated glucose uptake or 
DAG/ceramide content, but TAG levels did increase significantly (166).  Together, these results 
indicate that high levels of dietary saturated fatty acids may directly contribute to the 
development of insulin resistance independent of systemic hormone regulation or tissue cross-
talk.  Rather, saturated fatty acid-induced insulin resistance may occur via incomplete 
degradation of TAG’s (DAG, MAG, or ceramides).  The results may also partially explain the 
athlete’s paradox given that obese individuals likely have a much higher intake and storage of 
saturated fatty acids compared to lean endurance athletes.   
Higher levels of unsaturated fatty acids incorporated into TAG stores may improve 
insulin sensitivity by limiting lipid metabolite accumulation.  This may be due to the fact that 
one of the enzymes involved in lipogenesis (DGAT, discussed below) preferentially utilizes 
unsaturated fatty acids rather than saturated fatty acids (167).  Thus, not only is total TAG 
storage important, but also the content of the TAG stores.  Unfortunately, as previously 
mentioned, this content can be quite variable given that fatty acids can range from 14-24 carbons 
and have a variety of locations which may be unsaturated and each TAG can contain any 
combination of these fatty acids (7). 
Niacin 
 To gain a more complete understanding of lipid formation, it is helpful to examine 
models in which this process is either accelerated or inhibited.  Aside from exercise intervention, 
which will be thoroughly examined in chapter four, one such way to accomplish this task in 
human models is through pharmacological intervention.  Nicotinic acid, also known as niacin or 
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vitamin B3, is pharmacologically used to improve cholesterol levels by blocking fat breakdown 
in adipose and liver tissue, but it also appears to play a role in lipogenesis.  As a consequence of 
this supplement’s actions, VLDL formation decreases in the liver, and in turn, less low-density 
lipoprotein (LDL) is formed, and more high-density lipoprotein (HDL) is formed, thereby 
lowering blood lipids (168).  Niacin is also a precursor to the coenzymes NAD+/NADH as well 
as NADPH.  In addition to being involved in DNA repair and steroid hormone production, these 
coenzymes are involved in fatty acid synthesis via NADPH, tissue respiration, and utilization of 
carbohydrates via NADH in skeletal muscle (7). 
Interestingly, the effect of niacin appears to have different effects in hepatocytes, 
myocytes, and adipocytes, suggesting tissue-specific effects which must be taken into 
consideration when examining the whole body effects of this supplement.  One study 
investigating the cellular mechanisms of niacin demonstrated an up-regulation in the degradation 
of ApoB, which is a protein involved in LDL transport, in human HepG2 (hepatic) cell cultures, 
thus lowering plasma LDL concentrations possibly by decreasing the synthesis and secretion of 
TAG and VLDL into the blood stream.  Supplementation also inhibited fatty acid synthesis and 
esterification (169).  Niacin also appears to limit the degradation of ApoA (a protein component 
of HDL) in hepatic cells, thus increasing plasma HDL concentration.  Niacin appears to elicit its 
effects by acting on hormone sensitive lipase (HSL) to inhibit lipolysis in adipocytes and it 
acting on diacylglycerol acetyltransferase (DGAT) to inhibit TAG synthesis (170).  Thus it 
appears that in skeletal muscle, niacin can contribute to fatty acid synthesis while inhibiting 
lipolysis.  On the other hand, niacin can also block fatty acid synthesis in adipose and liver cells.  
This apparent disconnect may be explained by niacin’s effects on the various tissue-specific 




Diacylglycerol acetyltransferase (DGAT) catalyzes the only committed step in TAG 
synthesis using DAG and fatty acyl CoA as substrates (156).  Thus, without proper expression 
and activity of this enzyme, lipid intermediates will not be incorporated into TAG, rather they 
will accumulate.  Accumulation of these intermediates, as previously discussed, play an integral 
role in the development of insulin resistance.  There are two basic isoforms of DGAT, both of 
which appear to be necessary for proper functioning in mammals (171).  DGAT1, which is 
considered “overt” and is involved in formation of TAG in cytoplasm of ER in liver cells and 
DGAT2, which is “latent” and is involved in formation of TAG in lumen of ER in liver cells, 
which are then involved in the formation of VLDL (172).   
The DGAT reaction can come from multiple pathways (1) de novo synthesis catalyzed by 
mitochondrial glycerol-3 phosphate acetyltransferase (mGPAT), (2) esterification of MAG 
catalyzed by monoglyceride acetyltransferase (MGAT), or (3) hydrolysis of TAG or 
phospholipids.   
Given its critical role in TAG synthesis, it has been suggested that inhibiting DGAT1 
may decrease the expression of genes involved in fatty acid oxidation (i.e. PPAR genes) and 
decrease adiposity and diet-induced obesity (173).  Indeed DGAT1 KO mice exhibited these 
traits and improved insulin sensitivity, however, mice deficient only in skeletal muscle DGAT1, 
rather than whole body DGAT1 deficiency exhibited decreased insulin sensitivity, again 
demonstrating the importance of tissue-specific isoenzymes and tissue-specific development of 
insulin resistance (156).  In fact, DGAT1 gene expression has been shown to be up-regulated 
following a single bout of moderate-intensity aerobic exercise in humans (56).  This increased 
expression of DGAT1 increased IMCL stores, while decreasing DAG concentration.  As 
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mentioned in chapter one, high levels of DAG are thought to activate pro-inflammatory 
pathways as well as specific protein kinase C’s (PKC’s), which in turn phosphorylate serine 
residues on insulin-receptor 1 (IRS-1), and decrease insulin sensitivity (22, 140).  Thus, up-
regulating TAG synthesis is skeletal muscle may act to limit the development of insulin 
resistance.   
This hypothesis is supported by earlier findings in mice which showed that DGAT1 over-
expression increases small lipid droplet accumulation around the cell periphery, whereas DGAT2 
over-expression increases large lipid droplet accumulation in the cytosol (171).  As mentioned in 
chapter one, small adipocytes have been shown to secrete insulin-sensitizing hormones such as 
adiponectin and leptin, whereas large adipocytes have been shown to secrete insulin-
desensitizing hormones such as retinol-binding protein (RBP-4) and resistin (8).  In addition to 
forming large lipid droplets, which may be linked to insulin resistance, the over-expression of 
DGAT2 in mice has been shown to decrease insulin sensitivity due to storage of TAG in 
glycolytic fibers (174).  Oxidative fibers have many mitochondria and rely primarily on fatty 
acid oxidation for energy.  These types of fibers are capable of storing and utilizing TAG’s 
within the muscle and are more predominant in aerobically trained individuals.  Glycolytic 
fibers, conversely, have few mitochondria and therefore cannot effectively oxidize stored TAG’s 
to produce energy.  Therefore, it seems plausible that in obese, insulin resistant individuals, 
DGAT2 expression is increased in skeletal muscle.  Since these individuals are less active, it is 
likely that they have fewer oxidative fibers and more glycolytic fibers.  Thus, the paradox 
between IMCL storage in insulin resistant individuals and IMCL storage endurance trained 
athletes could also be due to a combination of the inability of the glycolytic fibers to break down 
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and oxidize stored TAG as well as an up-regulation in DGAT2, which furthers TAG storage in 
these glycolytic fibers. 
With the given information about DGAT2, it may seem plausible that inhibition of 
DGAT2 may help limit the development of insulin resistance.  Whether or not there is an up-
regulation in DGAT1 and a down-regulation of DGAT2 following chronic exercise is currently 
unknown and warrants further investigation.   
The over-expression of DGAT 1 and DGAT2 in mouse liver cells has been shown to 
cause an excessive accumulation of lipid stores within the liver without inducing insulin 
resistance or glucose intolerance (175).  This may indicate that excess lipid storage in liver alone 
may not be a direct cause of insulin resistance; rather it may be an effect of the development of 
insulin resistance via inflammatory pathways.   
Other Enzymes 
Though DGAT is the rate-limiting enzyme and is the only committed step in lipogenesis, 
the role of other possible enzymes involved in lipid synthesis, such as mGPAT and SCD1, which 
desaturates fatty acids into monounsaturated fatty acids to be incorporated into TAG stores, must 
also be examined.  Alterations in the expression of these enzymes may also lead to a build-up of 
fatty acid metabolites which have been linked to insulin resistance (155).  Work on these 
enzymes, particularly in skeletal muscle is limited, but studies examining whole organisms and 
other tissues can provide possible future directions for study.  For example, SCD1 KO mice are 
resistant to diet-induced obesity, likely due to the inability to store saturated fatty acids (176). At 
the other end of the spectrum, SCD1 protein expression and activity is up-regulated in rats 
following a high fat diet, causing the rats to became more insulin resistant (166).  This does not, 
however, indicate that up-regulation of this enzyme induces insulin resistance per se; rather it 
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may act as a protective mechanism to limit the formation of DAG and ceramides associated with 
high levels of saturated fatty acids as seen in the study by Lee et al. (166).  In contrast, GPAT 
over-expression in rats directly contributes to DAG storage in the liver, increased IMCL storage 
and increased hepatic, peripheral, and systemic insulin resistance (177).  
With this in mind, it seems that increasing the expression of specific lipogenic enzymes 
through dietary manipulations or otherwise can contribute to insulin resistance while the 
increased expression of other enzymes may have no effect or may improve insulin sensitivity.  
The reasoning for this is not entirely clear although it seems likely that the over-expression of an 
enzyme such as GPAT, involved in the first step of TAG synthesis may take away from the FFA 
pool that may have otherwise been utilized for oxidation.  On the other hand, depending on the 
tissue, increased expression of DGAT or SCD1 may limit the accumulation of DAG and 
ceramides. 
While it is apparent that variations in lipid synthesis can greatly affect insulin sensitivity, 
variations in lipid mobilization, hydrolysis, and oxidation are just as critically important to 
examine in order to gain a more complete understanding of lipid metabolism and its links to 










CHAPTER 3: Lipid utilization in healthy vs. insulin resistant skeletal muscle 
There are multiple enzymes involved in the complete process of degrading TAGs to FFA.  
The extent to which each of these enzymes are complimentary versus redundant is still not clear.  
Therefore it is important to examine some of the major enzymes involved in lipolysis and how 
alterations in the expression or activity of these enzymes may contribute to insulin resistance.  
Lipoprotein lipase (LPL), hormone sensitive lipase (HSL), and adipose triglyceride lipase 
(ATGL) are three of the major enzymes contributing to the initial breakdown of TAGs.  As 
discussed in earlier chapters, numerous factors can affect the activity of these enzymes, and in 
turn, the extent of lipid breakdown.  This chapter of the review will examine the fasting state, 
which activates these specific lipolytic enzymes, but to a different degree in healthy versus 
insulin resistant individuals.  Another aspect that will be examined is tissue specificity given that 
lipolysis in liver, skeletal muscle, and different muscle fiber types are regulated by differing 
mechanisms.  Finally, the mobilization of lipids will be examined since the amount of lipolytic 
enzymes and intermediates in the blood vary between insulin resistant and healthy, but also 
depend on where the TAG are mobilized from (skeletal muscle, liver, or adipose tissue). 
Major Enzymes 
As its name suggests, LPL is involved in the lipolysis of TAG in lipoproteins.  Following 
feeding (high insulin levels), excess circulating TAG will be stored primarily in adipose tissue.  
However, TAG must first be hydrolyzed from VLDL or chylomicrons via LPL into FFA and 
then re-esterified into TAG.  Adipose tissue and skeletal muscle have different isoenzymes of 
LPL which are regulated by differing mechanisms (178) which helps explain why the storage of 
TAG in adipose occurs readily while storage of TAG in skeletal muscle is more limited, at least 
in healthy, untrained individuals.   
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A second enzyme involved in lipolysis, which essentially has the opposite actions of LPL 
hydrolyzes TAG, DAG, and MAG to be oxidized for fuel (rather than stored) and is sensitive to 
the concentrations of insulin and glucagon (7).  Therefore this lipase is often referred to as LPL-
HS or hormone sensitive lipase (HSL).  Much like LPL, HSL is expressed in both adipose and all 
types of skeletal muscle fibers, but the expression appears to be the highest in adipose, followed 
by oxidative, then glycolytic muscle fibers (159).  LPL hydrolyzes TAG from lipoproteins for 
storage in adipose tissue and skeletal muscle whereas HSL hydrolyzes TAG from adipose or 
IMCL reserves for oxidation (125).  In the presence of insulin, HSL activity decreases in both 
adipose and skeletal muscle, whereas LPL activity increases in adipose and skeletal muscle 
tissue.  As a result, lipid degradation increases, but lipid storage increases as well.  This is due to 
the anabolic action of insulin (179), which makes sense considering that the body always 
attempts to be as energy efficient as possible.  If both enzymes were up-regulated, there would be 
a futile cycle between lipid storage and breakdown.  Interestingly, skeletal muscle inactivity also 
appears to decrease LPL activity in all muscle fiber types (180), suggesting a role of physical 
activity in maximizing lipolysis, which will be discussed further in chapter four.  However, more 
recent studies have indicated that these two enzymes alone are not solely responsible for the 
hydrolysis of TAG and that there may be numerous other complimentary or redundant enzymes 
or pathways involved.  
ATGL 
One such enzyme involved in lipolysis is adipose triglyceride lipase (ATGL).  Once 
again, as its name suggests, it is involved in the hydrolysis and mobilization of TAG from 
adipose tissue, however this enzyme is also expressed in skeletal muscle (145).  ATGL has been 
shown to be expressed exclusively in type I fibers, appears to play a role in converting TAG to 
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DAG and may play a role in fatty acid handling, lipid storage and breakdown (145).  Given the 
deleterious effects of excessive plasma DAG, one school of thought is that if TAG degradation to 
DAG is limited, insulin sensitivity will improve.  This has been shown to be the case in ATGL 
KO mice, which demonstrated increased glucose tolerance and insulin sensitivity despite TAG 
accumulation in multiple tissues.  Insulin-stimulated PI3K, Akt activity also increased and 
phosphorylation of tyrosine residues on IRS-1 increased in skeletal muscle and adipose tissue in 
vivo (10).  While this could potentially be an attractive pathway for the prevention of diabetes, it 
has been demonstrated that ATGL and HSL are needed for lipolysis in skeletal muscle and 
adipose to sustain normal substrate metabolism both at rest and during exercise (57).  ATGL 
gene deletion in mice causes an increase in carbohydrate utilization, a decrease in circulating 
FFA at rest.  Decreased circulating FFA leads to an increased dependence on glucose oxidation, 
thus, liver and muscle glycogen stores decrease.  Interestingly, resting glycogen storage was not 
affected in HSL KO mice nor was fatty acid transport affected in ATGL or HSL knockout mice 
(57).  However, the exercise-induced increase in FFA and glycerol mobilization was blunted in 
both KO mice, indicating a decrease in lipolysis, an increase in CHO oxidation, and a reduced 
endurance capacity.  A similar study examining ATGL KO mice yielded similar results, again 
indicating that ATGL is required for the hydrolysis of TAG from skeletal muscle and adipose 
tissue, and thus, proper energy supply during exercise (181).  Without this enzyme, the body 
cannot utilize lipid for energy and is in turn, forced to rely on glucose metabolism.  This will lead 
to an up-regulation in glucose transport, which could help explain the improvement in insulin 





Tri-di- and monoglycerides  
 Currently, the role of individual enzymes responsible for the conversion of TAG to 
DAG, DAG to MAG, and MAG to FFA and glycerol has not been examined in great detail.  
However, recent evidence suggests that these enzymes may play a key role in the accumulation 
of DAG and ceramides, and in turn, contribute to the development of insulin resistance.  
Triacylglycerol hydrolase, which converts TAG to DAG and diacylglycerol hydrolase, which 
converts DAG to MAG was recently examined in lean and healthy male and female subjects, all 
of which were sedentary.  As seen in past studies, it was found that females exhibited higher 
levels of IMCL than males, obese subjects exhibited higher IMCL, DAG and ceramides than 
lean subjects (182).  Expectedly, TAG hydrolase activity was higher in obese compared to lean, 
and higher in females compared to males.  Interestingly, despite elevated DAG and ceramide 
levels in obese subjects, DAG hydrolase activity was actually lower for this population compared 
to lean subjects (182).  This is critical as it suggests that while TAG hydrolase activity may be 
up-regulated in individuals with higher levels of IMTG storage, such as females or endurance 
trained athletes, obesity appears to induce changes in DAG hydrolase in skeletal muscle, though 
increased levels of adiposity are independent of this change in enzymatic activity.  This 
incomplete lipolysis could contribute to the formation of DAG seen in insulin resistance; 
however, the mechanisms are not yet apparent. 
It should be noted that ATGL acts as TAG hydrolase and HSL acts as both a TAG 
hydrolase and a DAG hydrolase, at least in the white adipose tissue of murine models (183) and 
therefore the activity of ATGL and HSL are often representative of these various hydrolases.  
MAG lipase appears to be its own unique enzyme and may also play a role in incomplete 
lipolysis although currently there are no studies examining the role of this enzyme in insulin 
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resistance.  This may be because this particular enzyme is neither rate-limiting nor a committed 
step in lipolysis; however, examining this enzyme along with others could provide greater insight 
into differences between insulin resistant and healthy skeletal muscle metabolism.  A fasting 
state (i.e. low insulin, high glucagon concentration) will clearly activate these enzymes in 
adipose tissue and to some extent in skeletal muscle; however, there is limited research on the 
extent that each of these enzymes truly function in healthy and insulin resistant human skeletal 
muscle.  This will be an important area of future research with regards to possible links between 
incomplete lipolysis and insulin resistance. 
The study by Schenk and Horowitz (22) is one of the few studies that have examined 
DAG levels following an acute aerobic exercise bout.  In the aforementioned study, DAG levels 
were significantly reduced following exercise, but further study is clearly necessary to either 
support or oppose this research and to further determine if mono- and diacylglycerol levels are 
altered following chronic exercise.  Even without the incorporation of exercise, few studies have 
explicitly examined MAG and DAG levels.  This is due largely to the fact that standard 
enzymatic assays measure all partial acylglycerols as triacylglycerols. Fielding et al. (184) have 
suggested that these partial acylglycerols may account for less than 3% of total acylglycerols in 
fasted human subjects.  Despite this low percentage, these partial acylglycerols may still play a 
critical role in the development of insulin resistance.  However, at this point it is unknown if, and 
to what extent, those numbers may be altered as a result of acute aerobic exercise.  It is possible 
that there may be a link between changes these lipid intermediates and insulin sensitivity.  In 
both humans (16) and mice (57), increased fat oxidation in skeletal muscle has been shown to 




Fasting vs. Fed state 
In a fasted state, the body will rely primarily on fat stores to supply energy and will 
conserve glycogen stores for essential brain, kidney, and red blood cell function or sudden 
increases in energy demand (7).  However, the dependence on fat utilization in a semi-fed state 
will depend greatly on diet.  A recent study demonstrated that in a fasted state, serum NEFA 
levels were not different in high fat (HF) and standard chow (SC) fed mice, indicating both were 
able to utilize fatty acids as a fuel source.  However, NEFA concentration was significantly 
lower in fed SC mice compared to the fed HF mice, which suggests that SC mice were able to 
uptake and store fatty acids then subsequently utilize the immediately available glucose for fuel.  
On the other hand, the authors suggested that the mitochondria in HF fed mice apparently could 
not adjust to the feeding and continued to oxidize fatty acids despite the increased available 
glucose; indicating an impaired ability to switch which substrate is utilized for energy (140).  
This could provide implications for testing in post-prandial state as well as in a fasted state.  As 
previously suggested, fasting lipid responses in healthy and insulin resistant individuals is 
drastically different (55).  In addition, the study by Koves et al. suggests differences following 
feeding, therefore testing in a fed or semi-fed state may elicit more pronounced responses in lipid 
metabolism and should be examined in addition to the fasted state. 
The differences seen in the fasted state may, however, be tissue specific.  In a study done 
on diabetic and lean rats, fasting induced significant increases in IMCL storage in white tibialis 
anterior (wTA) and extensor digitorium longus (EDL) in both groups, though to a greater extent 
in the diabetic group (185).  In addition, malonyl CoA concentrations decreased in these muscles 
of both groups, but to a greater extent in the lean group.  The red soleus (SOL) muscle on the 
other hand did not exhibit changes in malonyl CoA concentrations in either group (185).  This 
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suggests that starvation does not induce changes in lipid metabolism to oxidative muscles, such 
as the SOL, regardless of insulin sensitivity, whereas both lipid uptake and oxidation are 
activated in more glycolytic muscles like wTA and EDL when FFA availability is high due to 
starvation.  However, since glycolytic fibers contain fewer mitochondria than oxidative fibers, 
even if malonyl CoA levels are suppressed, β oxidation will still be limited by the number of 
mitochondria and mitochondrial enzymes present.  It may be that wTA and EDL muscles can re-
esterify FFA and store them as IMCL primarily to cope with elevated FFA levels during fasting 
whereas the SOL muscles can cope with elevated FFA levels primarily via β oxidation.  There 
also appear to be CPT1 enzymes that are insensitive to malonyl CoA,  (186) which may also help 
partially explain why malonyl CoA levels were not altered in the SOL muscles for this study. 
Gender Differences 
Though lipolytic enzyme activity may be similar between men and women, lipid 
metabolism is clearly different in men and women and is worth briefly addressing here.  In 
general, women tend to perform better at ultra-endurance events and there may be several 
reasons for this occurrence.  Women naturally store more fat, in the form of IMCL or otherwise, 
and utilize a greater percentage of fat for energy compared to men.  The role of estrogen likely 
has an effect on both of these.  Variations in fiber type percentages could help partially explain 
why women tend to have higher gene expression for specific β-oxidative enzymes.  In a recent 
study comparing differences in fatty acid handling in men and women, results indicated that 
there were no significant differences in mRNA content for β oxidative enzymes, yet there were 
significant differences in protein content of β oxidative enzymes (114).  However, this study did 
not show any significant differences between men and women for the transcription factor PPAR.  
Thus, it seems very likely not only that various systems are interacting, but there are several 
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post-translational modifications taking place.  If women do indeed preferentially utilize fat as a 
fuel source, it would be expected that genes responsible for β oxidation as well as lipolysis and 
the TCA cycle would be up-regulated.  Further studies need to investigate additional 
transcription factors as well as other proteins involved in fatty acid transport, binding, and 
oxidation.  It would also be useful to examine various key enzymes involved in the TCA cycle to 
help determine if all components of fatty acid oxidation are higher in women or if it is just 
specific enzymes, such as the ones involved in β oxidation.  An interesting point, although not 
significant was that short-chain hydroxyacyl co-A dehydrogenase (SCHAD), responsible for 
short-chain oxidation, was slightly higher in men.  This may indicate that men have the same or 
slightly higher capacity than women to break down short-chain fatty acids.  It may be possible 
that there are gender differences in the percentage of short, medium, - and long-chain fatty acids, 
all of which have unique lipolytic enzymes.  It is important to remember that this study examined 
only skeletal muscle and some if its respective β-oxidative enzymes.  Adipocyte, skeletal muscle, 
and hepatic lipolysis are all different and therefore, future studies are needed to examine these 
aspects as well.  From an observational perspective, it seems logical that if women naturally 
store more fat than men, they should be able to utilize fat more readily as a fuel source, thus the 
findings of this study seem plausible; however, the underlying mechanisms, particularly at a 
transcriptional and translational level are not yet clear. 
Though it is apparent that much work is still needed to gain a better understanding of 
complete lipid hydrolysis, mobilization, and oxidation within skeletal muscle, even less is known 
about how this pathway and its respective enzymes are affected by exercise.  Though exercise 
acts in a similar manner to fasting in order to provide energy to working muscles, it is evident 
that there are several differences that separate the effects of exercise and the effects of fasting.  
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Numerous studies have shown that exercise improves several health parameters, including 
insulin sensitivity.  However, the mechanisms for this improvement, specifically with regards to 
lipid metabolism are still not fully understood.  Chapter four will discuss these differences and 
























CHAPTER 4: Effects of exercise on lipid synthesis/degradation in healthy vs. insulin 
resistant 
Weight loss, specifically a decrease of abdominal adiposity, through caloric restriction, 
exercise, or a combination of the two, has been linked to improved insulin sensitivity (187) 
through various mechanisms.  In addition, a reduction of abdominal adiposity has been shown to 
significantly increase insulin sensitivity.  Interestingly, even without weight loss, exercise can 
improve insulin sensitivity (23) though the mechanisms responsible for the improvements in 
insulin sensitivity appear to be much different when weight loss is not present.  Regardless of the 
type, intensity, or duration of exercise, chronic or acute, exercise has irrefutably been shown to 
help to prevent, or at least limit several health disparities including cardiovascular disease, 
obesity, cancer, and diabetes.  However, the mechanisms are apparently variable and are 
dependent on numerous factors.  This chapter will be broadly divided into acute aerobic, chronic 
aerobic, acute resistance, and chronic resistance training to examine how the modality of 
exercise affects changes in lipid metabolism and how a single bout of exercise can affect lipid 
metabolism compared to several weeks of training. 
Aerobic Exercise 
Aerobic exercise has been shown to up-regulate lipolysis and improve insulin sensitivity 
whereas excess lipid storage in adipose tissue as well as within skeletal muscle has been linked 
to insulin resistance (56).  In general, any form of exercise appears to improve insulin sensitivity; 
however, the underlying mechanism is still largely unknown.  It may be due to interconnections 
of improved mitochondrial function and enzymatic activity, decreased lipid metabolites, and 
decreased inflammatory cytokines.  Due to the variability in methodology and analysis between 
studies, it has also been difficult to establish which variables play the most significant roles for 
increasing lipid breakdown and improving insulin sensitivity. Not only can the measurement 
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technique used (gas analysis, tracers, biopsy, plasma) and experimental model (cell cultures, 
animal models, humans) affect the results of a study, but gender, training status, diet, muscle 
fiber type, muscle glycogen content, exercise intensity, exercise duration, exercise type, all affect 
lipolysis and lipid synthesis differently during and following exercise, making it difficult to 
compare the effects between studies and thus, all of these variables need to be taken into 
consideration when conclusions are made regarding the effects of  exercise on lipid metabolism. 
Acute aerobic exercise 
Before examining the literature, it should be noted that in general, most acute exercise 
studies are carried out when participants are in a fasted state.  It has been demonstrated that an 
overnight fast does provide valid and reliable responses to exercise.  However, examining 
participants in a postprandial state may provide a more "real world response".  Exercising, 
especially at high intensities, immediately after consuming a meal may result in undesired 
consequences, specifically vomiting.  Therefore, allowing food to digest for a few hours prior to 
exercise may be ideal.  Presumably, most of the population does not exercise on a regular basis 
following an overnight fast, rather exercise takes place after some form of nutrients have been 
consumed.  Additionally, several studies have shown that the ingestion of carbohydrates 
enhances endurance performance (102).  In addition, as mentioned in chapter three, one study 
demonstrated that serum NEFA levels were not different in fasted high fat and standard chow 
mice; however, NEFA concentration was significantly lower in the fed standard chow mice 
whereas concentrations remained elevated in the high fat mice (140).  This suggests an impaired 
ability in the high fat fed mice to switch from utilizing primarily fats in the fasted state to 
carbohydrates in the fed state.  This provides clear implications for exercise testing in a fed or 
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semi-fed state to see more distinguishable results between populations and to provide much more 
useful information as it applies to the general public.   
Timing 
When examining the effects of an acute exercise bout, a very important consideration is 
the timeline for which the measurements are taken.  The rate of fat oxidation changes during 
exercise compared to immediately, and several hours afterward.  Changes in metabolite 
concentration, enzymatic activity, or gene expression may be rapid, but changes in protein 
expression or protein modification may be much more delayed.   
Within skeletal muscle, an acute bout of aerobic exercise will increase cytosolic calcium 
levels and decrease the ATP/AMP ratio, both of which result in the activation and increased 
expression of PGC-1α (188).  Several studies have demonstrated that increased levels of PCG-1α 
result in mitochondrial biogenesis by means of a complex signaling cascade described elsewhere 
(188, 189).  However, previous studies have shown that exercise-induced mitochondrial 
biogenesis is altered or reduced in both humans and rodents with obesity and insulin resistance 
(54, 190).  The question becomes whether the obesity caused the reduction of mitochondria or if 
low mitochondrial density caused the obesity.  Warram et al. (19) suggested it can be the latter 
for some individuals.  This predisposition to obesity can easily lead to insulin resistance and the 
development of type 2 diabetes, both of which have been linked to the down-regulation in the 
expression of several genes responsible for oxidative phosphorylation, several of which are 
under the control of PGC-1α (191).  A likely contributor to this down-regulation is a dysfunction 
of the mitochondria (54).  It may also be due to a loss of oxidative fibers and an increase in the 
percentage of glycolytic fibers, which in turn decreases PGC-1α expression (190).  It is likely a 
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combination of several factors, each of which plays a role in the development of insulin 
resistance. 
Some authors have suggested that an incomplete breakdown of fatty acids may lead to an 
accumulation of lipid intermediates such as DAG, ceramides, and acylcarnitine species, 
increasing the likelihood of developing insulin resistance (8, 22).  However, no studies to date 
have examined specific enzyme activity of ATGL, HSL, and MAGL in a single study, all of 
which are involved in the complete breakdown of lipids.  Furthermore, while a sufficient number 
of studies have looked a TAG levels and exercise, very few studies have reported information on 
DAG or MAG following exercise. 
Complete Synthesis 
A single aerobic exercise session has been shown to increase IMCL synthesis, 
particularly when fat availability is high (22).  These increased levels of IMCL synthesis by 
increasing protein expression of DGAT1, mGPAT, and SCD1, which in turn, prevented the 
accumulation of metabolites like DAG and ceramides known to activate pro-inflammatory 
pathways.  Similar results have been seen in rats.  When given the drug Thiazolidinedione, 
IMCL synthesis increased while metabolite accumulation decreased and subsequent pro-
inflammatory pathways were inactivated (49).  Interestingly, the research shows that, at least in 
rats, it is an acute bout of aerobic exercise, rather than chronic training, which can act to down-
regulate these pro-inflammatory pathways (21).  As seen in the study by Nassis et al. (23), 
improvements in insulin sensitivity from chronic aerobic training may be more attributed to fiber 






Another variable that greatly influences the relative contribution of fat versus glycogen 
utilization is exercise intensity.  High-intensity exercise results in, among other things, an 
accumulation of ammonia, which activates phosphofructokinase (PFK), and thus accelerates the 
rate of glycolysis (192).  This results in a greater percentage of fuel utilization from anaerobic 
glucose metabolism and in turn, the production of lactate of and H+ ions which decrease blood 
pH.  Lower pH levels have been shown to inhibit CPT I, thus limiting fat oxidation (193).  This 
indicates that the onset of lactate accumulation inhibits FFA release from adipose tissue.  It has 
been suggested that maximum fat oxidation in untrained individuals occurs between 35-48% 
VO2max, which is considered to be low-intensity (188).   This may be due to the fact that fast 
twitch fibers are recruited more heavily during high-intensity exercise, which is when the 
production of ammonia has been shown to be highest and product inhibition limits lipid 
metabolism (192).   
Caffeine 
One way to increase lipid utilization during acute aerobic exercise is to ingest a caffeine 
supplement.  The extent of enhanced lipid utilization via caffeine can be altered by the dosage 
taken, intensity, duration, and type of exercise being performed, whether the exercise is chronic 
or acute, as well as the training status, and diet of the participants.  Maximal fat oxidation in 
trained individuals appears to occur around 62.5% VO2max, and minimal fat oxidation appears to 
be around 86% VO2max.  Untrained individuals tested at 75% VO2max elicited no benefit from 
caffeine supplementation (92).  It is likely that the intensity of this exercise necessitated a greater 
reliance on glucose oxidation for these untrained individuals, and thus, the caffeine was 
ineffective.  In addition, the total duration of this study was only 30 minutes, subjects did not go 
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until volitional fatigue and thus, it is possible that metabolism and rating of perceived exertion 
(RPE) may have been different between trials.  Prior to the exercise intervention, these 
individuals did not participate in any regular physical activity.  During and immediately 
following exercise, participants demonstrated high levels of lactate, likely due to their untrained 
status.  High lactate levels are known to inhibit lipolysis and thus, the effects of caffeine may be 
overridden by the action of lactate.  
In several studies, caffeine has been shown to enhance FFA mobilization from adipose 
tissue, and in turn lowering the respiratory exchange ratio (RER) and spare muscle glycogen in 
submaximal acute exercise lasing 30-60 minutes (7, 89).  This mechanism is likely due to an 
increase in catecholamine concentration, which enhances glucose release from the liver, FFA 
release from adipose tissue and FFA oxidation (7).   
Despite this proposed mechanism, some studies have seen no effect of caffeine on 
aerobic function, RER or FFA uptake into skeletal muscle (90-92).  Although in these studies, 
individual fatty acids were not examined nor was lipid breakdown examined.  It is possible that 
while total fatty acid uptake did not change, there may have been changes in individual fatty acid 
uptake or breakdown.  This was seen one a study where the authors showed increased 
unsaturated fatty acid mobilization (c18:1) and decreased saturated fatty acids (16:0 and 18:0) 
(194).  This suggests that future studies involving changes in lipid synthesis and degradation 
following exercise should include not only overall changes, but also changes in individual fatty 
acid chain lengths and level of saturation.  Another important consideration is whether the lipids 





IMCL Stores and Muscle Fiber Type 
The extent to which IMCL contributes to fuel utilization during exercise is not well 
known though it seems likely that there is more contribution from these stores with longer 
duration, lower intensity type exercise.  In healthy untrained individuals, glycogen stores will 
decrease with prolonged exercise and lipids will take over as main substrate.  The extent of 
glycogen depletion will vary depending on the type of muscle an extent of muscle activity.  
Indeed, it has been shown that IMCL stores decrease with prolonged exercise and there is more 
use of IMCL in oxidative muscles compared to glycolytic muscles (195) further supporting the 
notion that lower intensity exercise maximizes fat utilization. 
While low-intensity exercise will yield a greater percentage of fat utilization compared to 
high-intensity exercise, high-intensity aerobic exercise has still been shown to improve fat 
oxidation during exercise in recreationally active individuals (16, 24).  An interesting note is that 
lipolysis apparently was not up-regulated.  These subjects had increased expression of fatty acid 
binding protein (FABP), hydroxyacyl-CoA dehydrogenase, and citrate synthase, while fatty acid 
translocase CD36 and HSL were not up-regulated.  Although these results cannot be readily 
explained, this may indicate that the oxidation of free fatty acids is up-regulated, as suggested in 
chapter one, while the mobilization of stored triglycerides is not up-regulated following this type 
of training.  This may also indicate that lipid oxidation is more of a limiting factor than 
hydrolysis or transport during exercise and thus, there was no need for an up-regulation in HSL 
or CD36.  During exercise, increased oxidation may be due to enhanced mitochondrial fatty acid 
uptake through the up-regulation of carnitine transport system, allowing long-chain fatty acids 
LCFA’s into the mitochondria, which in turn, results in more CPT1 activity (16).   
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Clearly, the type of activity, or lack thereof, in addition to genetics can greatly affect 
muscle fiber type, and thus, influence the rate of lipid metabolism.  In a comparison of ob/ob 
mice to lean littermates, the cross-sectional area of the EDL and sternomastoid were significantly 
reduced in the obese group.  The obese mice also had smaller type II (glycolytic) fibers, and 
more “hybrid” fibers, suggesting fiber type shifting in obese mice (196).  Similar fiber type 
shifting occurs following chronic aerobic training and will be discussed later in this chapter. 
Altered Oxidative Gene Expression 
Another change that occurs as a result of acute aerobic training is the up-regulation of 
various genes involved in fat metabolism.  Uncoupling protein 2 and 3 (UCP-2 & UCP-3) gene 
expression has been examined in detail in both human and mouse models.  UCP is responsible 
for transforming substrates to ATP via uncoupling mitochondrial respiration and therefore plays 
an important role in oxidative metabolism (197).  UCP-3 in particular is expressed primarily in 
human skeletal muscle and may act to help regulate thermogenesis as well as utilize lipids as 
fuels by increasing fatty acid oxidation within the muscle (198).  This FFA oxidation is seen with 
endurance exercise as well as fasting.  Because of this, it would make sense that endurance 
exercise may act to increase UCP-3 mRNA.  Noland et. al (197) discovered that an acute bout of 
endurance exercise does, in fact, up-regulate UCP-3 in untrained humans, however, this up-
regulation was not seen in trained individuals.  The exact reasoning for this is unclear.  It may be 
attributable to a lower body fat percentage in trained individuals and therefore less need for the 
expression of UCP gene or it may be due to a higher initial expression of the UCP gene in 
trained individuals and thus, less of a need to up-regulate gene expression. 
Specific factors that regulate UCP gene expression are not well understood, however it is 
evident that UCP-3 mRNA expression is dependent on the metabolic state of the skeletal muscle.   
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Cortright et. al (199) for example, identified that fasting increases UCP-3 mRNA up to eight fold 
and that re-feeding brings UCP-3 back down to basal levels or below.  Part of the reasoning for 
why it has been so difficult to establish specific mechanisms behind changes in gene expression 
within skeletal muscle may be because skeletal muscle grown in culture lacks systemic input, 
lacks a motor nerve, and exclusively relies on glycolytic metabolism, consequently making it 
difficult to compare to fatty acid handling in intact, fully functioning adult myofibers within an 
organism.  
However, several studies have been done in vivo to gain a better understanding of fatty 
acid metabolism.  Hilderbrandt et. al (200) used a technique which involved isolating nuclei from 
skeletal muscle in combination with real-time polymerase chain reaction techniques (RT-PCR) 
to determine muscle fiber-specific and gene-specific changes in transcription rate of several 
genes including UCP-3, LPL, muscle CPT I, long-chain acetyl-CoA dehydrogenase (LCAD), 
and medium-chain acetyl-CoA dehydrogenase (MCAD), all of which are intricately involved in 
fatty acid metabolism.  The authors found that fasting induces increased expression of the UCP-3 
gene as well as several other genes associated with lipid metabolism, specifically in fast-twitch 
muscle fibers, which is intriguing given that fast twitch fibers are primarily glycolytic.  However, 
considering that oxidative fibers likely already express high levels of the UCP-3 gene, these 
results suggest some level of fiber-type fuel shifting, reinforcing the notion that the body relies 
heavily on fatty acid metabolism during starvation.   
Interestingly, the addition of acute aerobic exercise, which increases metabolic demand 
and glucose utilization, actually decreased the transcription of genes associated with lipid 
metabolism, specifically in slow-twitch muscle fibers.  This showed that the physiological 
mechanisms responsible for these changes in gene expression due to fasting may oppose the 
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mechanisms responsible for changes in gene expression due to exercise.  This may help explain 
why UCP-3 gene expression after acute bouts of exercise varies among trained and untrained 
individuals.  Trained individuals may have a more repressed UCP-3 gene due to the chronic 
increased metabolic demand placed on the muscles.  The important point to keep in mind is that 
although individuals that exercise regularly (trained) appear to have specific genes which are 
responsible for lipid metabolism to be repressed more than in those individuals that do not 
exercise regularly (untrained), this does not mean a lack of exercise leads to increased fat 
oxidation.  It may simply indicate that trained individuals tend to carry a lower body fat 
percentage, and hence, are more metabolically efficient and do not need to transcribe those genes 
at such high rates.  In addition, as mentioned in chapter one, increased β oxidation does not 
necessarily indicate improved lipid metabolism.  Without up-regulation of complete lipolysis, the 
TCA cycle and ETS, increased fat oxidation may actually increase the concentration of 
deleterious lipid intermediates associated with insulin resistance. 
Understanding how exercise can regulate the transcription of specific genes is an 
important first step in understanding the mechanisms of how exercise can help prevent metabolic 
diseases such as diabetes.  As previously discussed, skeletal muscle plays a central role in 
metabolic homeostasis; however, other tissues such as liver and adipose tissue are involved as 
well.  Hoene et al. (20) demonstrated that hepatic gene expression PCG-1α and PDK4, both of 
which are involved in lipid utilization hepatic gluconeogenesis, were up-regulated as a result of 
60 minutes of aerobic exercise.  This particular study also demonstrated that acute aerobic 
exercise induces increased IRS-2 protein expression while decreasing serine residue 
phosphorylation on the IRS residues known to interfere with proper insulin signaling (20).  One 
important note is that the expression of these genes was higher in the liver than in slow-twitch or 
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fast-twitch skeletal muscle, indicating that some of the immediate benefits of exercise on insulin 
sensitivity take place in the liver.  However, all tissues for this study were dissected and frozen 
immediately following the completion of the exercise session.  It is possible that transcriptional 
changes in the liver may occur rapidly, whereas translational or protein expression changes in 
skeletal muscle may be more delayed.  In addition, protein expression of PGC-1α and PDK4 
were not examined in this study.  Therefore before any conclusions can be made regarding 
differences in these genes in various tissues, further study examining protein expression at 
various time points following the completion of acute aerobic exercise is deemed necessary. 
Chronic Aerobic 
It has been clearly demonstrated that aerobic exercise training increases the size and 
number of mitochondria in addition to increases in mitochondrial enzymes involved in fatty acid 
oxidation, TCA cycle, ETS, and ATP synthesis, and thus, insulin sensitivity (54).  Even 
independent of weight loss, exercise seems to elicit improvements in insulin sensitivity.  One 
study involving obese girls showed that twelve weeks of aerobic exercise improved insulin 
sensitivity without any changes in body weight, percent body fat, or markers of inflammation 
(23).  This may suggest that changes such as muscle fibers switching to more oxidative type, 
increasing mitochondrial density, GLUT-4 concentration, glycogen synthase activity, and 
decreased IMCL are more responsible for changes in insulin signaling as a result of exercise 
compared to changes in hormone and inflammatory signaling seen in acute aerobic studies. 
In an untrained state, PGC-1α is expressed at a higher level in more oxidative muscles 
and thus, has a greater ability to oxidize free fatty acids (201).  Previous studies have shown that 
following chronic aerobic exercise training, all fiber types increase their capacity to oxidize FFA 
by increasing activation, transport and β oxidation of, among several others, LCFAs and 
155 
 
components of the ETS (202).  However, since fast-twitch muscle intrinsically has a lower initial 
oxidative capacity, these types of fibers may have a greater ability to adapt to the exercise 
stimulus (203), whereas a more oxidative muscle will not have to undergo any major 
biochemical changes and therefore will not adapt to the same extent. 
One study has shown that plasma FFA decreased in trained individuals following cycling 
indicating that trained individuals rely more on intramuscular TAG stores for fat oxidation 
during exercise (16).  It also demonstrated that trained individuals have higher rate of FFA 
uptake and oxidation during exercise compared to untrained, both of which were tested at 75% 
VO2max (high-intensity).  This indicates the important role of training status, as will be discussed 
later in this chapter. 
Regardless of the mechanisms involved, clearly chronic aerobic exercise improves 
insulin resistance, although different exercise and measurement variables create different effects 
on lipid metabolism.  Some of those variables will be addressed here. 
Muscle Tissue Variation 
Another variable that must be taken into consideration when examining changes within 
skeletal muscle following chronic exercise is muscle fiber type.  The vast majority of studies 
involving human models have taken muscle samples from the vastus lateralis, mainly because 
this muscle is easily accessible.  The vastus lateralis is more involved with short, quick 
contractions and less involved with long, slow contractions.  Therefore it generally has a higher 
percentage of fast-twitch fibers and a lower percentage of slow-twitch fibers whereas the soleus 
for example, is involved with standing and posture and therefore has a higher percentage of 
slow-twitch fibers.  If a researcher were to obtain muscle samples from the vastus lateralis and 
the soleus of a trained athlete, the percentage of fast-twitch fibers in the soleus would likely not 
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be the same as an untrained individual, making it difficult to infer that one individual may be 
more effective at metabolizing lipids than another.  The “in between” muscle fiber types must be 
considered as well.  Most, if not all muscles, are not purely fast-twitch or slow twitch, rather they 
are on a continuum somewhere in between and the percentage of a specific fiber type can vary 
within the same muscle.  The percentage of fast-twitch fibers at the origin may be different than 
at the insertion, so unless multiple samples are taken from the same muscle, it will be 
challenging to assess how lipids are truly metabolized within a muscle, and even then, there are 
other factors to consider.   
Training Status 
 Endurance trained individuals rely more on intramuscular IMCL stores for fat oxidation 
during exercise whereas untrained individuals will rely more heavily on muscle glycogen and 
circulating FFA.  As previously mentioned, plasma FFA concentration decreases in trained 
individuals following cycling (16).   In addition to utilizing a higher percentage of IMCL, this 
also shows that trained individuals have higher rate of FFA uptake and oxidation during exercise 
compared to untrained, even at 75% VO2Max (high-intensity).  Also, the rate of appearance of 
glycerol higher in trained men vs. untrained indicating that esterified fatty acids are being 
hydrolyzed in the muscle.  Though endurance trained individuals will store higher levels of 
IMCL, skeletal muscle does not contain glycerol kinase, which is required to re-phosphorylate 
glycerol into glycerol-3 phosphate (G3P), thus once stored TAGs have been hydrolyzed, glycerol 
must be released from the muscle.  Thus, although the FFA’s released via lipolysis was equal in 
both groups, the trained individuals were clearly utilizing a greater percentage of lipid stores 
(16).  Fat oxidation was also twice as high in trained, likely due to the fact that that training 
increases fat oxidation during exercise by enhancing mitochondrial density and thus, fatty acid 
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uptake through higher expression and activity of CPT1.  Though not specifically measured in 
this study, it may be concluded that aerobic exercise training up-regulates not only the number of 
mitochondria which can be utilized for β oxidation, but the carnitine transport system for LC-
FAs into the mitochondria may be up-regulated as well though further research is needed to 
confirm these findings. 
Implications for Diabetes 
Adiponectin, as mentioned in chapter one, is a cytokine secreted by adipose tissue, plays 
an important role in insulin sensitivity as well as glucose and lipid metabolism (2).  When a wide 
range of normal weight, overweight, and obese individuals with normal glucose tolerance, 
impaired glucose tolerance, and type II diabetes were placed on a four-week physical training 
regimen, Bluher et al. (2) found that exercise increased the expression of adiponectin and its 
receptors (AdipoR1 & AdipoR2).  AdipoR1 receptors are expressed in skeletal muscle cells and 
AdipoR2 receptors are expressed in skeletal muscle and liver cells.  This increased expression 
may act to mediate improvements in insulin sensitivity, glucose metabolism, and lipid 
metabolism seen as a result of exercise.  They also noted that the more insulin resistance that a 
given participant had, the lower the expression of the AdipoR2, regardless of body fat 
percentage, indicating that even if an individual is not obese, poor insulin sensitivity can drive 
down the expression of important proteins needed for glucose and lipid metabolism. 
Non-insulin dependent diabetes also induces several impairments, specifically in 
mitochondrial function.  This includes decreased lipid metabolism, decreased UCP-3, low and 
mitochondrial density, which in turn, limits oxidative capacity (204).  As discussed above, 
exercise counteracts several of these imbalances although the physiological mechanisms remain 
unclear.  It has been determined by Lumini et al. (199) that exercise, in addition to restoring 
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UCP-3 gene expression, may increase mitochondrial biogenesis by increasing the expression of 
PGC-1α and heat shock proteins (HSPs) ultimately resulting in helping to prevent the 
development of diabetes.  Similar results were seen by Toledo, Watkins, and Kelly (205).  They 
demonstrated that when sedentary obese humans without diabetes were placed on a calorie 
restricted diet in combination with an exercise regimen, there was a significant increase in both 
the size and total number of mitochondria in the skeletal muscle.  This increased oxidative 
capacity, increased lipid metabolism, and improved insulin sensitivity.  This demonstrated that 
improvement in mitochondrial size and density as a result of exercise leads to not only improved 
muscle metabolism, but improved insulin sensitivity as well, although changes in insulin 
sensitivity were likely partially due to caloric restriction.  Again, this may be a result of more 
complete β oxidation as well as more complete breakdown of esterified fat stores. 
Evidence in the literature clearly indicates the high correlation between obesity (lipid 
accumulation) and type 2 diabetes (insulin resistance).  Kelly, Goodpaster, Wing, and Simoneau 
(55) made this correlation even more evident by showing that obese individuals express 
diminished CPT activity as discussed earlier and they have a reduced oxidative enzyme capacity.  
Improvements in insulin sensitivity and fat oxidation in these obese participants improved as a 
result of a four month weight loss intervention using caloric restriction.  Once again, insulin 
sensitivity and metabolic flexibility improved following feeding, but no changes were observed 
in a fasted state.  It seems plausible that an exercise intervention, which clearly improves insulin 
sensitivity, may act to limit lipid utilization following feeding while caloric restriction may act to 




More recently, Haskell-Luevano et al. (206) looked at a melanocortin-4 receptor (MCR4) 
knockout (KO) mouse model to see if exercise alone affected specific genes associated with 
obesity, insulin resistance, and other metabolic syndromes.  Altered MCR4 gene phenotypes 
have been identified in obese human and mouse models and therefore mice without this gene 
will express obesity, insulin resistance, and hyperleptinemia.  Indeed, the study showed that eight 
weeks of exercise improves insulin sensitivity and effects the expression of proopiomelanocortin 
(POMC), orexin, melanocortin-3 receptor (MCR3), and neuropeptide Y (NPY), all of which are 
important in maintaining energy homeostasis.  Exercise intervention creates this homeostasis and 
can, in turn, prevent obesity and diabetes, even in genetically predisposed MCR4 KO mice.  It 
can also help prevent hyperleptinemia, which is simply high levels of circulating leptin, a 
hormone derived from adipocytes that is necessary for controlling body weight.  Björnholm et al. 
(207) demonstrated that mutations in leptin gene phenotype or leptin receptor expression results 
in the inability of leptin to bind to its receptor site in the hypothalamus.  When leptin is unable to 
bind, this creates higher levels of circulating leptin and increases excess lipid storage.  
Interestingly, following chronic aerobic exercise intervention these perturbations are reversed 
only in the presence of weight loss (208).  This demonstrates that levels of adiposity may be 
directly responsible for changes in circulating leptin levels and that improvements seen following 
exercise intervention independent of weight loss occur from mechanisms other than changes in 
leptin levels.  Indeed this has been seen in previous studies (23).  
Clearly, aerobic exercise, whether acute or chronic, improves insulin sensitivity and some 
of the cellular mechanisms are beginning to emerge.  However, it is currently unknown if 
resistance training has similar effects on lipid metabolism to those seen with aerobic training.  
Since resistance training is an attractive alternative form of exercise for individuals that are 
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unable or unwilling to perform aerobic exercise, understanding the effects of resistance training 
on insulin sensitivity compared to those seen with aerobic training is critical. 
Resistance Training 
Much like aerobic exercise training, there are multiple variables that can affect lipid 
metabolism responses following resistance exercise training (training status, gender, tissue type, 
etc).  However, there are far fewer studies that have examined this particular research area.  This 
is probably attributed to the fact that this type of exercise is not continuous and that the 
variability between different types of exercises, number of exercises, muscle groups worked, 
type of resistance used, sets, reps, rest between sets, relative intensity, and number of days per 
week make this type of exercise much more difficult to control and measure compared to aerobic 
type exercise.  In addition, until fairly recently, resistance type exercise was not given much 
consideration as to its effectiveness in improving insulin sensitivity, especially with regards to 
lipid metabolism.   Given that much of the United States population is now overweight or obese, 
it is evident that most of these types of patients, especially those with type 2 diabetes, do not 
engage in regular physical activity.  While aerobic exercise clearly has its benefits, if patients do 
not regularly adhere to this type of exercise throughout their lives, health status is not likely to 
improve.  With a limited aerobic capacity in these patients, especially at first, engaging in 
resistance training offers and attractive alternative to possibly help combat obesity and the 
development of diabetes; however it should appear evident by the end of this chapter that much 





As previously mentioned, skeletal muscle accounts for the majority of glucose uptake, 
therefore, by increasing the size of the muscle via resistance training, one should be able to 
increase the capacity of whole-body glucose disposal and in turn, limit hyperglycemia.  Muscle 
contraction alone, whether through resistance or aerobic exercise requires the utilization of ATP 
(energy expenditure) and induces calcium release.  This alone may have some protective effects 
against insulin resistance.  This has been demonstrated in numerous studies.  Transgenic 
mice expressing activated calcineurin in skeletal muscle had improved insulin uptake in the 
glycolytic extensor digtorum longus (EDL) muscle when fed a high fat diet.  This was associated 
with an up-regulated expression of insulin receptor, Akt, GLUT-4, and PGC-1α expression (44).   
In normally functioning muscle cells, calcineurin is activated by increased levels of cytoplasmic 
calcium, thus this study implies that muscle contraction alone does indeed improve insulin 
sensitivity and glucose uptake via an insulin-independent mechanism.   
Numerous studies have also suggested that AMP, which is a product resulting from ATP 
hydrolysis, activates AMP activated protein kinase (AMPK), and in turn phosphorylates and 
inhibits acetyl-CoA carboxylase (ACC), which stops the production of malonyl-CoA and 
relieves the inhibition of CPT1 to transport long-chain fatty acids into the mitochondria (40).  
AMPK also increases skeletal muscle glucose uptake, increases citrate levels, and increases 
levels of NAD
+
 and Sirt-1, both of which increase PGC-1α expression.  The extent of AMPK 
activation appeared to be directly related to exercise intensity, and thus ACC inactivation appears 
to be dependent on exercise intensity (40, 41). 
However, other studies suggest insulin sensitivity appears to be independent of exercise 
intensity with acute resistance training.  One study examined glucose uptake and insulin 
sensitivity in resistance trained individuals following a control (no exercise), low-intensity, or 
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high-intensity workload and found no differences at the two intensities (209).  All participants 
for this study were trained individuals, which may have confounded the results.  It seems likely 
that if untrained or insulin resistant individuals were to complete this protocol, differences may 
be observed. 
Acute resistance training also improves post-exercise lipid oxidation for up to 24 hours, 
although the mechanism is unknown.  Some authors have attributed this improvement to 
decreased IMCL stores (26), however, this alone is not likely responsible for these changes as 
the literature points more toward the notion that changes in IMCL content and lipid turnover may 
be altered. 
In resistance trained men, caffeine supplementation increased 1RM but had no effect on 
leg extension or muscle endurance.  This may indicate again that lactate supersedes the effects of 
caffeine.  It could also suggest that caffeine elicits different effects in different muscle groups 
(104).  However, this study had no crossover and participants only consumed 200 mg of caffeine, 
and habitual vs. non-habitual consumption was not taken into consideration.  It is likely that if 
more caffeine were ingested, there may have been more beneficial effects given that caffeine 
dosages between 3-6 mg/kg of body weight have been identified as being optimal dosages for 
improving performance (93). 
Chronic Resistance Training 
As seen with aerobic exercise, there are significant differences between the beneficial 
effects of acute resistance training compared to chronic resistance training, however, there are 
some similarities as well.  A six-week study comparing untrained healthy men and type 2 
diabetic men showed that 30 minutes of resistance training three days per week increased 
strength and muscle mass, as expected (12).  Since skeletal muscle is responsible for the majority 
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of glucose disposal, a larger muscle mass allows for greater glucose uptake, and thus better 
glycemic control.  Although six weeks of resistance training will improve strength significantly 
in untrained individuals, is not an adequate enough time period to see any significant changes in 
muscle mass.  Rather, the results of this study indicated that GLUT-4 protein, insulin receptor 
protein, and glycogen synthase protein and activity increased as a result of training.  This 
suggests that although there may have been slight changes in muscle mass, changes in protein 
expression were primarily responsible for the improved glucose uptake and insulin sensitivity.  
This change in protein expression appears to be due to increased muscle contraction, as was seen 
in acute resistance training.  This makes sense given that resistance training is predominantly and 
anaerobic activity and therefore the working muscles must predominantly rely on glucose 
metabolism.  Thus, the question becomes whether the effects seen in this study were truly due to 
chronic adaptations or residual effects of an acute bout of exercise. 
It is important to keep in mind that the time course in which measurements are taken can 
factor into the outcomes.  Measurements for the previously mentioned study were carried out 16 
hours after the final exercise session.  In another study, diabetic men were placed on a resistance 
training plus weight loss protocol or just a weight loss protocol for three days per week for six 
months.  Measurements were taken 48 hours after the last exercise training session and it was 
found that, similar to the study by Holten et al. (12) that resistance training increased strength 
and muscle mass and had greater improvements in glycated hemoglobin (HbA1c) levels (13).  
However, plasma insulin and glucose as well as blood lipid concentrations did not improve.  
Thus, this study indicates that whole-body glycemic control improves as a result of chronic 
resistance training whereas changes in plasma insulin glucose concentrations may only improve 
transiently as a result of acute resistance training. 
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A more recent study supports these findings but suggests that insulin sensitivity does 
improve as a result of chronic resistance training.  In measurements taken 72 hours after the 
completion of a 16 week resistance training intervention in older type 2 diabetic Hispanic men 
and women, whole-body insulin sensitivity and HbA1c levels improved (62).  This correlated 
with decreased inflammatory markers and increased adiponectin levels.  Similar to Dunstan et al. 
(13), plasma glucose and insulin did not change significantly, however, HOMA, determined as 
[fasting glucose*fasting insulin/22.5] was significantly improved following training.  This may 
be due to improvements in glucose translocation, possibly via insulin-independent mechanisms 
such as increased calcineurin activation as suggested by Ryder et al. (44). 
While these, along with several other studies have shown clear improvements in insulin 
sensitivity and glycemic control with resistance training, few have truly examined changes in 
lipid handling.  Some studies have examined parameters such as plasma TAG, HDL, LDL, 
VLDL, and total cholesterol and seen improvements (27) whereas others have not seen 
improvements in these parameters (25).  The different results yielded in these studies and others 
can likely be attributed to the heterogeneity of exercise modality, duration, and intensity.   
Given the mostly anaerobic metabolic demands placed on skeletal muscle during 
resistance training, chronic exposure will cause muscle fibers to shift to more fast-twitch, 
glycolytic (type II fibers).  As mentioned previously, this will affect the ability of the muscle cell 
to oxidize fatty acids since this type of fiber contains fewer mitochondria compared to oxidative 
fibers.  Initially, this may seem detrimental to lipid metabolism, but it is important to keep in 
mind that other factors such as complete synthesis and hydrolysis may have a larger impact on 
insulin sensitivity, and other factors, such as fatty acid and glucose translocation also play a role, 
which is why despite the fiber type shifting, resistance training can still improve insulin 
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sensitivity.  Also, other changes, such as increases in resting metabolic rate (RMR), following 
resistance training results in greater daily energy expenditure, and thus there is less likelihood 
that energy consumption will exceed energy expenditure, leading to less lipid storage, less lipid 
intermediates, and improved insulin sensitivity.   
Combined, these results suggest that exercise improves insulin sensitivity primarily by 
increasing metabolic demand on skeletal muscle.  This increases lipid turnover, improves 
oxidative capacity, up-regulates GLUT-4 translocation, and increases glycogen storage capacity.  
In turn, skeletal muscle can store more glycogen and utilize more fat.  This in turn is likely to 
lower fasting RQ and improve metabolic flexibility, however further research is needed to 
confirm this theory. 
Further study following both acute and chronic resistance training is clearly necessary to 
examine parameters such as TAG, DAG, MAG, glycerol and their associated lipolytic and 
lipogenic enzymes to gain a better understanding of changes in lipid handling following this type 
of training.  In addition, examining changes in the RQ in both the fasted and fed state of insulin 
resistant individuals following resistance training may provide a more mechanistic insight as to 










CHAPTER 5: Conclusions and Future Directions 
Though there are several aspects involved in the development of insulin resistance, 
including but not limited to lipid intermediate accumulation, inflammation, change in adipocyte-
derived hormone expression, changes in oxidative gene expression, impaired glucose stimulated 
insulin secretion, impaired glucose uptake, impaired glucose and fatty acid transport and 
translocation, incomplete lipolysis, decreased or incomplete β oxidation, incomplete TAG 
synthesis, the literature irrefutably shows that all of these aspects are interconnected and result 
from an energy imbalance (8, 126, 155).  Linking of all these aspects of insulin resistance has not 
fully been established, due in large part to the fact that insulin resistance can develop from 
numerous pathways.  Furthermore, the improvement of insulin resistance through means of 
calorie restriction, exercise, or otherwise can result in various metabolic changes depending on 
the means utilized.  Finally variation among populations (training status, age, gender, ethnicity, 
diet, level of insulin sensitivity) along with measurements taken (enzymatic assays, mRNA, 
protein expression, chromatography, glucose clamp, HOMA, biopsy, tracer) and the time course 
for these measurements can all yield different outcomes.  Thus, broad, general statements 
regarding the development of insulin resistance as it relates to lipid metabolism cannot be made.  
However, evidence in the literature has allowed for some more specific conclusions to be made. 
Physical activity, or lack thereof, calorie restriction, calorie overconsumption, weight loss 
and weight gain all lead to changes in gene expression, which in turn, affects the capacity to 
hydrolyze, mobilize, oxidize, and synthesize lipids.  Research has indicated that lipid 
accumulation in general (i.e. obesity) is highly correlated with the development of insulin 
resistance, but since high levels of lipids do not directly cause insulin resistance, these changes in 
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gene expression may help partially explain how elevated lipid levels can lead to the development 
of insulin resistance. 
Altered gene expression and enzymatic activity is tissue-specific.  Changes in the liver do 
not necessarily represent changes in the muscle and vice versa.  It seems likely that individual 
organs and tissues are specifically regulated, but inter-organ communication creates a global 
effect on lipid metabolism and insulin sensitivity, thus when examining possible mechanisms 
linking lipid metabolism and insulin resistance, the state of each of these tissues and organs must 
be considered.  Also, the effects of exercise on lipid degradation and lipid synthesis is different 
in healthy versus insulin resistant individuals and therefore, it is important to keep in mind that 
simply because studies demonstrate improvements in lipid metabolism in healthy skeletal muscle 
does not necessarily mean the same results will be seen in insulin resistant skeletal muscle. 
Given the “athlete’s paradox” and the multiple studies directly linking excess IMCL 
stores to insulin resistance, the composition TAGs themselves need to be considered.  Fatty acid 
chains can vary in length and level of saturation.  A TAG consists of a glycerol molecule and 
three fatty acids, all of which can contain short, medium, or long chains, and can be saturated or 
unsaturated.  TAGs consisting of more saturated fatty acids may be more difficult to metabolize 
and may lead to incomplete degradation.  This could partially explain why obese individuals 
with high IMCL are more insulin resistant compared to their endurance-trained counterparts. 
Future Directions 
An important note for future studies is that the heterogeneity of exercise and 
measurement variables have not allowed for any consistent results to be established.  While it is 
not possible to standardize one procedure given that each of these variables have their pros and 
cons depending on resources, subject availability, and outcome measurements, following 
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previously established effective exercise programs and measurement techniques will make 
studies more comparable in the future. 
Currently, few studies have examined aerobic exercise-induced changes in lipid synthesis 
and degradation and its effects on insulin sensitivity and even fewer studies have examined 
changes in lipid metabolism following resistance training.  Given the numerous metabolic 
changes that occur as a result of resistance training, it is likely that resistance training will elicit 
changes in lipid metabolism, leading to improved insulin sensitivity.  Other types of training, 
such as yoga, pilaties, or intensive stretching, which also alter skeletal muscle metabolism 
through contraction-mediated responses, may also lead to improvements in lipid metabolism; 
however, this has not been examined.  If found to improve lipid handling, resistance and 
alternative types of training could prove to be an attractive alternative to endurance type training 
in insulin resistant or obese individuals who may not otherwise engage in regular physical 
activity. 
Exercise does improve insulin sensitivity, regardless of training status, modality, 
duration, or intensity.  In terms of “the big picture”, for the general population this is the most 
important outcome.  This general idea has been known for years, the question has now become 
“what are the primary mechanisms responsible for this improvement and is there a more ideal 
exercise in terms of modality, time, intensity, and frequency?”  In order to gain a better 
understanding of the mechanisms behind this improvement, it will be necessary to develop more 
specific pathways linking exercise to improved insulin sensitivity, particularly with regards to 
lipid metabolism.  This may be done by examining each step involved in lipid degradation and 
synthesis in various populations and how these steps are affected by different types of exercise 
training.  The activity of LPL, ATGL, HSL, MAG lipase, G3P, and various enzymes β oxidative, 
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TCA, and ETS enzymes, in healthy and insulin resistant individuals may allow researchers to 
more accurately pinpoint where decrements in lipid metabolism occur both at rest and following 
exercise. 


























APPENDIX 2. PARTICIPANT QUESTIONNAIRES 
 








Resting Blood Glucose____________________ 
Has Father_______ Mother______ been diagnosed with type 2 diabetes?  Mark all that apply 
How many times/week do you drink coffee/tea_____ _ Energy drinks/shots______
 Soda_______ 
How many times/week do you typically perform the following exercises? 
Running__________ Walking_________ Cycling_________ Swimming__________ 
Weight Lifting________  Other (specify) __________ 
 
% BF from 7-site skinfold 
Chest_____ Ab______ Thigh_______ Tricep_______ Suprailliac_______ 
Subscapular_______ Midaxilary________ 
 
1 mile run time____________ 
 





3 Day Dietary Recall (Please be as specific as possible.  What did you eat?  How much?  Where 
was it from?  What time?  Also include all drinks except water.) 



























List your prescribed drugs and over-the-counter drugs, such as vitamins and inhalers 
Name the Drug Strength Frequency Taken 
   
   
   
Allergies to medications/foods 




HEALTH HABITS AND PERSONAL SAFETY 
ALL QUESTIONS CONTAINED IN THIS QUESTIONNAIRE WILL BE KEPT STRICTLY CONFIDENTIAL. 
Exercise  Sedentary (No exercise) 
 Mild exercise (i.e., climb stairs, walk 3 blocks, golf) 
 Occasional vigorous exercise (i.e., work or recreation, less than 4x/week for 30 min.) 
 Regular vigorous exercise (i.e., work or recreation 4x/week for 30 minutes) 
Diet Are you dieting?  Yes  No 
If yes, are you on a physician prescribed medical diet?  Yes  No 
# of meals you eat in an average day? 
Rank salt intake  Hi  Med  Low 
Rank fat intake  Hi  Med  Low 
Caffeine  None  Coffee  Tea  Cola                          [] Energy Shots/Drinks 
# of cups/cans per day? 
Alcohol Do you drink alcohol?  Yes  No 
If yes, what kind? 
How many drinks per week? 
Tobacco Do you use tobacco?  Yes  No 
  Cigarettes – pks./day   Chew - #/day   Pipe - #/day   Cigars - #/day 
  # of years   Or year quit 
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